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A b s t r a c t
The retina is a highly complex tissue. It is involved in the cogniative perception of the visual 
range of the electromagnetic spectrum of an organism’s environment. Recently, it has been 
shown, in mammalian and non-mammalian species, to possess an intrinsic timing mechanism 
that organises the temporal expression of local physiological processes (Herzog and Block, 
1999; Wilsbacher et al., 2002).
Molecular biochemistry of melatonin synthesis, in the mammalian retina (Baler et al., 1999; 
Tosini and Menaker, 1996a; Tosini and Menaker, 1996b) has been well defined but is subject 
to inter-species variation (Greve et ai., 1999). Melatonin has been shown to directly attenuate 
and potentiate a number of retina specific pathologies(Kvetnoy, 2002; Sugawara et al., 1998). 
In the light of these data there is an increasing need for an accessible model of the human 
retina to advance the understanding of how the retinal clock and melatonin synthesis integrate 
to influence retina physiology/pathology.
The study of the human retina is limited to the use of post-mortem specimens; the use of which 
has inherent draw backs. The Y79 retinoblastoma ceil is the only available retinal cell line that 
has been shown to exhibit retina-like responses (cf refs Table 3) and possess a reliable marker 
(melatonin) of the retinal clock (Ding 1992, Pierce 1991). Here we propose to assess the 
expression of clock components or circadian production of melatonin in this cell line.
The aims of this thesis were to investigate: (a) the temporal profile of melatonin synthesis and 
clock gene expression, (b) the effect(s) of alternating nutrient composition (e.g serum factors) 
on melatonin output, (c) the glutamatergic control of melatonin production in this cell line.
Y79 cells were maintained on an entraining 12:12 LD cycle from seeding of experimental 
cultures. Measurement of melatonin synthesis (RIA) and clock gene expression (RT-PCR 
analysis) was assessed under DD at 4 h intervals, in two separate studies, over at least 4 days. 
Melatonin production and the expression of clock genes was detected throughout, however
they were not found to oscillate. Melatonin synthesis was not cumulative indicating presence of 
an endogenous feedback mechanism and/or an active metabolising process. The nutrient 
composition of the experimental media had a significant differential effect on total melatonin 
output. Melatonin production of cells in media containing glutamate or without FCS was 10 fold 
less compared to cells in basic media.
The presence of all known clock genes suggested that this cell line is capable of generating 
circadian rhythms. The glutamate content of media used in previous studies is known to 
activate iGluR and mGluR responses in vivo targeting peri expression catabolic turnover of 
BMAL1 (Tamurau 2000; Oishi 1998, Akiyama 1999). A dose-response effect was observed 
between mGluR3 agonist (DCG-IV) and melatonin output when cells were seeded/maintained 
on glutamate free media, under conditions described above. RT-PCR profiling of mGluRs in 
this ceil line was shown to strongly express mGluR 3,5 and 7. Future studies should include: 
(a), antagonist study to determine if the dose response effect is reversable and real, (b). effects 
of glutamate analogues on clock genes (and proteins) and cAMP levels in Y79 cells, (c) repeat 
temporal analysis of clock gene expression and melatonin output in glutamate-free media. The 
data from these studies would provide a mechanistic link between stimulation of mGluR and 
the suppression of oscillatory melatonin synthesis and clock gene expression.
These data suggest that the clock mechanism (tack of rhythmicity in melatonin synthesis) in 
this cell line is suppressed via the tonic effect of glutamate on BMAL1 via mGluR signaling 
pathway. These studies further confirm the potential utility of this cell line in human circadian 
biology.
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1 In troduction
The basic function of the eye is to transduce photic stimuli into nerve impulses that can be 
interpreted by the brain to perceive the various image and non-image aspects of the animal’s 
environment
The eye consists of:
> Aperture (the pupil) through which light enters the eye. The amount of light entering 
the eye is limited by a photo-responsive sphincter (the iris).
> Light absorbing chamber (the retina) lined with specialised neuronal cells that 
capture/process light energy into nerve impulses (photoreceptors). Photoreceptors in 
turn pass on these nerve impulses to second order neurones (namely the bipolar, 
amacrine and horizontal cells), in the form of a tiered stream[s] of neurotransmitter 
circuits. The second order neurones channel various components of the photoreceptor 
signals to stimuli selective ganglion cells. Ganglion cell convey this information to the 
optic centres of the brain via the optic nerve.
> Photo-refractive elements (cornea, lens and ciliary body) that focus and enhance the 
properties of light onto the retina.
1.1 t h e  m am m alian retina.
The mammalian retina contains 55 functionally distinct types of neurones that are arranged into 
10 discrete layers (Jeon et al., 1998; Tsukamoto et al., 2001)(Figure 1). Morphological, 
biochemical and functional characteristics of each of these cell types reveal the identity of 5 
retinal cell types; namely photoreceptors, bipolar, amacrine, horizontal and ganglion cells (Jeon 
et al., 1998) (Figure 1).
Exposure of the retina to particular a light source (e.g. movement, form or colour) established 
transient stimuli selective neural microcircuits across the retina. The variant subtypes of the 
cell in the retina have specific stimuli thresholds; above or below which triggers a specific
i
pattern of coupling between same or different nuclear layers (or cell types) (Hack and Peichl, 
1999; Masland, 2001a; Masland, 2001b; Tsukamoto et al., 2001)
Light is absorbed by photoreceptors in the outer segment of the retina where it is transduced 
into nerve impulses by a biochemical process known as the phototransduction cascade. These 
nerve impulses are relayed to the second order neurones in the inner nuclear layer (INL) 
(namely the horizontal, amacrine and bipolar cells), by the neurotransmitter glutamate. Signals 
from the second order neurones are transmitted (and channeled) to stimulus-selective ganglion 
cells. Ganglion cells in turn transmit this signal to the CNS via the optic nerve (Hack and 
Peichl, 1999; Masland, 2001a; Masland, 2001b; Tsukamoto et al., 2001).
The mammalian retina possesses visual systems that are efficient under low illumination (or 
scotopic) or high illumination (or photopic) environmental conditions (Boycott and Wassle, 
1999; Calkins et al., 1998; Daw, 1973). The scotopic visual system is served by rod 
photoreceptor celis that are important in sensing movement and appearance/disappearance of 
light. The photopic system has three different cone photoreceptor cell types that discriminate 
colour and fine image detail (Boycott and Wassle, 1999; Calkins et al., 1998; Jeon et al., 1998; 
Masland, 2001a; Masland, 2001b; Tsukamoto et al., 2001). The following section highlights 
various properties of each cell involved in the processing of light, it should be noted that the 
retina is not a uniform structure with regions of the retina containing a higher or lesser density 
of each cell types (Masland, 2001a; Masland, 2001b).
1.1.1 The photoreceptor celt.
Photoreceptors cells (cones and rods) are elongated, polarised, morphologically and 
functionally divided into two compartments. The outer segment contains stacks of 
membranous discs rich in light absorbing pigments. Visual pigments consist of a glycoprotein 
(opsin) that anchors the pigment and its chromophore (11 cis-retina!) to the membrane. Cone 
photoreceptors, in humans, either contain pigments that are sensitive to short (Xmax 419nm; 
designated the blue or S cone), medium (A.max 531 nm; designated the green or M cone) or 
long (A,max 558nm; designated the red or L cone) wavelengths of light energy (cite). The rod 
photo-system only contains one type of photoreceptor possessing a photopigment, which is 
sensitive to Xmax 505nm (Calkins and Sterling, 1999; Calkins et al., 1998).
The inner segment contains the majority of the photoreceptor’s organelles organised into two 
functional unit-the myoid and ellipsoid regions. The myoid region is responsible for the 
production of photoreceptor cell proteins. It is located near the cell nucleus of the 
photoreceptor cell and is densely packed 'with endoplasmic reticulum and Golgi apparatus. 
The ellipsoid region is devoted to respiration and energy production and is densely packed with 
mitochondria.
Figure 1. Illustrates the structural organisation of the 5 neuronal cell types of the mammalian retina. Arrow indicates the path 
of light through the retina. Key AM: amacrine cells, B: bipolar cells, C: cone photoreceptors, G: ganglion cells, GCL: ganglion 
cell layer, H: horizontal cell, ILM: inner limiting membrane, INL: inner nuclear layer, IPL: inner plexiform layer, IS inner segment 
of photoreceptor cells, M: muller cell, OLM: outer limiting membrane, ONL: outer nuclear layer, OPL: outer plexiform layer, OS: 
outer segment of photoreceptor cells, R: nod photoreceptor, RPE retinal pigmented epithelium.
Rod photoreceptors synapse onto single rod-specific bipolar cells in the GPL. This signal is 
conveyed to rod-specific amacrine cells (namely All cells) that transmit it to the ganglion cell on 
the axon terminal of a cone-bipolar excited ganglion cell (Boycott and Wassle, 1999; Strettoi et 
al., 1990; Strettoi and Masland, 1995; Tsukamoto et al., 2001).
The signal transduction pathway from the cone photoreceptor to the optic nerve is more 
complex (reflecting the more discriminatory nature of its task) than that described for the rod 
system. A cone cell connects (chemical synapses or gap junctions) to several subclasses of 
bipolar cell.
1.1.2 Bipolar cell
Bipolar cells are responsible for defining and establishing the specific microcircuit pathways 
that discriminate the various properties of cone output to the CNS (Brandstatter et al., 1995; 
Masland, 2001a; Masland, 2001b). Bipolar cells establish different microcircuits in response to 
high frequency (transient) or low frequency (sustained) stimuli (Masland, 2001a; Masland, 
2001b; Tsukamoto et ai., 2001). Their capacity to establish stimuli selective microcircuits is 
made possible by the variant physiology of each bipolar subtype (Masland, 2001a; Masiand, 
2001b; Tsukamoto et al., 2001):
> Different rates of activity (recovery from desensitisation, temporal adaption).
> Distinct neurotransmitter profile.
> Variant glutamate receptor profiles (neurotransmitter affinities).
> Different excitation/inhibition feedback response threshold with other retinal neurones.
> Different post-synaptic responses.
> Different modes of intracellular signaling.
> Divergent INL cell body and dendritic distribution.
> Connectivity’s with different amacrine, horizontal and ganglion ceil subtypes.
Bipolar cells connect with amacrine and horizontal cells in the inner nuclear layer.
1.1.3 Amacrine ceils
The mammalian retina contains 29 subtypes of amacrine ceils (Calkins et al., 1994; Calkins 
and Sterling, 1999; Calkins et al., 1998; Masland, 2001a; Masland, 2001b). Each subtype has
d
distinct pre- (& post-) synaptic partners, neurotransmitter profile, morphology and 
neurotransmission characteristics (Bonfanti et al., 1996; Cenni et al., 1996; Masland, 2001b; 
Strettoi and Masland, 1995, Masland, 2001 #1039). Amacrine cells aggregate signals 
originating from bipolar cells that have been stimulated by at least two cone photoreceptors 
(Bonfanti et al., 1996). In doing this they shape the firing pattern (type of stimuli information) 
and receptive field of ganglion cells (Bonfanti et al., 1996; Cenni et al., 1996; Masland, 2001b; 
Strettoi and Masland, 1995, Masland, 2001 #1039). Amacrine cells are also responsible for 
spatial timing of signal transmission to ganglion cells (Bonfanti et al., 1996; Masland, 1996a; 
Masland, 1996b; Strettoi and Masland, 1995)
I.1.4 Horizontal cell
Horizontal cells enhance contrast between adjacent photoreceptor outputs, adjusting 
microcircuit response to the overall illumination (Hack and Peichl, 1999; Hack et al., 1999; 
Strettoi and Masland, 1995). They do this by defining the receptive field of second order 
neurones with respect to photoreceptor output (Hack and Peichl, 1999; Hack et al., 1999). 
Horizontal cells establish excitation core of stimuli receptive second order neurones regulating 
responsiveness of neighbouring cells to local image stimuli (Hack and Peichl, 1999; Hack et al., 
1999). They do this by transmitting signals to the retina, which exceed or fall below mean 
illuminace over a broad region of the retina (Hack and Peichl, 1999; Hack et al., 1999).
II.5  Ganglion cell
Ganglion cells (RGCs) shape and recombine various bipolar signals before transmitting them to 
the optic centres of the brain (Sterling et al., 1988; Strettoi et al., 1990; Tsukamoto et al., 2001). 
In the primate retina 15 distinct RGC have been identified from their dendritic architecture, the 
area of visual field they cover and their electroretinogram (ERG) profiles (Sterling et al., 1988; 
Strettoi et al., 1990; Tsukamoto et al., 2001). RGCs have been shown to be dedicated to either 
blue-yellow, red-green spectral contrast. (Tsukamoto et al., 2001).
1.2 Phototransduciion
Phototransduction (Figure 2) begins with a photon of light being absorbed and 
photoisomerising (activating) the photopigment rhodopsin, in the rod photoreceptor cell (Baehr
et ai., 1982; Hurwitz et al., 1990; Lamb et al., 1979; Yau et ai., 1979). Activated rhodopsin (R*) 
repeatedly induces molecules of the heterotrimeric guanyl nucleotide binding protein (G) to 
exchange GTP for GDP bound to the a-subunit of transducin; giving rise to the activated G 
protein (G* a). Two molecules of G* a  binds to cGMP phosphodiesterase (PDE) releasing 
and activating the catalytic PDEo/p subunits. PDEo/p hydrolyses cGMP to 5’GMP (Yamazaki et 
al., 1983). The reduction in cytoplasmic concentrations of cGMP results in the closure of the 
cyclic nucleotide sensitive cation channels (CNG); located in the outer segment of the 
photoreceptor, and blocks the inward flux of cations rendering the photoreceptor cells to its 
hyperpolarised state. The Na+/Ca2+ exchanger, however, continues to pump out Ca2+ ions until 
the cytoplasmic concentration of Ca2+ ions reaches a critical threshold (Cook and Kaupp, 1988; 
Dizhoor et ai., 1994; Fowles et al., 1989; Hanke et al., 1988; Lamb and Pugh, 1992a; Lamb 
and Pugh, 1992b; Torre et al., 1992; Wagner et al., 1989). At or below such a concentration at 
least four Ca2+ feedback mechanisms are known to restore the ‘photo-responsiveness’ of the 
photoreceptor or adapt the photoreceptor to continuous illumination (Fowles et ai., 1989; Lamb 
and Pugh, 1992a; Lamb and Pugh, 1992b; Torre et al., 1992). The resolution of these 
mechanisms rapidly restores intracellular cGMP to pre-light exposure levels inducing opening 
of CNGs and restoring the influx of cations, consequently re-establishing the electrical current 
between rod photoreceptor cell and second order retinal neurones (Dizhoor et ai., 1994; Lamb 
and Pugh, 1992a).
Cone photoreceptors possess much higher sensitivity thresholds to light and rates of dark 
adaption than described for rod photoreceptors (Hurwitz et al., 1990; Yau, 1994). These 
properties are conferred on the cone system by variations in the amino acid sequence 
comprising specific subunits of enzymes isolated from the phototransduction cascade in the 
cone photoreceptor (Nathans, 1999; Shichida et al., 1994). The amino acid sequence of 
photopigment isolated from S and M/L photoreceptors in humans’ shares a 40% identity to 
rhodopsin (Calkins and Sterling, 1999; Calkins et al., 1998; Yokoyama et al., 1989). 
Transducin in cone photoreceptor is composed of a2, J32 and y2 subunits (Lochrie et al., 1985; 
Peng et al., 1992). cGMP phosphodiesterase in cone photoreceptors is a cone specific isoform 
a homodimer (designated a ’), which interacts with the cone specific inhibitory y subunit 
(Hurwitz et ai., 1990). Two subtly different isofoms of the g subunit are found in S and M/L
cones. The cGMP-gated cation channels in cone photoreceptors possess divergent 
pharmacological and kinetic properties to those described for rods (Shichida et ai., 1994; Yau, 
1994)
Vertebrate photoreceptor ceils can detect, with high levels of sensitivity and temporal 
resolution, signals over a wide range of light intensities (Cook and Kaupp, 1988; Dizhoor et al., 
1994; Fowles et al., 1989; Lamb and Pugh, 1992b; Masland, 1996b; Masland, 2001a; Masland, 
2001b; Torre et al., 1992; Tsukamoto et al., 2001; Wagner et al., 1989; Wang et al., 1999). 
These properties are, in part, endowed by the single-photon sensitivity of photoreceptors and 
efficient shut-off of each activated intermediate created during the activational gain of the 
phototransduction cascade (Boycott and Wassie, 1999; Yau, 1994). In the normal cycle of day 
and night, the illumination at the earths surface varies over 11 orders of magnitude. The visual 
system must therefore continually adjust its performance to this continually changing ambient 
level of illumination. Light adaption is primarily managed by the diurnal switching between rod- 
and cone-dominated pathways (Boycott and Wassle, 1999; Masland, 2001a; Masland, 2001b; 
Tsukamoto et al., 2001; Yau, 1994). Adaption to steady background illumination at the 
biochemical level is attributed to mechanisms within the phototransduction cascades which 
truncate the full development of the photoresponse making the response smaller and peak 
sooner, thereby hastening the recovery process (Boycott and Wassle, 1999; Masland, 2001a; 
Masland, 2001b; Tsukamoto et al., 2001; Yau, 1994).

1.3.1 Histogenesis of the mammalian retina
The human eye begins to be formed at the 16-day embryo stage (E-16) from bilateral 
invaginations (or optic vesicles) of the forebrain segment of the anterior neuroectoderm 
(designated ANE). The optic vesicles then invaginate to form double walled optic cups. The 
two epithelial layers of the optic cup are continuous with the ventricular cavity of the embryonic 
brain and surrounding lumen (or optocoel). Cells bordering the optocoel (or ependymal layer) 
develop into rod and cone photoreceptors. Second order retinal neurons and support cells 
develop from cells adjacent to the ependymal layer (or mantle layer). Axons of the various 
nerve cells of the mantle layer are organised on the surface of the mantle layer (or marginal 
zone) that later becomes the plexiform layers. The optic nerve is derived from the convergence 
of nerve fibers within the marginal zone to form the optic stalk.
1.3.2 Retinogenesis
Development of the retina is a continuous process that begins with active cell proliferation in 
the mantle layer of the optic cup until maturation of visual acuity in the postnatal animal 
(Belliveau and Cepko, 1999; Cepko, 1999). The fate of newly born cells (retinal progenitor 
cells or RPCs) is determined by a series of changes in the intrinsic state of the cell; controlling 
its competence to make different cell types (Belliveau and Cepko, 1999; Cepko, 1999). The 
intrinsic properties of the RPC are influenced by extrinsic factors (such as the composition of 
the extracellular matrix and growth factors released from other cells) as the RPC encounters 
more competent cells and micro-environments; supplemented by more differentiated cells 
(Belliveau and Cepko, 1999; Cepko, 1999).
Cell fate tracing experiments have shown that RPCs differentiate, in a strict chronological 
sequence, into five retinal cell types: namely rod & cone photoreceptors, bipolar cells, amacrine 
cells, horizontal cells and ganglion cells (Alexiades and Cepko, 1996; Belliveau and Cepko, 
1999; Bruhn and Cepko, 1996; Cepko, 1996; Cepko, 1999; Cepko et al., 1996; Kido et al., 
1996; Morrow et al., 1998a; Morrow et al., 1998b). RPCs are thought to be biased to make one 
of few cell types, by intrinsic and extrinsic factors, during the terminal mitotic cycle. Cell fate 
determinism is governed by temporal spatial action of extrinsic factors (such as intercellular
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adhesion molecules (ICAMs) and paracrine factors) presented by more competent cells on the 
intrinsic capacity of the cell (master regulatory genes) (Belliveau and Cepko, 1999; Cepko,
1999). The competence of a cell, however, is not essentially restricted to one cell type 
(Belliveau and Cepko, 1999; Cepko, 1999). Even during the later stages of retinogenesis 
competent cells can be forced to skip the next competent state if placed in an alternatively 
biased microenvironment (Belliveau and Cepko, 1999; Cepko, 1999).
The first retinal cell types (E-22) to be borne from the RPC pool belongs to the cone-dominated 
pathway (i.e. ganglion»horizontal»cone photoreceptors) at around E16. A second wave (PO 
to P7) of RPC differentiation results in the birth of the rod-dominated pathway (i.e. rod 
photoreceptors, remaining amacrine and bipolar cells).
1.3.3 Genetic basis of retinogenesis
The intrinsic competence of a progenitor cell to become a specific cell type is conferred by a 
network of master regulatory genes that are linked together by feedback loops (Belliveau and 
Cepko, 1999; Cepko, 1999). All the master regulatory genes isolated and characterised to date 
belong to the basic helix loop helix (bHLH) transcription factor family (Belliveau and Cepko, 
1999; Cepko, 1999). The expression profile of these genes can overlap and/or become 
restricted to specific cell lineage and/or stage of development (Table 1). The function of these 
genes has also been shown to grossly change with ontogeny. The cascade of master 
regulatory genes known to be responsible for determining the five retinal cell types (Cite) is 
universal during the early stages of development and becomes peculiar to cell lineage at 
specific interval of retinogenesis (Belliveau and Cepko, 1999; Cepko, 1999; Morrow et al., 
1998a).
PAX6, RX1 and OTX1 are expressed in the presumptive eye field of the ANE (designated in
1.3.1 now in abbrev list). Mis-expression of these genes in the ventral ectoderm act to change 
the fate of such progenitor ceils to become RPCs instead of cortex. Patterning of the 
vertebrate eye appears to be controlled by mutual regulation (and progressive restriction) of 
these genes (Cepko, 1996).
Table 1 Key genes involved in establishing the photoreceptor phenotype from embryonic tissue.
Gene Expression Function Knock out 
Models
Rx
(Chuang and Raymond, iOOl)
ANE
Cone photoreceptor
Defining area of ANE 
fated to become retinal 
tissue
No eyes
Over expression leads to 
ectopic retinal tissue in 
other areas of the brain 
mass
Six
(Niiya 1998, Kawakami 1996)
ANE Transcription repressor of 
non-retinogenic genes 
(e.g. ax2)
Expansion of eye field in 
ANE
Gross malformations of 
the retinal tissue.
OTX
(Furukawa al al. 1997; Furukawa at al., 
1999X(Kimura el al.. 2000)
ANE
Rod/one photoreceptor
Establishment of eye field 
in ANE
Gross occular 
malformations of the. 
Sustained proliferation of 
RPC pool.
Incomplete apoptotic 
patterning of the retina
Pax6(Belecky-Adams el al, 1997; Czemyetal., 1999; Davis and Reed, 1996; Haider el al., 
f995a; Haider et al, 1995b; Hlrsch and Harris, 1997)
ANE
AC
Transcriptional activator 
of pro-retinogenic genes 
(e.g. Rx)
Postnatal expression 
confined to AC
Neuroectoderm fails to 
form optic vesicles
Shh(Belecky-Adams el al, 1997; Czerny el al, 1999, Davie and Reed, 1996; Haider el al, 1998a; Haliar at al, 1995b; Hlrsch and Harris. 1997)
Rod/cone Photoreceptors Promotes photoreceptor 
differentiation of RPC. 
Transactivated 
photoreceptor specific 
genes (e.g. IRBP)
Atypical cone/rod 
photoreceptor ERG 
activity.
CRX(Belecky-Adams et al, 1997; Czemy etal, 1999; Davis and Reed, 1996; Haider el al, 1995a, Haider et al, 1995b; Hlrsch and Harris, 1997)
Photoreceptor-fated
RPCs
Transactivation of 
rod/cone photoreceptor 
specific genes (e.g. genes 
associated with 
phototransduction 
cascade and and AANAT
Fail to form outer segment 
of the photoreceptor. 
Atypical cone/rod 
photoreceptor ERG 
activity.
1.3.4 Extrinsic factors involved in the development of the retina
The micro-environment of the developing retina contains factors; supplemented by more
differentiated RPCs, which interact with surface receptors of less differentiated RPCs to
promote their transition to more committed retinal phenotypes (Belliveau and Cepko, 1999;
Cepko, 1999; Lahaie et al., 1998; Morrow et al., 1998a; Morrow et al., 1998b). The activity of
these factors is apparent over short or long distances. The identity of these extrinsic factors is
under active research with the aim of controlling the pathogenesis of common eye diseases
(Cepko, 1996; Morrow et al., 1998a; Morrow et al., 1998b).
Topical application of fibroblast growth factor (FGF), taurine, retinoic acid and s-lamanin has 
been shown in vitro to promote RPCs to differentiate into rod photoreceptors (Belliveau and 
Cepko, 1999; Morrow et al., 1998a; Morrow et al., 1998b). The activity of these factors to force 
RPCs to become photoreceptors was only observed when applied to post-mitotic cells. 
Furthermore, RPCs response to these factors has been shown to be dose and time specific 
(Belliveau and Cepko, 1999; Cepko, 1999)
1.3.5 The photoresponsive retina
The retina, in rodents, has been shown to activate retino-recipient centre of the brain in 
response to light within days (e.g. in rat P1 and mice P4) of parturition (designated Pn) (Bruhn 
and Cepko, 1996; Morrow et al., 1998a, Lahaie, 1998 #255; Morrow et al., 1998b). At this 
stage in development rodents eyelids are sealed and the retina is still undergoing significant 
amount of modeling. For instance, in P4 mice the outer segments of rod/cone photoreceptors 
are still undergoing maturation and photoresponse; detected as an electroretinogram, restricted 
to the INL and GCL of the retina (Alexiades and Cepko, 1996; Belliveau and Cepko, 1999; 
Bruhn and Cepko, 1996; Cepko, 1996; Cepko, 1999; Cepko et al., 1996; Kido et al., 1996; 
Morrow et al., 1998a; Morrow et al., 1998b). This pattern of activity does not correlate to cone 
or rod photoreceptor output instead has been attributed to non-image visual functions of the 
retina; such as those known to be involved in the regulation of the biological clock (Alexiades 
and Cepko, 1996; Belliveau and Cepko, 1999; Bruhn and Cepko, 1996; Cepko, 1996; Cepko, 
1999; Cepko et al., 1996; Kido et al., 1996; Morrow et al., 1998a; Morrow et al., 1998b).
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1.4 Circadian Rhythms
The natural environment is governed by four main geophysical cycles; namely tidal, solar, 
seasonal and lunar, collectively referred to as circarhythms. Life on earth has evolved 
endogenous mechanisms to anticipate and adapt to circarhythms.
Living organisms generate a diverse array of internal or biological rhythms. The period length 
(designated x) of these biological rhythms varies from seconds to years. Circadian rhythms are 
those that complete one cycle every 24 hours (e.g. core body temperature in humans). 
Ultradian rhythms, or high frequency rhythms, are defined as those that have a period shorter 
than 24 hours and, therefore, a frequency greater than one cycle in 24 hours (e.g. heart beat in 
vertebrates and invertebrates). Infradian rhythms, on the other hand, cycle with a period 
greater than 24 hours (e.g. menstrual cycle in humans).
Organisms have been shown under constant experimental conditions to possess an innate 
ability to generate and measure circadian time. Endogenous circadian rhythm (designated x) 
typically exhibits, at particular time points (or phases), in a circadian cycle specific amplitude[s] 
of biological or behavioural activity. Circadian rhythmicity is evident at many levels of an 
animal’s activity (e.g. wheel running in rodents), physiology (e.g. core body temperature in 
humans) and behaviour (e.g. sleep in humans). The intrinsic period length of all organisms’ 
circadian rhythms is not exactly 24 hours. If an organism is kept in a constant environment 
their rhythms drift (or free run) incrementally ahead or behind that recorded in the previous 
eycle-[s] (Armstrong et al, 1986; Aronson et a!., 1993; Aschoffand Tok.ura, 1986; Ferraro and 
McCormack, 1986; Kokkoris et al., 1978; Weitzman et al., 1978). However, in alternating 
iterative environmental schedules these rhythms become synchronized (or entrained) to the 
period length of the imposed schedule.
Circadian rhythms in the environment (designated T) are influence by changes in the 
availability of food, quality of light or changes in atmospheric/ground temperature. The effect of 
these time cues (or zeitgebers) on the direction and amplitude of a rhythm is phase-specific. 
The most potent zeitgeber on the endogenous circadian system is; universally, thought to be 
light. In order for the organism to attain an optimal existence in its niche it must stay in 
synchrony with the solar cycle and reset its rhythms at frequent intervals (Brainard et al., 2001;
Czeisler et al., 1981; Lewy et al., 1980b; Thapan et al., 2001). The solar cycle is marked by 
daily changes in:
> Light levels (irradiance) ranging over 6 log units between dawn and dusk
> Spectral composition, with a predominance of shorter wavelengths (<500 nm) at dawn 
changing to mid-long wavelengths (550 to 650 nm) at dusk.
The exact properties of the photic environment, however, are subject to seasonal variation as 
determined by the astronomical relationship between the earth and its orbit with the sun. This 
phenomenon only impacts on organisms within temperate and polar zones of the earth. These 
organisms, must therefore, daily reset (or photoentrain) endogenous period to seasonal 
changes in the solar cycle.
The potency of light to entrain circadian rhythms has been shown in humans, under artificially 
created environmental conditions, to compress or expand the period length to 19 and 31 hours; 
respectively (Aschoff et al., 1986; Wever, 1985; Wever, 1986; Wever, 1989; Wever et al., 
1983). However, there are limitations to the plasticity of circadian rhythms. Forcing the 
biological clock to entrain to extreme alternating environmental schedules outside the normal 
circadian range desynchronises internal from dependent-environmental circadian rhythms 
(external desynchronisation) and/or other more robust endogenous rhythms (internal 
desynchronisation).
The direction and extend of entrainment of specific circadian rhythms is dependent on the 
relative sensitivity of the endogenous circadian rhythm pacemaker (see section) to the new 
properties of light at the new x: T position. For instance, a single exposure of bright white light 
during the late subjective night can acutely phase advance (0.6 to 2 hours) the onset of 
melatonin secretion in humans (Abe et al., 1991; Arendt and Broadway, 1987; Broadway et al., 
1987; Orth and Island, 1969). Conversely, a single exposure of bright white light given during 
the late subjective afternoon or early night phase delays the onset of melatonin secretion by up 
to 74 minutes in humans (Bernstein et a!., 1984; Czeisler et al., 1981; Shanahan and Czeisler, 
1991).
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1.4.1 The biological ciock[s]
Circadian rhythms, in plants and organism alike, are generated and maintained by some form 
of biological dock. The mammalian biological clock essentially is a cell-autonomous 
pacemaker, which receives entraining input from sensory structures. Integration of this 
information entrains emerging rhythms of the pacemaker to the entraining zeitgeber. In turn 
changes in the x of the pacemaker are imposed on downstream rhythmic processes.
Organisation of the central pacemaker
Three mechanistic components are required by the organism to enable it to entrain 
endogenous circadian rhythms to those of the external world (Figure 3):
1. A device to detect and discriminate changes in the intensity and duration of the 
external zeitgeber; designated the DECTECTOR.
2. A driving oscillator or pacemaker to
a) Generate the rhythms[s],
b) Integrate detectable changes in the environment and
c) Augment an appropriate modulation in a dependent rhythm[s], 
designated the PACEMAKER.
3. An efferent pathway, which imposes the relative phase-shifting response on the 
effector systemfs] to interpolate circadian time; designated EFFECTOR SYSTEMS.
1.4.1.1 The detector
Circadian rhythms are predominantly entrained to the light:dark cycle of the solar day. 
Photoentrainment in mammals must therefore be a photic phenomenon and the detector the 
photoreceptor. Convincing evidence placing the detector as the retina in the photoentraining 
pathway came from a series of ocular enucleation experiments carried out on rodents. In these 
experiments enucleated animals were shown to free-run in entraining light schedules.
A number of behavioural photoentrainment studies in humans and rodents have shown that the 
photoreceptor pathway of the circadian system is different from that required for vision. This 
data has been supported using coneless, rodless and various other transgenic rodent models 
(Lucas et al., 2001a; Lucas and Foster, 1999; Lucas et al., 2001b), which were shown to exhibit 
identical circadian responses to photoentraining schedules as observed in wild-type animals. 
Berson et al (2002) showed that a subset of retinal ganglion cells (RGCs) exhibited
photoresponsive properties (such as spectral tuning and sensitivity) as known to photoentrain 
behavioural (wheel running) and physiological (suppress melatonin synthesis onset) circadian 
rhythms in the rat (Berson et al., 2002; Hattar et al., 2002). This subset of RGCs was, 
uncharacteristically, fount to possess an active phototransduction cascade and retrograde 
cytoiogical tracing methods showed their axon terminals to directly innervate the central 
pacemaker (i.e. suprachiasmatic nuclei or SCN) (Berson et al., 2002; Hattar et al., 2002). The 
identification of a circadian photopigment has been intensively studied area with various 
candidates, such as the cryptochromes, being considered (CITE). The selection and 
characterisation of photopigment candidates precipitating the regulation of the circadian system 
has been complicated by the lack technology needed to discriminate minimal differences in 
electrophysiological specific properties associated with each photopigment; and the reluctance 
by various schools of thought, to consider non-photoreceptor cells as potential photoreceptive 
candidates (Lucas et al., 2001b). Recently a study showed that a retinaldehyde based 
photopigment called melanopsin localised to a subset of RGCs identified as being involved in 
the detection of photoperiod changes (Berson et ai., 2002; Hattar et al., 2002). 
Characterisation of the spectral dynamics of melanopsin showed it to initiate a photo response 
in these cells similar to that required to photoentrain circadian rhythms at the whole 
animal((Berson et al., 2002; Hattar et al., 2002; Lucas et al., 2001 b).(Hannibal and Fahrenkrug, 
2002; Hannibal et al., 2002)
Photoentrainment signals pass from the retina to the SCN via the retinohypothalmic tract 
(RHT)(Barattini et al., 1993; Brown et al., 1997; Crowne et al., 1993; Larsen et al., 1993; Leak 
and Moore, 1997; Moga and Moore, 1997; Moore., 1988; Moore, 1993; Moore,. 1997; Shihata 
and Moore, 1988; Shibata and Moore, 1993). The RHT synapses with the ventrolateral area of 
the SCN and, to a lesser extent, the dorsiomedial, anterior hypothalamus and retrochiasmatic 
area. Photoperiodic information is transduced from the retina to the SCN through the release 
of glutamate at the post-synaptic junction of the RHT with the ventral surface of the SCN. 
Glutamate is a common neurotransmitter and has been shown in vitro to cause phase delays 
and advance in behavioural and physiological rhythms. However, the direction of topical 
glutamate induced phase shifting has been shown to be time-dependent (Akiyama et al., 
1999a; Akiyama et al., 1999b; Best et al., 1999; Gillette et al., 1993; Gillette et al., 1995; Haak, 
1999; Tamaru et al., 2000)
1 f,
A separate photoentrainment pathway exists from the RGCs to the SCN via the intergeniculate 
leaflet (IGL) of the thalamus (Akiyama et al., 1999a; Akiyama et al., 1999b; Card and Moore, 
1989; Moga and Moore, 1997; Moore, 1993; Moore and Speh, 1993). The IGL is an 
anatomically and functionally distinct region of the lateral geniculate complex, which receives 
bilateral innervation from the eyes. The neurones, which form the IGL, expresses neuropeptide 
Y and gamma amino butyric acid (GABA). The IGL also processes non-photic information from 
other brain structures such as the brain stem. These structures are associated with 
homeostatic functions and are thought to be important in feeding back steady state parameters 
to the SCN and circadian system (Gillette et al., 1993; Gillette et al., 1995; Gillette and Prosser, 
1988; Medanic and Gillette, 1993).
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Figure 3 Circadian organization of rat pineal melatonin biosynthesis system 
(Taken from 
Arendt 1995)
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1.4.1.2 The pacemaker
The driving circadian pacemaker in mammais is the SON (Gillette et al., 1993; Gillette et al., 
1995; Gillette and Prosser, 1988; Medanic and Gillette, 1993; Moore and Eichler, 1972; Ralph 
and Block, 1990; Ralph et al., 1990; Stephan and Zucker, 1972a; Stephan and Zucker, 1972b). 
Two groups initially demonstrated this in 1972 that showed that chemical and physical ablation 
of the SCN in rodents resulted in the loss of circadian function (Moore and Eichler, 1972; Ralph 
and Block, 1990; Ralph et al., 1990; Stephan and Zucker, 1972a; Stephan and Zucker, 1972b). 
More recently the position of the SCN in the organisation of the mammalian circadian system 
has been unequivocally by other studies:
1) Circadian function can be maintained ex vivo (Earnest and Sladek, 1986; Earnest and 
Turek, 1986; Gillette et al., 1995; Gillette and Prosser, 1988)
2) Transplantation of fetal SCN into the third ventricle of arrhythmic, SCN lesioned 
rodents restored behavioural rhythmicity in those animal with a period comparable to 
the phenotype of the donor animal (Bartness et al., 1991; DeCoursey and Buggy, 
1989; Ralph etal., 1990)
3) Cross-transplantation between tau mutant hamster (period length 20 h) SON with wild 
type hamster (period length 24.1 h) SCN gave rise to animals with reciprocal period 
lengths of the donating animal (Davies and Mason, 1994; Nolan et al., 1995; Sollars et 
al., 1995; Sollars and Pickard, 1993; Sollars and Pickard, 1995).
The SCN is a paired structure located in the anterior hypothalamus juxtaposed to the optic 
chiasm. In rodents, the SCN contains approximately 8,000 neurones in each lobe (Moore, 
1993; Moore and Bernstein, 1989). The neurones ramify extensively within the nuclei forming 
an interneuronal network, which project onto other brain structures. The neurones in the 
ventrolateral lobe, the major RHT input site, are noticeably larger than those in the dorsomedial 
lobe (Moga and Moore, 1997; Moore and Bernstein, 1989). The ventrolateral neurones are 
characterised by aggregations of vasoactive intestinal polypeptide (VIP) while the dorsomedial 
neurones predominantly contain vasopressin (Hannibal, 2002).
The electrical activity of individual SCN neurones has been shown to exhibit robust circadian 
rhythms (Welsh et al., 1995, Gillette, 1995 #22). Peak firing rates of individual SCN neurones 
are observed during the subjective day declining throughout the subject night (Gillette et al., 
1993; Gillette et al., 1995; Gillette and Prosser, 1988; Welsh et al., 1995). The pattern of
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neurotransmission within a given population of SCN neurones varies significantly (Gillette et al., 
1993; Gillette et a!., 1995; Gillette and Prosser, 1988; Welsh et al., 1995). SCN neurones also 
exhibit differential sensitivities to phase adjustment, which mirror those seen for the differential 
effects of light, at the whole animal, at different times over a circadian cycle. The capacity of 
SCN neurones to preferentially phase shift at specific time points was demonstrated in vitro 
using glutamate and cAMP analogues (Ebling, 1996; Gillette et al., 1995; Hastings et al., 1996; 
Meijer and Schwartz, 2003; Prosser and Gillette, 1989; Prosser et al., 1989). Selective ablation 
of neurones within the SCN, however, has not been shown to result In arthymia (Reppert et al., 
1987; Schwartz et al., 1987; Welsh et al., 1995). These data suggests that individual SCN 
neurones are capable of generating circadian rhythms as detected in the whole animal (Welsh 
et al., 1995). Reppert et al (1995) demonstrated in vitro that individual SCN neurones display 
robust circadian firing rate rhythms that can be sustained over a number of weeks (Reppert et 
al., 1987). This group also showed that each neurone has a specific firing rhythm profile that is 
distinct from other cells in the same culture. These rhythms could be reversibly inhibited; re- 
emerging with unaltered circadian periods.
1.4.1.3 Effector systems
The SCN, as indicated above, is an integrator of locomotor, behaviour and homeostatic brain 
function (Klein et al., 1983; Moore, 1993; Rusak, 1979). It imposes circadian time on these 
processes through specific reciprocal connection with brain centres, which manifest those 
functions.
1.4.2 Peripheral clocks
The SCN was thought to impose ail circadian phenomena to the rest of the body. However, 
destruction of the SCN, isolation of individual tissues and large abrupt changes in entraining 
schedules has proved otherwise. A number of tissues such as the retina (Yamazaki et al.,
2000), skeletal muscle (Yamazaki et al., 2000) and lung (Yamazaki et al., 2000) have been 
shown ex vivo in rodents to possess self-sustaining circadian oscillators. However, current 
data suggest that the propensity of such oscillators to drive circadian rhythms in isolation is 
limited and requires the SCN to regulate and maintain rhythmicity in peripheral tissues. The 
SCN, however, has been shown to be important in the phase control of peripheral oscillator 
with respect to changes in the external world (Yamazaki et ai., 2000).
1.4.2.1 Retinal molecular physiology is under the control of a retinal specific oscillator 
The suggestion of the existence of a retinai clock in mammals came from observing in SCN
lesioned and pinealectomized rats the persistence of rhythmic rod outer segment (ROS)
photoreceptor disc shedding (Fisher et al., 1983; Young and Vaney, 1991) and melatonin
synthesis (Besharse and luvone, 1983; luvone et al., 2002; Sakamoto et al., 2002; Terman et
al., 1993).
Distal ROS damaged by free radicals generated during the photoresponse are replaced by new 
material produced at the proximal end of the ROS. It is the most studied retinai circadian 
rhythm (Fisher et al., 1983; Young and Vaney, 1991). Replacement of ROS starts at light 
onset under alternating L-D cycle and in a constant environmental system with comparable 
period lengths when the same animal is switched from one schedule to the other (Fisher et al., 
1983; Young and Vaney, 1991). The rhythm in ROD shedding is retained following destruction 
of the optic nerve and/or iesioning of the SCN ((Fisher et al., 1983; Young and Vaney, 1991).
Other retinai rhythms have been detected at the molecular level in a number of species. 
Transcription and translation of various retina specific genes (von Schantz et al., 1999)), 
maintained under alternating and constant environmental conditions, involved in:
1) Phototransduction cascade; such as rhodopsin (von Schantz et al., 1999)
2) Molecular Clock, such as bMAL1, peri, per2 and per3 (Jin et al., 1999; Kume et 
al., 1999; Shearman et al., 1999; Zylka and Reppert, 1999; Zylka et al., 1998)
3) Enzymes involved in melatonin synthesis (AANAT and HIOMT) (Bernard et al., 
1999; luvone et a!., 1997; Niki et al., 1998; Roseboom et al., 1998) (Greve et al., 
1999) have been shown to oscillate with a circadian rhythm.
The oscillator which drives retinai rhythms, such as those described above, was located to the 
photoreceptor layer in a study in rodents, in which specific layer of retina were chemically 
ablated. This study specifically showed that the rhythmic occurrence of melatonin synthesis 
and AANAT activity/transcription was retained following the destruction of inner neuro-retina 
layers. Fiowever, this study could not associate the circadian influence of the photoreceptor 
layer on rest of the retinal physiology. Cahill et al (1991) and Tosini et al (1996) showed that
the retinal melatonin rhythm could be maintained in retinal explants and that melatonin 
synthesis was circadian, with a tau and phase concomitant with the intact animal (Cahill and 
Besharse, 1990; Cahill and Besharse, 1991; Cahill et al., 1991; Tosini and Menaker, 1996a; 
Tosini and Menaker, 1996b). Observations in the retinal degeneration (rd) mouse 
demonstrated the dependence of the retina on the photoreceptor layer to drive ocular rhythms. 
The rd mouse has a mutated gene for the j3 subunits of the rod-specific cGMP PDE (Dryja et 
al., 1995; Dryja and Li, 1995; McLaughlin et al., 1995). This mutation leads to the progressive 
degeneration of rod photoreceptors. The oscillation and amplitude of retinal melatonin 
synthesis in the rd mouse weakens with the loss of rod photoreceptors. Arrhythmia in the 
retina of this mouse was observed at 60 day following maturation of the aduit retina (Tosini and 
Menaker, 1998a).
1.4.3 A common molecular oscillator drives circadian rhythm
Ultimately, the function of the biological clock is genetically determined. Reverse and forward 
genetic screening methods (Reviewed in Wisor 2001) have characterised 8 genes; namely 
peri, per2, per3, cryl, cry2, tim, clock and bmall that in vivo and in vitro from most tissue 
systems (and mammalian species) exhibit in concert transcription-translation feedback (the 
oscillator) loops that manifest and potentiate the biological clock.
An oscillator essentially is a complex of transcription factor (designated the osciliator complex), 
belonging to bHLH PER ARNT SIM (PAS) transcription factor family (Hogenesch et al,, 1998), 
that is recruited to and regulates the circadian properties of genes containing E-box motiffs] 
(CACGTG). E-box motifs electrostatically recruit’s bHLH transcription factors; such as CLOCK 
and BMAL1, to gene in which such regulatory motifs are active (Chen and Baler, 2000; 
Hogenesch et al., 1998; Kyriacou and Rosato, 2000; Munoz and Baler, 2003; Munoz et al.,
2002). These elements are principally located within the 5’ untranslated region of a gene 
(CITE) and are known to confer other regulatory functions on the gene. The CLOCK:BMAL1 
heterodimer however exhibits a strict preference for particular Ebox motifs (Munoz and Baler, 
2003; Munoz et al., 2002). The Ebox motif in genes upregulated by the CLOCK: BMAL1 
heterodimer has universally been shown to provide the minimal element required to bring about 
a circadian change in the expression of clock and clock controlled genes (CCGs) (Kyriacou and 
Rosato, 2000). Transgenic animals which have green fluorescent protein reporter gene driven
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by mperl promoter (2.1 kb) were observed to emit tight on a circadian basis. In other reporter 
gene studies deletion analysis of this region shows that three E-boxes are required to bring 
about optima! amplitude changes in transcript level of mper1{Ripperger and Schibler, 2001; 
Ripperger et al., 2000; Yamazaki et al., 2000). CLOCK:BMAL1 has also been shown to 
regulate circadian expression of mcryl and mperl from E-boxes located in the 5’ untranslated 
region; circadian expression of mcry2, mper2 and mper3 is driven from E-boxes located in the 
first intron of the these genes (Lee et al., 2001). The composition of the oscillator complex 
changes over a 24 hour period and Is governed by an auto-regulatory feedback loop. The 
positive arm of the feedback loop consists of the heterodimer CLOCK:BMAL1 that upregulates 
the expression of clock genes (peri, per2, per3, cryl and cry2) and the activity of CCGs 
(Darlington et al., 1998; Gekakis et al., 1998; Kuhlman et al., 2000; Kuhlman et al., 2003; 
Sakamoto et al., 2000; Sangoram et al., 1998). CLOCK:BMAL1 up-regulates clock genes until 
the CLOCK:BMAL1 complex has successfully de-stabilised and deactivated (Lee et al., 2001). 
The expression of Clock is constitutive but transcription of BMAL1, on the other hand, has been 
shown to vary over a circadian interval; peaking at the dark to light transition point of the solar 
day. BMAL1, presently, is thought to be the rate-limiting component of the oscillator complex 
(Tamaru et al., 2000). Most clock proteins moderate the temporal and stimuli-directed activities 
of CLOCK:BMAL1 through direct interaction with this heterodimer. PER and CRY proteins 
once translated form multimeric complexes that enter the nucleus and; directly or indirectly, 
alter the dynamics and composition of the CLOCK:BMAL1-E-box complex (Eide et al., 2002; 
Eide and Virshup, 2001). The composition and activity of the various complexes on the activity 
of the E-Box containing genes alters with circadian time (Eide et al., 2002; Eide and Virshup,
2001)
1.4.3.1 Overlapping timing mechanism
Each clock gene has a specific temporal transcription/translation and activity profile that has 
been shown to oscillate with the same frequency and interval in the SCN and peripheral tissues 
(Lee et a!., 2001). However, the exact timing of these events in the peripheral oscillators 
exhibits a 60°phase angle to similar processes in the SCN (Yamazaki et al., 2000).
Under the current working model of the molecular clock in the mouse SCN (Lee et al., 2001; 
Ripperger et ai., 2000; Shearman et al., 2000a; Shearman et al., 2000b; Shearman and
Weaver, 1999; Shearman et al., 1999; Shearman et al., 1997) circadian time (CT) 0 is 
distinguished by the CLOCK: BMAL1 mediated transcription of per and cry genes (Reppert and 
Weaver, 2001).. Transcription of per and cry genes persists, although at different rates, until 
late subjective morning CT 10-11. pe/1 mRNA reaches maximal expression between CT4-6, 
per3 between CT 6 -8, peri at CT8, cry2 at CT 8-16 and cryl at CT 12. Following CT 12 per 
and cry mRNA transcripts are synchronously translated enabling them to form muitimeric 
nuclear active proteins which rapidly downregulates the activity of CLOCK:BMAL1 complex but 
remain active to establish expression of BMAL1 transcription by CT 15-18 and resumption of 
CLOCK:BMAL1 mediated clock gene transcription by CT 23-0.
1.4.3.2 C lock proteins have specific roles
1.4.3.2.1 Cryptochromes
The cryptochromes are structural homologues of pternin/flavin-containing protein, which are 
involved in DNA repair activities (Hsu et al., 1996). Circadian biologists have shown these 
proteins to be a critical part of the circadian clock. CRY1 and CRY2 appears, from recent 
behavioural and physiological studies involving single and double knockout transgenic animal, 
to act as negative regulators of the molecular clock (Eide et al., 2002)
Homozygous targeted deletion of mcryl was found to shorten behaviour rhythms in mice 
maintained under classical circadian experimental (Eide et al., 2002; Okamura et al., 1999; 
Okamura et al., 2002). cryl knockout mice, on the other hand, displayed lengthened periods. 
In double knockout mice, when placed in DD, wheel-running rhythms were found to be 
arrhythmic. At the molecular level these knockout models were found to differently affect the 
magnitude of mper2 expression and mperl cycling (Eide et al., 2002; Okamura et al,, 1999; 
Okamura et al., 2002). Protein interaction screens revealed that CRYs regulate the 
transcriptional activity of CLOCK and BMAL1 protein in the circadian oscillator (Eide et al., 
2002; Okamura et al., 1999; Okamura et al., 2002).
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CRY proteins inhibit CLOCK:BMAL1 dependent gene expression by directly interacting and 
destabilising this positive regulator of the molecular clock from the E-box, consequently 
affecting the activity of the general transcription initiation complex (King et al., 1997b; Kume et 
al., 1999; Okamura et al,, 1999; Okamura et al., 2002). The exact mechanism of how the CRY 
proteins disrupt CLOCK:BMAL1 transcription is still unclear. It is thought to be CRY’s ability to 
alter the electrostatic interaction of the heterodimer with the E-Box motif. CRY proteins are 
pterin/flavin-containing proteins (Bognar et al., 1999; Hall, 2000; Zhu and Green, 2001). Flavin 
proteins can induce redox reactions upon association with other proteins so altering the redox 
or electrostatic potential of that protein (Bognar et al., 1999; Hall, 2000; Zhu and Green, 2001). 
However, whether CRY proteins electrophysically wrenches CLOCK:BMAL1 from the E-box in 
toto pull or destabilises the complex in situ remains to be confirmed (Eide et al., 2002; Eide and 
Virshup, 2001).
1.4.3.2.2 PERIOD 2
PER2 is a positive transcriptional regulator of BMAL1 (Chen and Baler, 2000; Jin et al., 1999; 
Scheving and Jin, 1999; Shearman and Weaver, 1999; Shearman et al., 1999; Zylka et al., 
1998). The MPERBrdM1 (deletion mutation encoding a protein missing 87 residues in the PAS 
domain) mutant displays a shortened circadian period, which becomes arrhythmic in DD, and 
blunted BMAL1 transcript levels (Chen and Baler, 2000; Jin et al., 1999; Scheving and Jin, 
1999; Shearman and Weaver, 1999; Shearman et al., 1999; Zylka et al., 1998). However, 
MPERBrdM1 mutant still displays rhythmicity in may/, mcry2, mperl and mper2 transcription; 
comparable to that observed in wild-type animals under LD conditions. PER2 up-regulates 
BMAL1 transcription until the ratio of active BMAL1 to CLOCK proteins reaches a critical level 
at which they form heterodimers and re-establish transcription of per,cry and CCGs (Ripperger 
and Schibler, 2001; Shearman et al., 2000a; Shearman et a!., 2000b; Shearman et al., 1999). 
However, PER2 does not contain a recognisable DNA binding motif, which could initiate 
transcription of BMAL1. Interestingly, PER2 has been shown not to use its PAS domain during 
nuclear translocation with other known clock proteins suggesting it might dimerise with a yet 
unknown DNA binding protein partner facilitating transcription of BMAL1 (Ripperger and 
Schibler, 2001; Shearman et al., 2000a; Shearman et a!., 2000b; Shearman et al., 1999).
14.3.2.3 CLOCK
Clock was the first of the clock genes to be clones in mammals (King and Takahashi, 2000; 
Ripperger and Schibler, 2001). IT was isolated from a behavioural screen of chemically 
induced mutant mice which exhibit mis-aligned circadian rhythms (King and Takahashi, 2000; 
King et al., 1997a; Panda et al., 2002; Ripperger and Schibler, 2001; Ripperger et al., 2000; 
Sangoram et al., 1998). Homozygote mCLOCK mutant animals displayed lengthened periods 
in wheel-running rhythms, which became arrhythmic in DD (Ripperger and Schibler, 2001; 
Ripperger et al., 2000). The mutation (51 amino acid deletion encoded by exon 19) disrupted 
the PAS domain of CLOCK in a manner that allowed it to bind to BMAL1 but compromised its’ 
ability to upregulate mperl and mperl transcription (Baisalobre, 2002; Okamura et al., 2002; 
Ripperger and Schibler, 2001; Ripperger et al,, 2000). Interestingly, BMAL1 transcript level in 
mutant animals were found to be elevated in peripheral tissues but blunted in SCN, at all 
circadian time points (CITE). These data suggested that CLOCK:BMAL1 heterodimer activity 
normally represses peripheral clock BMAL1 transcription (Ripperger and Schibler, 2001; 
Ripperger et al., 2000). The importance of CLOCK to the molecular oscillator was proven 
conclusively when transgenic mCLOCK mutant mice containing wild type mCLOCK bacteria 
artificial chromosome clone rescued rhythmic phenotype of the mutant animals (King and 
Takahashi, 2000).
1.4.3.2.4 Casein kinase 1 e/5
Casein kinase 1 c/5 are involved in the post-translational regulation of the molecular oscillator; 
responsible for gating the nuclear entry (and activity) of the period proteins (Camacho et al., 
2001; Eide et al., 2002; Eide and Virshup, 2001; Keesler et al., 2000; Lowrey et al., 2000; 
Lowrey and Takahashi, 2000). They were characterised from the tau mutant (point mutation 
Cys 178>Arg 178) Syrian hamster (Camacho et at., 2001; Keesler et al., 2000; Lowrey et al., 
2000; Lowrey and Takahashi, 2000). Molecular genetic screens and behavioural observations 
of a population of these animals revealed a spontaneous, semi-dominant negative mutation, 
which caused short-period wheel-running behaviour. Protein interaction studies comparing 
mutant to wild type casein kinase 1 s ability to bind with mPER1 and mPER2 is affected by the
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tau mutation and disabled it's ability to phosphorylate the mPER proteins (Camacho et ai., 
2001; Eide et al., 2002; Eide and Virshup, 2001; Keesier et al., 2000). The dominant negative 
effects of this mutation manifested by prolonged retention of the mPER proteins in the 
cytoplasm and activation of the positive limb of the clock (Camacho et al., 2001; Eide et al., 
2002; Eide and Virshup, 2001; Keesier et ai., 2000; Lowrey et al., 2000; Lowrey and 
Takahashi, 2000).
i .4.3.2.5 TIM
In the fruit fly Drosphila, TIM is central to the regulation of the molecular clock functioning as a 
nuclear translocator of dPER (Sangoram et al., 1998; Williams et al., 2001)Zylka, Shearman et 
al. 1998. TIM is expressed, in the SCN of rodent, together with the other components of the 
molecular clock and is located within the nucleus, at low leveis and is arrhythmic. However, its’ 
function in mammals still remains elusive (CITE). It has been shown to interact with CRY 
proteins in vitro but the functional significance of this partnership is unknown but may provide 
an additional negative regulator to the molecular clock Zylka, Shearman et al. 1998.
1.4.3.3 The effects of light on Clock genes and the ‘oscillator complex’.
The circadian system at the whole animal and biochemical level is known to be acutely 
sensitive to light (Okamura et al., 1999).
Glutamate is the principle neurotransmitter in the photoentrainment pathway of the mammalian 
system (Akiyama et al., 1999b; Ebling, 1996; Tamaru et al., 2000). As discussed in section 
2.2.1-2 glutamate can phase shift SCN circadian activity and is released by the RHT onto the 
ventral surface of the SCN (Ebling, 1996; Hannibal, 2002). The mechanism by which 
glutamate adjusts the clock is time dependent (Ebling, 1996). Topical administration of 
glutamate on SCN slices during the early subjective night targets NMDA receptors and phase 
delays SCN circadian eiectrophysiologicai output (Hannibal, 2002; Hannibal et al., 2001). 
Activation of NMDA receptors in the SCN leads to the activation of ryanodine receptors and 
release of Ca2+from intracellular stores triggering kinase activity (Colwell and Foster, 1992; 
Colwell et al., 1991; Colwell and Menaker, 1992; Colwell et al., 1992; Michel et a!., 2002). 
Exposure of glutamate to SCN slices during the late subjective night results in a phase
advance of eiectrophysiological output (Ebling, 1996). Glutamate during this period activates 
mGluR6 inducing nitric oxide production which in turn stimulates soluble guanyi cyclase 
resulting in an increase in cGMP and activation of cGMP dependent kinases (Haak, 1999),
The transcription profiles of peri and per2 genes have been shown in the mouse, chicken and 
rat to become significantly elevated following a short pulse (10 minutes) of bright light during 
the early subjective night (Jin et al., 1999; Kuhlman et al., 2000; Kuhiman et al., 2003; Morris et 
al., 1998; Wilsbacher et al., 2002; Yamazaki et al., 2000; Zylka et al., 1998) (Namihira et al., 
2001; Namihira et al., 1999a; Namihira et al., 1999b). The response of these genes to light 
correlates to changes in behaviour and eiectrophysiological measure in the same animals. The 
effect is dose and time dependent. Use of anitsense DNA technology in vivo and in vitro 
supported peri role as the primary resetter of the clock (Colwell, 1997; Kuhlman et al., 2000). 
Injections of antisense peri into the SCN of mice prior to the peak of mperl expression and 
exposure to light blunted behavioural responses (Colwell, 1997; Ding et al., 1997).
Light induction of peri and per2 results in phosphorylation of cAMP response element binding 
protein, which is actively recruited, and upregulates CRE containing genes (Namihira et ai., 
2001; Namihira et ai., 1999a; Namihira et ai., 1999b; Shearman et al., 1997; Tamaru et al., 
2000; Yamazaki et al., 2000; Zylka et al., 1998). Deletion mapping analysis of the 5’ promoter 
region of mperl identified the light responsive element as cAMP responsive element (CRE) 
(Kuhlman et al., 2000; Kuhlman et al., 2003). in a transgenic mode! in which 2.1 kb of mperl 
promoter drove a luciferase reporter gene the response of this gene to light was found to be 
absent when CRE was removed (Kuhlman et al., 2000; Kuhlman et al., 2003). The result of 
premature increase in mperl leads to extended period of mcry2 activity prolonging the effect of 
the negative limb of the molecular clock; consequently phase delaying the molecular clock 
(Colwell, 1997; Ding et al., 1997; Kuhlman et al., 2000; Kuhlman et al., 2003).
per2, unlike peri, is only induced by light during the late subjective night (Best et al., 1999; 
Namihira et al., 2001; Namihira et al., 1999a; Namihira et al., 1999b). Light induction of per2 is
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driven by a CRE element in its 5’ promoter. Per2 upregulates BMAL1 expression. Therefore 
exposing an animal to tight between CT 12-16 promotes (or phase advances) the clock position 
towards a new cycle (Field et al., 2000).
Under alternating light dark schedules the expression and activity of clock genes entrain to the 
new lighting schedule (Abe et al., 2001; Griffin et al., 1999; Namihira et al., 2001; Namihira et 
al., 1999a; Namihira et al., 1999b). However, the phase interval, following the new lighting 
schedule, between the clock genes remains synchronised to that described under constant 
conditions. The autonomy of the molecular oscillator has been shown to persist ex vivo, in vivo 
and in vitro under various light schedules; in most laboratory species (Namihira et al., 2001; 
Namihira et ai., 1999a). For example, explant SCN culture from a transgenic rat in which 
luciferase was driven by the PER1 promoter was observed to emit light with a rhythm 
comparable to the whole animal, which was detectable for 32 days (Kuhlman et al., 2000).
1.4.3.3.1 The effect of light on BMAL1
Light, as discussed above, potentiates the negative limb of the molecular clock through the 
release of glutamate (Abe et al., 1998; Abe et al., 1999; Eide et al., 2002; Sanada et ai., 2002; 
Tamaru-et al., 2000). An alternative mechanism that directly affects the positive limb of the 
clock has been shown by Tamaru et ai (2000). This group demonstrated that the BMAL1 
content in rat SCN cetis is significantly decreased following a 10 minute light pulse (Abe et al., 
1998; Abe et al., 1999; Sanada et al., 2002; Tamaru et al., 2000). The sharp reduction in 
BMAL1 content releases the CLOCK:BMAL1 complex from E-boxes resulting in the rapid 
decline (and circadian expression of) in per genes and CCGs. The effect of glutamate on the 
BMAL1 protein cycle was found to be time dependent and mimics the differential phase shifting 
effects of light (and glutamate) observed on overt circadian rhythms (1998; Abe et al., 1998; 
Abe et al., 1999; Eide et al., 2002; Lowrey and Takahashi, 2000; Sanada et al., 2002; Tamaru 
et al., 2000; Vielhaber et al., 2000).
Topical administration of glutamate analogues on SCN slices given during the early subject 
night (CT 15 or ZT 14) significantly reduces BMAL1 protein and delays BMAL1 protein cycle 
(Oishi et al., 1998; Tamaru et al., 2000). BMAL1 protein synthesis is on the rising slope of its 
rhythm at this time (Hogenesch et al., 1997; Hogenesch et al., 1998). A phase delay in the 
protein cycle is caused by the fact that a lag in translation of BMAL1 transcription occurs in 
which pre-light exposure levels of protein have been reached and that of the upward slope of 
the rhythm. The ratio of CLOCK to BMAL1 over a circadian cycle is critical and a sensitivity 
feature or value of the oscillator such that a transient drop in available BMAL1 will have a knock 
on delayed effect on the status of the circadian clock.
When SCN slices are treated with glutamate during the late subjective night (CT 21); 
corresponding to the descending limb of BMAL1 protein synthesis rhythm, relatively moderate 
effects on BMAL1 protein content was observed although has been observed to phase 
advance the rhythm in de novo synthesis of BMAL1 protein (Tamaru et al., 2000). The 
intracellular mechanism that augments the effects of light (or glutamate) on the translation of 
BMAL1 transcripts remains to be elucidated. Despite this lacuna in the regulation of BMAL1, it 
does however appear to be the light sensor of the molecular clock (Balsalobre, 2002; Tamaru 
et al., 2000). Acute reduction of BMAL1 (and consequently available CLOCK:BMAL1 
heterodimer) following a light pulse prevents further activation of E-box dependent gene 
expression such that the rate of transcription from these genes is suppressed consequently 
phase shifting the molecular clock and at the gross level clock control phenomenon.
1.4.3.3.2 Phosphorylated clock proteins marks time!
The activity of a protein is restricted or enhanced by modification to its tertiary structure; 
primarily through addition or removal of charged moieties such as phosphate. Proteins contain 
numerous phosphorylation sites which when modified influence the properties of the protein. 
The addition (and sequence) of a phosphorylation group to a protein reveals motifs within the 
protein that:
> Enable it to dimerise with homoiogues or other proteins
in
> Targets the protein for proteosomal degradation.
Only recently has the importance of phosphorylation to the functioning of the molecular clock 
begun to be understood (Balsalobre, 2002; Camacho et al., 2001; Eide et al., 2002; Keesier et 
al., 2000; Lowrey et al., 2000; Lowrey and Takahashi, 2000; Vielhaber et al., 2000). The 
characterisation, in mammals, of casein kinase 1 epsilon (CKIs) has forced the field to revise 
previous paradigms to include this alternative gating mechanism within the oscillator (Eide et 
al., 2002).
CRY proteins are known to be important in the nuclear translocation of clock proteins and 
specifically the PER proteins at or around CT 12 (Eide et al., 2002). However, studies in vitro 
and using selective knockout models have shown this relationship not to be reciprocated and 
inconsistent (Eide et al., 2002; Griffin et ai., 1999). PER proteins are thought to have 
numerous phosphorylation sites that if phosphorylated enhance or impede interaction with 
other proteins such as CRY (Eide et ah, 2002). Clues to the gating of clock proteins nuclear 
activity have come from studies on the fruit fly Drosophila. In Drosophila DOUBLETIME, an 
orthologue of CK1s, has been shown to maintain equimolar ratios of PER to TIM. PER in the 
fly requires TIM for nuclear entry, however PER is expressed much earlier than TIM (Eide et 
al., 2002; Kloss et ah, 2001). A similar model is thought to occur in the mammalian system 
from the observation of phosphorylated PERs higher rate of turnover in culture. As discussed 
above PER1 & 2 are expressed 4 hours in advance of CRY therefore leading to the suggestion 
that CK1e limits the availability of PER protein until the levels of Cry have reached a sufficient 
level to permit the formation of dimer (Eide et ah, 2002; Kume et al., 1999; Shearman et al., 
2000b)
The stability (or half life) of PER1 and PER2 is reduced in its phosphorylated state (Eide et ah, 
2002; Keesier et al., 2000). in vivo and in vitro studies have shown CK1s binds upstream of 
the nuclear localisation sequence (NLS) of PER1 (Eide et ah, 2002; Griffin et al., 1999). Co­
expression of CKIs and PERI in various cell lines showed PER1 to be retained in the 
cytoplasm and prolonged dimersiation with PER2 (Eide et al., 2002; Griffin et al., 1999). This 
situation phase delays the molecular clock and PER1 transcription, inactivation of CK1s in 
similar experiments showed PER1 to be nuclear active and had no effect on phase position of
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the molecular clock. These data suggested that CK1s phosphorylates sites that influence and 
mask the NLS motif in the PER1 protein limiting the nuclear activity of PER1 (Eide et al., 2002; 
Griffin et al., 1999).
1.4.3.S.3 Clock-controlled genes: E-box motifs interface the core molecular clock to physiological 
processes.
The first clock controlled gene to establish the organisation of the molecular clock with respect 
to a physiological rhythm was the neuropeptide arginine vasopressin (Ingram et al., 1996; Jin et 
al., 1989; Jin et al., 1999; Kalsbeek et al., 1996a; Kalsbeek et al., 1996b; Lam et al., 1999). 
Vassopressin is involved in the homeostatic control of peripheral electrolyte balance and 
modulation of neuronal firing rates (Ingram et al., 1996; Jin et al., 1989; Jin et al., 1999; 
Kalsbeek et al., 1996a; Kalsbeek et al., 1996b; Lam et al., 1999). In the SCN vasopressin is 
produced (and released from axons) in a circadian manner. Transcription of vasopressin 
displays a circadian rhythm that is independent of its own bioactivity (Jin et al., 1999; Kalsbeek 
et al., 1996a; Kalsbeek et al., 1996b). In the homozygous clock mutant mouse vasopressin 
output is severely impaired and arrhythmic (Jin et al., 1999). The characterisation of E-box 
motif in the non-coding regions of the vasopressin gene suggested that the expression of this 
gene is directly driven by the molecular clock (Jin et al., 1999). In vitro reporter gene and 
protein-DNA interaction analysis of the promoter of the vasopressin gene showed all the 
components of the molecular clock to establish an oscillator, which could drive rhythmic 
expression of the reporter, gene transcript (Jin et al., 1999).
Melatonin synthesis (section 1.5.1) in the retina and pineal display a robust circadian rhythm. 
(Klein and Weller, 1972; Niki et al., 1998). The rate of melatonin production is dependent on 
processes that either limit the rate of AANAT transcription or post-transcriptional (-translational) 
processes which affect its activity, intracellular localisation and/or the stability of AANAT protein 
(De Angelis et al., 1998; Gastel et al., 1998; luvone et al., 1997; luvone et al., 2002; luvone et 
al., 1999; Klein et al., 1997a; Niki et al., 1998; Roseboom et al., 1996; Roseboom et al., 
1998).(Baler et al., 1997) AANAT transcription in the retinae of mammalian and non­
mammalian species has repeatedly been shown to be rhythmic; peaking between CT 9 and 
CT15 (Klein et al., 1997a). Northern blot and RT-PCR analysis of clock genes in the retinae of
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rodents maintained under DD and LD conditions showed that expression of CLOCK and 
BMAL1 transcripts mirrored that of AANATI (Bernard et al., 1997a; De Angelis et a!., 1998; 
luvone et al., 1997; Klein et al., 1997a; Roseboom et al., 1996). Sequence analysis of the 
AANAT gene in the rat (and later in human) revealed an E-box motif within the first intron of the 
gene (Baler et al., 1997; Coon et al., 1999; Coon et al., 1996; Ingram et al., 1996; Jin et al., 
1989; Jin et al., 1999; Kalsbeek et al., 1996a; Kalsbeek et al., 1996b; Lam et al., 1999; Niki et 
al., 1998). In vitro reporter gene analysis (dissociated retina primary cell and NIH3T3 cell 
culture systems) showed that the first intron of the rat AANAT gene was capable of recruiting 
the bMAL1/CLOCK heterodimer and remaining components of the molecular clock (as 
implicated by the rhythmic production of the reporter gene) (Ingram et al., 1996; Jin et al., 1989; 
Jin et al., 1999; Kalsbeek et al., 1996a; Kalsbeek et al., 1996b; Lam et al., 1999; Niki et al.,
1998). The dependence of the rhythm in AANAT transcription on the molecular oscillator was 
further confirmed when similar reporter gene experiments were carried out using a reporter 
construct with the first intron of AANAT which contained a 2 bp insertion mutation in the E-Box 
motif (Chen and Baler, 2000; Niki et al., 1998).
15 Melatonin
Melatonin is a neurohormone that was first extracted and studied by McCord et al in 
1917(Karasek, 1999). However, it tool until 1959 to identify the chemical structure of melatonin 
as 5 methoxy-Nacetyltryptamine (Karasek, 1999). Melatonin has since been detected in the 
pineal, retina, harderian gland and various compartments of whole blood; in a variety of species 
(Karasek, 1999; Liebmann et al., 1997; Vivien-Roels et al., 1981). In mammals the pineal 
gland has been shown to be the source of blood plasma melatonin (Arendt and Broadway, 
1987; Lincoln et al., 1982; Thomas and Miles, 1989). The direct action melatonin on individual 
tissue systems is still unclear, however, the characterisation of 3 melatonin receptors 
(Dubocovich et al., 1999; Ebisawa et al., 1994; Reppert et al., 1994) in a number of tissues 
(e.g. retina, pars tuberalis, the pituitary gland, the PVN, and preoptic area of the hypothalamus) 
suggests that it might influence homeostatic functions such as electrolyte balance, 
thermoregulation and sleep propensity (Dubocovich et al., 1999).
Melatonin in the blood displays a robust day-night or circadian profile in ail nocturnal and 
diurnal species studied to date; reaching maximal levels during the night (see discussion of 
comparative studies in Arendt et al (Arendt et al., 1995). The onset of melatonin secretion into 
the bloodstream, in humans, occurs usually between 21-22:00 h elevating to peak 
concentrations at around 02-04:00 h before declining to daytime levels around 08-09:00 h. 
Such an oscillation in pineal melatonin output is highly sensitive to the animal’s exposure to 
light (Cronin et al., 2000). However, the circadian rhythm in melatonin production can persist in 
constant darkness as it is under the control of the SCN (Figure 3 & 4).
The presence of melatonin in blood is now used as a marker of circadian phase during in vivo 
experiments designed to assess various components of the circadian timing system (Cronin et 
al., 2000). Tissue- and time-specific properties of melatonin synthesis and action, in 
vertebrates and non-vertebrates, have defined its role as the ‘night signal’. Pineal derived 
melatonin has been the subject of much study, however, it was not until recently that the 
significance of peripheral tissue melatonin to local physiology has been assessed.
Nocturnal pineal melatonin production is acutely sensitive to light exposure. Several studies 
have attempted to define the lower threshold of light intensity, which could elicit light-mediated
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suppression of pineal melatonin. For instance, Lewy et al (1980) showed that night time 
melatonin secretion was suppressed following 1500lux broad-spectrum light pulse (see 
comparative study in (Arendt et ai., 1995)). Later, (Lewy et al., 1980a; Lewy et al., 1980b) and 
(McIntyre et al., 1987) showed that suppression of melatonin in plasma could be achieved at 
low or dim light (150-500 lux) (ibid Arendt 1995). They showed that light-induced melatonin 
suppression during the first half of the night only required dim light while bright light was found 
more effective during the second half of the night. Other parameters, which are considered to 
be important to the suppression of melatonin, are duration of light exposure, timing of the light 
pulse, irradiance of the light source and wavelength of the light pulse. Short 15 minute pulses 
of 1500 lux between 22:00-23:00 and 5 minute pulses of 2500 lux at 02:00 have been shown to 
suppress melatonin levels (ibid Arendt 1995). Recently findings have shown that light-induced 
melatonin suppression is particularly sensitive to blue/green wavelengths of light (Brainard et 
al., 2001; Thapan et al., 2001).
1.5.1 Melatonin and the retina
The retina of most species synthesises melatonin in a rhythmic manner. This has been shown 
in eyecup preparations from Xenopus (Cahill and Besharse, 1992), mouse (Tosini, 2000), rat, 
and hamster (Lucas et al., 1999; Tosini and Menaker, 1998b). Melatonin is produced in the 
photoreceptor layer of the retina (Figures 1) (Vivien-Roels et al., 1981). Retinal melatonin 
production, in rodents and aves, peaks during the late subjective night (Bernard et al., 1997a; 
luvone et al., 1997; Tosini and Menaker, 1996a; Tosini and Menaker, 1996b; Tosini and 
Menaker, 1998b). Melatonin rhythmicity is maintained under constant conditions and can be 
entrained to an alternative light schedule (Bernard et al., 1997a; luvone et ai., 1997; Tosini and 
Menaker, 1996a; Tosini and Menaker, 1996b; Tosini and Menaker, 1998b). The amplitude 
change in melatonin synthesis in the retina is much lower than that observed in the pineal 
gland (Bernard et al., 1997a; luvone et al., 1997; Tosini and Menaker, 1996a; Tosini and 
Menaker, 1996b; Tosini and Menaker, 1998b).
1.5.1.1 Possible roles for melatonin in the retina
Retinal physiologies, as discussed in section 1.4.3.1, are under the control of a circadian 
oscillator and persist in constant darkness. Melatonin and dopamine have been shown to be
clock controlled genes (Chen 2000). The output of the clock on the retinal physiology is 
thought to be through the coordinated actions of these neurohormones. Melatonin in the retina 
of most species is highest during the night and has been shown to promote dark adaptive 
responses in retinal processes. Dopamine is produced during the day and has been shown to 
regulate retinal physiology during the photoperiod (Besharse and luvone, 1992; Mitchell and 
Redburn, 1991; Tosini, 2000).
Melatonin is known to affect the activity of a number of neurotransmitters involved In the 
circadian regulation of vision. For instance, dopamine (Boatright et al., 1994a; Boatright et al., 
1994b) and acetylcholine (Mitchell and Redburn, 1991) release from amacrine cells is inhibited 
by melatonin. Melatonin has also been shown to stimulate photoreceptor transmission by 
promoting the release of glutamate from photoreceptor terminal (Faillace et al., 1996). The 
robustness of the melatonin rhythm in the retina is now throught to be the circadian [paracrine] 
driver of the retinal clock triggering scotopic restricted retinal processes; such as ROS (Tosini 
1996).
Classical pharmacological experiments have shown melatonin to directly regulate 
photomechanical movements in photoreceptors and retinal pigmented epithelium (RPE). 
Furthermore, melatonin promotes rod outer segment disc shedding and phagocytosis by RPE 
(Green, 2003; Pierce and Besharse, 1985; Pierce and Besharse, 1988). The mechanism by 
which melatonin regulates these scotopic retinal activities in unknown.
A number of well-documented retinal rhythms, such as rod ERG b-wave activity (Fain and 
Usman, 1999; Manglapus et al., 1999), cone outer segment elongation (Pierce and Besharse, 
1988), have been shown to exhibit a similar circadian profile on melatonin. All of these 
processes have been shown, under classical circadian experimental conditions, to maintain 
their rhythmic profiles independent of environmental cues (i.e. they are endogenously 
rhythmic). Exogenous application of melatonin to eyecup preparations of the rat and xenopus 
has shown melatonin to drive the regulatory timing of these processes. For instance, Besharse 
et al (1983) In Xenopus eyecup preparations showed that melatonin could Induce a burst of rod 
disc shedding and Fain et al (1989) showed the ERG-b wave profile to be inhibited by 
melatonin.
Serotonin
Serotonin N-acetyltransferase (N AT) 
;C H2N H C O C H 3
N-acetylserotonin
Hydroxyindole-O-methyitransferase (HIOMT)
Figure 4. The melatonin synthetic pathway. Taken from Arendt, 1996)
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osciiiator (Ask et al., 1986). The melatonin rhythm in the pineal is driven by the SCN. The 
pineal receives direct input from the SCN via the peripheral sympathetic tract ascending from 
the superior cervical ganglion (Coon et al., 1997). The SCN signals circadian and entraining 
parameters to the melatonin synthesis pathway by releasing noradrenaline from terminal of 
sympathetic neurons(Bernard et al., 1997a; Klein et ai., 1997b). The targets of these receptors 
are melatonin synthesis pathway.
The retina, as described in section 1.4.3.1, contains an oscillator. The rhythm in melatonin 
synthesis in mouse, hamster and Xenopus retinae can be maintained ex vivo (Tosini and 
Menaker, 1998a). The interface between melatonin synthesis and the retinal oscillator is 
discussed later.
1.5.3 Regulation ofAANA T as with any protein is dependent on the rate of protein
synthesis and turnover.
1.5.3.1 Transcriptional control of AANAT gates melatonin synthesis
Transcription of AANAT, in the rat retina, begins to rise late in the subjective afternoon peaking
between circadian time (CT) 15-21 with an amplitude four order greater than the day (Coon et
al., 1995; Roseboom et al., 1996). This nocturnal rise in AANAT transcription has been shown
in the chick (Bernard et al., 1997a; Klein et al., 1997b), mouse (Tosini and Menaker, 1998a),
and hamster (Tosini and Menaker, 1998b) retinae to persist, in vivo (and ex vivo) in constant
darkness. These data provide further support for the existence of a retinal oscillator. The
mammalian pineal gland, however, is dependent on the SCN for time cues (Klein et al., 1997a).
Only AANAT has been shown to gate the timing of melatonin synthesis even though TPH
mRNA and protein oscillate (luvone et al., 1997). The nocturnal rise and diurnal fall in TPH in
the photoreceptor layer is thought to be a passive inhibitory response to light. However, it was
not until nucleotide sequence analysis of AANAT promoter in the rat and chicken that a
comprehensive understanding of the regulatory control of this gene was fully appreciated
(Fouikes et al., 1996; Maronde et al., 1999a; Maronde et al., 1999b; Niki et al., 1998;
Roseboom et al., 1998).
The promoter of a gene dictates the tropic (temporal and spatial) expression profile of that 
gene. Clues to the mechanism that regulates AANAT gene expression have come from the 
recent characterisation of AANAT promoter. It was found to contain regulatory motifs critical to 
the regulation of clock gene activity (Klein et al., 1997a; Niki et al., 1998).
1.5.3.2 The structure of Human AANAT
1.5.3.2.1 Negative modulators
AP-1 motif: proximal to the assembly point of RNA polymerase complex progressively 
recruiting the negative transcription regulator FRA-2. Binding of FRA-2 is thought to destabilise 
this complex preventing further rounds of de novo AANAT mRNA transcription.
ORE motif acts as a positive and negative regulatory element recruiting cAMP responsive 
element molecules such as ICER and CREB. Occupancy of this motif by ICER down regulates 
AANAT transcription in the presence of suppressed intracellular cAMP content.
Simultaneous occupancy of AP-1 by FRA-2 and CRE by ICER is currently though to 
downregulate transcription of AANAT.
1.5.3.2.2 Positive modulators
CRE motifs interacts with CREB, in the absence of ICER, amplifies transcription of AANAT.
Inverted CCAAT box recruits members of CATBP transcription family. Gene reporter studies 
have shown that the presence, position and sequence interval between this and the CRE motif 
are critical for basal and stimulated AANAT transcription.
1.5.3.2.3 Photoreceptor signal regulator
CRX motif homeobox element restricts gene expression to retina and pineal tissue. During 
development and subsequent ontogeny of the pineal gland and retina establishment of a gene 
expression programme which permanently switches on organotropic genes essential (and 
unique) to the function of these tissues.
IQ
1.5.3.2.4 Circadian regulator
E-box is thought to be the chronotrophic restricting element and is located within the promoter 
and first intron of the AANAT gene. Clock transcription factors are recruited to this element and 
adjust the amplitude of expression according to transient changes in the composition of 
oscillator complex.
The concerted action of these motifs tightly regulates and restricts the synthesis of melatonin to 
the scotophase in the photoreceptor and the pineal gland. Ali of these transcription factors and 
elements are acutely sensitive to thresholds in intracellular cyclic nucleotide; such as cAMP 
(Foulkes et al., 1996; Maronde et al., 1999a; Maronde et al., 1999b; Niki et al., 1998; 
Roseboom et al., 1998; Sugden et al., 1985).
1.5.4 cAMP regulates A AN A T activity.
cAMP serves a dual role in regulating AANAT either acting as a secondary messenger up- 
reguiating transcription/translation of the respective AANAT transcription factors (e.g. CREM 
and clock proteins) genes or as a substrate for kinase(s) to phosphorylate (and activate_ these 
transcription factors (e.g. CREB) (Bernard et al., 1997a; Bernard et al., 1997b; Foulkes et al., 
1996; tuvone et al., 1997; Klein et al., 1997a; Maronde et al., 1999a; Maronde et al., 1999b; 
Niki et al., 1998; Roseboom et al., 1998) (Foulkes et ai., 1996; Maronde et al., 1999a; Maronde 
et al., 1999b; Niki et al., 1998; Roseboom et ai., 1998)
1.5.4.1 cAMP frans-activates AANAT expression in the retina
cAMP in the retina does not display a significant change in amplitude although has been shown 
to decrease following short exposure to bright light (Bernard et al., 1997a; Bernard et al., 
1997b; luvone et al., 1997; Klein et al., 1997a; Maronde et al., 1999a; Maronde et al., 1999b). 
A rise in cAMP resulting from stimulation of a receptor-mediated pathway(s) induces cAMP 
dependent gene expression though activation of CREM transcription factors (Foulkes 1996, 
Roseboom 1998). A rise or fall in cAMP alters the ratio of activator (CREB) form to its 
repressor (ICER) form (Foulkes 1996, Roseboom 1998). CREB and ICER are transcribed from 
the same gene, namely the CREM gene. The gene products of CREM regulate its own and 
AANAT transcription through CRE motifs embedded in its untranslated region (Niki 1999,
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Molina 1993, Stehle 1993). ICER is constitutively transcribed from CREM via the 3’ promoter 
(designated the P2 element) while CREB is transcribed from the 5’ promoter (designated the 
P1 element) that is acutely sensitive to cAMP threshold (Foulkes et al., 1996; Foulkes et al., 
1997; Ganguly et al., 2001; luvone et al., 1997; Klein et al., 2002). These two functionally 
opposing transcription factors participate in an auto-regulatory loop that is re-iterated once 
ICER protein accumulates to a level that inhibits its own expression and induces CREB 
expression (Maronde et al., 1999a; Pfeffer et ai., 2000; Pfeffer et al., 1999). cAMP can also 
induce AANAT transcription by mobilising/activating CREB; where It acts as the substrate for a 
CREB-specific kinase(s). Studies in rats have shown basal and cAMP induced AANAT 
transcription (and activity) is suppressed when rat pineal gland cultures were exposed to 
protein kinase A antagonists; an enzyme which selectively phosphoryiates proteins using ATP 
as a source of phosphate (Maronde et ai., 1999a; Maronde et al., 1999b; Sugden et al., 1985).
1.5.4.2 AANAT activity is gated by factors that regulate protein stability
AANAT has unequivocally been shown to be the rate-limiting enzyme in the melatonin
biosynthesis pathway with a half-life of approximately 20 minutes(De Angelis et al., 1998) 
(Khalil et al., 1998). The kinetic fidelity of an enzyme is dependent on:
> modifications to the enzyme’s tertiary structure such as formation of oligmer 
complexes,
> cleavage of inhibitory peptides,
> sequential phosphorylation of the native proteins or
> the actions of proteolytic enzymes.
The contribution of post-translational AANAT and transcription mechanisms in the chick retina 
and pineal to gate melatonin synthesis have been shown to be tissue and species specific 
(Bernard et al., 1999; Coon et ai., 2001; Falcon et al., 2003; Klein et al., 2002; Maronde et al., 
1999a; Maronde et al., 1999b). These observations have led many groups to consider a post- 
translationai mechanism to be the major gating component of the melatonin rhythm in retina 
and pineal (luvone et al., 2002; Klein et al., 2002) (Bernard et al., 1999; Maronde et al., 1999a; 
Maronde et al., 1999b). Under constant conditions the mRNA and AANAT activity profiles are 
parallel but under diurnal conditions amplitudes in AANAT activity (and abundance of protein) 
are much greater than the abundance AANAT mRNA transcripts in both tissues (Klein et al.,
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2002; Scheibner, 2002). These observations are consistent with a proteasomaf proteolysis 
mechanism (luvone et al., 2002; Klein et al., 2002) such that the availability of active AANAT 
protein is reduced by proteolytic enzymes limiting the rate of acetylating serotonin and hence 
melatonin output. However, such a mechanism must interface and respond to modalities 
affecting transcription of AANAT such as those driven by an oscillator (Chen 2000, Niki 1998, 
Oishi 1998, Sakamoto 1998, Maronde 1999, Pfeffer 1999).
Proteasomal proteolysis as a means of regulating the circadian AANAT (and consequently 
melatonin) rhythm[s] has been demonstrated in pike, seabream and trout retinae (Falcon et al., 
2001; Falcon et al., 2003; Ganguly et al., 2001; Gastel et al., 1998; Klein et al., 1997a; Obsil et 
al., 2001). The trout retina expresses 2 isoforms of AANAT; namely AANAT1 and AANAT2. 
AANAT2 shares a similar kinetic profile and a high degree of DNA and amino-acid sequence 
identity with known mammalian AANATs (Begay et al., 1998; Coon et al., 1999; Falcon et al., 
1998; Falcon et al., 2001; Falcon et al., 2003; Gothiif et al., 1999; Mizusawa et al., 2000). 
Inhibition of the proteolytic pathway of AANAT in the trout retinal organ culture demonstrated 
melatonin synthesis to be dependent on the absolute amount of AANAT (Begay et al., 1998; 
Coon et al., 1999; Falcon et al., 1998; Falcon et a!., 2001; Falcon et al., 2003; Gothiif et al., 
1999; Mizusawa et al., 2000). The activity of AANAT was not diminished by the inhibitory effect 
of light suggesting that the availability of de novo AANAT protein is critical to melatonin 
synthesis (Falcon et al., 2001; Mizusawa et al., 2000; Willbold et al., 2002). This work has 
since been repeated in the rat retina in which an inhibitor of protein synthesis administered at 
night led to a decrease in AANAT protein pool and activity (Falcon et al., 2001; Mizusawa et al., 
2000; Willbold et at., 2002). The suppressive effect of light on AANAT activity was prevented 
when rat pineal cultures were treated with a specific 20S proteosome inhibitor (Klein et al., 
2002; Klein et al., 2003). cAMP has a role in the proteosomal proteolysis control of AANAT as 
observed when inhibitors of protein synthesis failed to impact on AANAT activity following 
elevation of intracellular cAMP level by forskolin treatment activity (Falcon et al., 2001; Klein et 
al., 2002; Klein et al., 2003; Mizusawa et ai., 2000; Willbold et al., 2002). Taking the above 
studies together with a model postulating how light and darkness impact on the melatonin 
rhythm suggests that cAMP regulates the availability of AANAT protein by stabilising AANAT 
protein through selective phosphorylation of the AANAT protein activity (Falcon et al., 2001; 
Klein et ai., 2002; Klein et al., 2003; Mizusawa et ai., 2000; Willbold et al., 2002).
AO
The kinetic parameters of the retinal AANAT enzyme are thought to be moderated through 
selective cAMP dependent phosphorylation of AANAT. AANAT contains numerous 
phosphorylation sites that may or may not be phosphorylated at any given moment (Ferry et 
al., 2002; Ganguly et al., 2001; Klein et al., 2002; Koch and Korf, 2002; Obsil et a!., 2001). The 
particular phosphorylation status of a protein dictates the activity of that protein, the intracellular 
location, its ability to interact with other proteins and ultimately its susceptibility to proteolytic 
events (Klein et al., 2002; Klein et al., 2003). However, one must bear in mind that upstream 
and downstream cAMP dependent pathways influence the expression of gene finjdirectly 
involved in melatonin synthesis.
1.5.5 Effects of light on retinal melatonin
Melatonin levels in the retina are dramatically reduced following short periods of light exposure 
during the scotophase (Bernard et al., 1999; Bernard et al., 1997b; Chong et al., 2000; luvone 
et al., 1997; luvone et al., 1999; Klein et al., 1997a). Thomas and luvone (1991) in a series of 
simple experiment in the chick retina in vitro demonstrated that 1 hour of broad spectrum white 
light administered around the mid-part of the scotophase resulted in a n 80% decrease in 
AANAT activity which was associated with a 30% drop in AANAT mRNA (Bernard et al., 1999; 
Cahill, 1996; luvone et al., 1999; Zatz et al., 2000). Comparing this data with that of other 
enzymes involved in the synthesis of melatonin (Figure 6) only TPH showed an appreciable 
drop in mRNA (30%); however this had negliable effect on the kinetics of 5-hydroxytryptophan 
production (Bernard et al., 1999; Cahill, 1996; luvone et al., 1999; Thomas et al., 1998; 
Thomas and luvone, 1991; Thomas et al., 1993). This and other studies Xenopus indicated 
that light suppresses retinal melatonin synthesis by altering the activity of AANAT (Bernard et 
al., 1999; Cahill, 1996; Greve et al., 1999; luvone et al., 1999). Two models have been 
postulated to describe the temporal photo-refractive kinetic gating of retinal AANAT.
1.5.6 Circadian oscillator regulates nocturnal rise in retinal AANA T expression
The iterative nocturnal rise in retinal melatonin synthesis and AANAT mRNA expression ex vivo
and under constant conditions suggested it is maintained by an endogenous timing mechanism 
(Tosini 1998). Bioinformatic analysis of AANAT of Xenopus (Cahill, 1996) and rat are almost
identical (Niki 1998, Fukuhara 2000, Chen 2000, Baler 1997, Namihira 1999). Similar analysis 
of AANAT in the pineal and retina showed that the same gene is expressed in both tissues 
(Niki 1998, Fukuhara 2000, Chen 2000, Baler 1997, Namihira 1999). Both tissues have been 
shown to express functional clock genes (Niki 1998, Fukuhara 2000, Chen 2000, Baler 1997, 
Namihira 1999). AANAT contains an active clock controlled E-box in its first intron (Chen 2000, 
Fukuhara 2000). As discussed in section 2.3.4 the promoter and this E-box can drive the 
circadian expression of AANAT transcription and reporter genes in vitro (Niki 1998, Fukuhara 
2000, Chen 2000, Baler 1997, Namihira 1999). Mutations to the clock controlled E-box result 
in arrhythmic AANAT synthesis (Niki 1998, Fukuhara 2000, Chen 2000, Baler 1997, Namihira
1999). However, the mammalian pineal does not to possess a pacemaker requiring the SCN 
to augment circadian expression of AANAT in the pineal (Pfeffer 1999, Baler 1999). 
Interestingly, reporter gene studies exist in which the promoter of a rat AANAT failed to drive 
rhythmic expression of the reporter gene when transfected into pinealocyte culture (Pfeffer 
1999, Baler 1999).
1.5.7 Species differences in retinal melatonin synthesis
It must however be stated that clear species differences in retinal melatonin rhythm are 
apparent in the non-mammalian species such as quail, chicken and Xenopus (Cahill 1996).
A note of caution repeatedly stressed in the literature states that melatonin synthesis is subject 
to tissue (and species) specific processes even though their AANAT gene product sequences 
share a high degree of sequence identity. For instance, the avian pineal exhibits a 10 fold 
change in melatonin output over a circadian cycle compared to a 100-fold amplitude change in 
melatonin production in the rat (De Angelis et al., 1998). Furthermore, the expression of 
AANAT mRNA in the rat pineal gland is 50 to 100 times greater than that detected in the retina 
(Roseboom et al., 1996). Authors in a recent publication have indicated that the amplitude of 
melatonin synthesis may reflect the divergent neuroanatomy of these tissues. The retina, for 
instance is an independent structure that directly innervates other CNS structures but receives 
little retrograde afferent signaling from the CNS. This contrasts with the pineal gland that is 
innervated from a variety of CNS structures. As mentioned in above the promoter of a gene 
contains elements that moderate its activity. Although the aforesaid motifs have been found to
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be active in the pineal and retina, further bioinformatic analysis of the remaining AANAT 
promoter sequence could reveal motifs which regulate the amplitude of transcription in specific 
tissues (Gastel 1998, Ganguly 2001, Falcon 2001, Bernard 1999, Zatz 2000, Roseboom 1998, 
1996).
1.5.8 Melatonin receptors
The action of melatonin (Section 1.5.1.) in the CNS and peripheral tissues is largely thought to 
be mediated by a subtype of pertussis toxin sensitive guanylyi nucleotide binding protein (G- 
protein) coupled receptor superfamiily (Dubocovich et al., 1999; Ebisawa et al., 1994; Nosjean 
et al., 2001; Reppert et al., 1994). Radioligand binding studies, using 2-[125l] iodomelatonin, (in 
vitro and in vivo) have identified, in a variety of species (and tissues), three melatonin-binding 
receptor subtypes; namely Mti, MT2 and Mt3 (Dubocovich et al., 1999; Ebisawa et al., 1994; 
Nosjean et al., 2001; Reppert et ai., 1994). Each of these melatonin receptor subtypes exhibits 
a distinct variance in their relative affinity for melatonin (and various analogues), kinetic mode 
of association (and dissociation) with melatonin and tissue distribution (Dubocovich et al., 1999; 
Ebisawa et al., 1994; Nosjean et al., 2001; Reppert et al., 1994).
The first of the melatonin receptors to be characterised at the molecular level was mti from 
Xenopus dermal melanopores (White et al., 1987). The molecular mass of this melatonin 
receptor, as estimated from affinity-gei chromatography, is 150 kDA and contains 420 amino 
acids arranged into extracellular domain, the seven transmembrane domain incorporating the 
melatonin binding pocket and the intracellular domain which couples with the G-protein 
(Dubocovich et al., 1999; Ebisawa et ai., 1994; Nosjean et al., 2001; Reppert et al., 1994). This 
cDNA clone subsequently acted as a template to screen tissues/species specific cDNA libraries 
for other melatonin receptor clones (Dubocovich et al., 1999; Ebisawa et al., 1994; Nosjean et 
al., 2001; Reppert et al., 1994). Melatonin receptors nucleotide and amino acid sequences 
show high degree of conservation between species (>60%) and receptor subtype (>90%). For 
instance, human (and the sheep) Mti shares a 60% amino-acid sequence homology with the 
Xenopus Mti (Dubocovich et al., 1999; Ebisawa et al., 1994; Nosjean et al., 2001; Reppert et 
al., 1994) (White et al., 1987). Dissimilarity in amino-acid sequence is noticeably evident at the 
NH- and COOH- terminus of the amino-acid sequence of these receptors (Dubocovich et al., 
1999; Ebisawa et al., 1994; Kokkola et al., 2003; Kokkola and Laitinen, 1998; Kokkola et al.,
1998; Nosjean et al., 2001; Reppert et al., 1994). The NH-terminus Influences the kinetic 
properties of melatonin binding pocket defining the selectivity of the receptor for specific (or 
combinatorial) molecular group[s] on the melatonin molecule (Dubocovich et al., 1999; Ebisawa 
et al., 1994; Kokkola et al., 2003; Kokkola and Laitinen, 1998; Kokkoia et al., 1998; Nosjean et 
al., 2001; Reppert et al., 1994). The COOH-terminus, on the other hand, is involved in 
differentially transducing melatonin signal to downstream effector signaling pathways 
(Dubocovich et al., 1999; Ebisawa et al., 1994; Nosjean et al., 2001; Reppert et al., 1994). The 
COOH-terminus is also important in determining the affinity-state of the receptor for melatonin 
(and its analogues) (Dubocovich et al., 1999; Ebisawa et a!., 1994; Kokkoia et al., 2003; 
Kokkola and Laitinen, 1998; Kokkola et al., 1998; Nosjean et al., 2001; Reppert et al., 1994). 
That is differential phosphorylation of the 6 known phosphorylation sites within the COOH- 
terminus couple or uncouples the receptor form G protein (Dubocovich et al., 1999; Ebisawa et 
al., 1994; Kokkola et al., 2003; Kokkola and Laitinen, 1998; Kokkola et al., 1998; Nosjean et al., 
2001; Reppert et al., 1994). in the uncoupled state melatonin receptors have a low affinity for 
ligand and in the couple state a high affinity for melatonin (Kokkola et al., 2003; Kokkola and 
Laitinen, 1998; Kokkola et al., 1998). In the coupled state melatonin binding to the receptor 
down regulated cAMP synthesis by inhibiting adenylate cyclase through it’s activated G-protein; 
consequently down regulating AANAT and melatonin production (section 1.5.4). Amino-acid 
sequences containing regulatory motifs such as the N-linked glycosylation and PKC 
phosphorylation sites are highly conserved between receptor subtypes and species (Kokkola et 
al., 2003; Kokkola and Laitinen, 1998; Kokkola et al., 1998).
1.5.8.1 Melatonin receptors and the retina.
The retina has been shown to express all three melatonin receptors. However, only Mti and 
M 2 have been shown to any degree to be biologically active in the retina (Ebisawa et a!., 1994; 
Reppert et a!., 1994)
Mti in the guinea pig (Beresford et al., 1998), chicken (Dubocovich et al., 1989), lizard 
(Wiechmann and Wirsig-Wiechmann, 1994), human (Meyer et al., 2002), and rabbit 
(Dubocovich and Hensler, 1986) show immunoreactivity throughout the neural retina (Figure 1).
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The highest density of Mti was found to be in the inner segment of the cone (and rod) 
photoreceptors and ganglion cell layer (Meyer et al., 2002; Savaskan et al., 2002; Scher et al., 
2002; Seron-Ferre et al., 2002). Lower, but yet functionally significant immunoreactivity in 
those species was also apparent in the horizontal cells, amacrine cells and plexiform layers 
(Savaskan et al., 2002; Scher et al., 2002; Seron-Ferre et al., 2002, Meyer, 2002 #1344). This 
has provided a mechanistic link between the multifarious effects of retinal melatonin on retinal 
physiology and the discriminative role of melatonin receptors. For instance, melatonin is known 
to enhance the sensitivity of horizontal cells in dark-adapted retina and suppress retinal 
dopamine production by amacrine cells (Savaskan et al., 2002; Scher et al., 2002; Seron-Ferre 
et al., 2002, Meyer, 2002 #1344). However, the direct association between the distribution of 
specific melatonin receptors subtypes and such physiologies has yet to be proven. The affinity 
and potency of Mti and Mt2 selected analogues in retina tissue between species does exhibit a 
degree of variance (Dubocovich et al., 1999; Ebisawa et al., 1994; Nosjean et al., 2001; 
Reppert et al., 1994).
Melatonin, in the retina, is synthesised and released by the photoreceptors where it freely 
distributes across the retina. The action (availability) of melatonin is site (as discussed above) 
and time specific (Carlberg, 2000; Dubocovich et a!., 1999; Ebisawa et ai., 1994; Nosjean et al., 
2001; Reppert et al., 1994). The density of melatonin receptors has been shown in Xenopus 
and rat SCN ceils, to exhibit a circadian rhythm (Green, 2003; Wiechmann, 2002; Wiechmann,
2003).
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1.6 Y 7 9  r e t in o b la s to m a  c e lls
Studies on the effects of melatonin on retinal physiology are limited to rodent and lower 
vertebrate species. Understanding the modalities of melatonin on human retinal processes is 
restricted to post-mortem tissue. A number of human cell lines have been developed to further 
our understanding of this subject. Y79 retinoblastoma ceil line is the only commercially 
available system that produces melatonin.
The Y79 retinoblastoma cell line was established as a human retina in vitro model from a 
primary human retinoblastoma tumour (Green et al., 1979; Jiang et al., 1984; McFail et a!., 
1978; McFail et al., 1977). Retinoblastoma presents as a metastatic intraocular tumour in 
children affecting 1 in 200,000 births. The aetiology of this tumour is a genetic lesion of the 
RB1 gene on the long arm chromosome 13. 95% of diagnosed cases spontaneously arise and 
5% are hereditary where parent[s] have been similarly affected (Griegel et al., 1990a; Griegel 
et al., 1990b; Leach et al., 1990). The gene product of RB1 is a tumour suppression factor, 
which is known to switch the cell cycle to a quiescent state. Loss of both RB1 alleles renders 
the rod photoreceptor cells anaplastic leading to the formation of a progressive tumor mass that 
eventually compromises the neural retina and ocular cavity resulting in loss of vision.(Chevez- 
Barrios et al., 2000)
The cell line was developed from a tumour derived from the left ocular orbit of a 2.5 year old 
female by Reid et al in 1974. Cells that had sloughed off from the tumour mass during an 
explant culture of the original tumour were sub cultured resulting in the clonal expansion of the 
Y79 cell line and development of an invaluable tool to define; in vitro, the cellular physiological 
mechanism of phototransduction cascade and melatonin synthesis.
The microenvironment of developing retina, as discussed in section 1.3, determines the fate of 
the RPCs. Similarly cells in culture are likewise responsive to growth substrate and growth 
promoting factors in the medium. The exact phenotype of this cell line, like any cell line, is 
dependent on the experimental culture conditions. To evaluate a retina specific process using 
a cell line system one has to consider the cytogenesis of that cell line.
1.6.1 Growth substrate
A key event during tumourogenesis is the ‘global’ modulation of intercellular surface adhesion 
molecule (ICAM) profile of the antecedent tumour cell to that of its ‘parent’ cell. During 
development ICAMs are known to be involved in differentiation of cell types (Belliveau and 
Cepko, 1999; Cepko, 1999). Loss of a specific ICAM profile is a classic feature of tumour cells 
and histologically associated with the de-differentiated phenotype of that tumour. 
Tumourogenesis leads to alteration in the cells’ ICAM repertoire that affects gene transcription 
via lack of sustained intracellular stimulus associated with ICAM-extracelIular matrix or 
neighbouring ceiluiar membrane (del Cerro et al., 1992; del Cerro et al., 1993).
In the case of the Y79 retinoblastoma cells comparative histochemical studies have shown 
(Higashi et al., 1988; Kato and Wakabayashi, 1988; Schiffman and Grunwald, 1992; Schmidt- 
Erfurth et al., 1997; Seigel and Notter, 1993; Seigel et al., 1994; Skubitz et al., 1994; Tombran- 
Tink and Johnson, 1989a; Tombran-Tink and Johnson, 1989b; Tombran-Tink et al., 1992; 
Tombran-Tink et al., 1994; Van Aken et al., 2002)
> Down regulation of a1 , a2, a3 and a5 integrin subunits that form receptors for type IV 
collagen, laminin and fibronectin of the Bruch’s membrane.
> Up-regulation of a4, aV and p1 integrins which serve as receptors for fibronectin.
Cell cultures are maintained in plastic vessels that have a net positive charge. Adhesion to the 
growth vessel either:
a. requires supplementation of the growth surface with basement membrane derived 
factors such as fibronectin fragments (33/66 Kda C terminal fragment or whole 
molecule) of adhesion moiecules derived from the Bruch’s membrane of the NHR RPE 
(Figure 1),.or
b. treatment of plasticware with a synthetic cell-plastic adhesion charged matrix such as 
poly D-lysine (or D-ornithine).
Although no formal comprehensive study has been conducted to evaluate the effect of 
constructing an artificial Bruch’s membrane morphology and physiological phenotype, Y79 cells 
grown as a monolayer resemble the photoreceptor cell type. However, the degree of 
differentiation is dependent on the time in culture and composition of the growth medium. The 
majority of published studies using Y79 cells as model system of the retina have only used poly 
D-lysine as the growth substrata (Table 3). Many of these papers describe these cells as
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dedifferentiated inducing a differentiated state using sodium butyrate (NABUT) reagent or 
dbcAMP (Table 2-3).
16.2 Growth medium
Y79 cells like retinal cells have a high metabolic capacity and therefore need to be 
supplemented with high amounts of glucose (typically 4-6 g/L/1 e6 cells). These cells can be 
maintained on most classic commercially available medium systems, as their demand for basic 
nutrient species is low. They do not require the use of feeder cells to supplement growth 
factors since they are able to derive them (e.g. insulin) from the medium and can grow 
adequately in serum free medium. No appreciable increase in cell death has been reported 
when Y79 cells are maintained in serum free, dialysed or serum containing medium (Janavs et 
al., 1995; McFall et al., 1977; Slade et al., 2003; Tombran-Tink and Johnson, 1989a; Tombran- 
Tink and Johnson, 1989b; Yorek et al., 1989).
1.6.3 Morphological and physiological similarities between the human retina and that 
o f Y79 cells.
The histological characteristics of Y79 ceils grown as a monolayer induced by poiy D-lysine 
and fibronectin resemble those of photoreceptors (Higashi et al., 1988; Kato and Wakabayashi, 
1988; Schiffman and Grunwald, 1992; Schmidt-Erfurth et al., 1997; Seigel and Notter, 1993; 
Seigei et al., 1994; Skubitz et al., 1994; Tombran-Tink and Johnson, 1989a; Tombran-Tink and 
Johnson, 1989b; Tombran-Tink et al., 1992; Tombran-Tink et al., 1994; Van Aken et al., 2002). 
Reid et al observed these cells to form Flexner wintersteiner rossettes arrange in a 9 + 0 
configuration consisting of low columnar cell type with ciliary (neurite) processes projecting 
from the apical border(Bartova et al., 2003). These macroscopic features together with sub 
cellular features such as sequential appearance of apico-lateral intercellular zonular adheren 
junction, nuclear envelope infolds, triple membrane structures, smooth muscle coated vesicles, 
aggregates of actin filaments forming filopoducle protrusions, and are concomitant with the 
inner segment of the photoreceptor(Bartova et al., 2003).
Y79 celts have repeatedly been shown to express, in monolayer culture, biochemical markers 
normally restricted to photoreceptor cells (table 2). Furthermore, these cells have been shown 
to express intact rod and cone phototransduction cascade (e.g. Di polo et al 1995), melatonin 
and catecholemine (Yorek et al., 1987a; Yorek et al., 1986; Yorek et al., 1987b) (Farber, 1995; 
Farber Debora et al., 1991) (Di Polo and Farber, 1995)biosynthesis pathway. These pathways 
have been shown to be as responsive to classic agonist/antagonists as observed in vivo. 
Adrenergic, dopaminergic and cholinergic neurotransmitter mechanisms have been described 
as being functionally intact (Yorek et al., 1987a; Yorek et al., 1986; Yorek et al., 1987b). The 
defining phenotypic marker of this cell line was the discovery which they co-express all the 
known photoreceptor specific homeodomain transcription factors; namely CRX, TLX, OTX, 
photoreceptor cell-specific nuclear receptor (PNR), ERX and NRL (Kobayashi et al., 1999). 
These transcription factors are known to be critical in establishing photoreceptor cell gene 
expression profile during development (Kobayashi et al., 1999). PNR for instance is 
exclusively expressed in the outer segment of the photoreceptor cell (Kobayashi et al., 1999). 
In Xenopus, PNR and TLX has been shown to be involved in regulating photoreceptor cell 
differentiation of and maintenance. Inhibition of PNR function results in termination of modeling 
of eye vesicles (Belliveau and Cepko, 1999; Cepko, 1999). PNR is thought to suppress; during 
development and ontogeny, gene expression that is refractory to photoreceptor cell function 
(Belliveau and Cepko, 1999; Cepko, 1999) (Kobayashi et al., 1999).
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N e u r o n a l P h o t o r e c e p t o r  f e a t u r e s
F e a t u r e s
Structural Biochem ical Rod C one Other
Neurite specific M AP2 Dopam ine p- Rod oc-PDE Cone A ’P D E Phosducin
(Bartova 2003, Green 1979) hydroxylase
(Yorek 1987)
(Di Poto 1995) (Hurwitz 1990, Di 
polo 1995)
(Craft etal., 1998)
C la s s  III p-hum an D2 dopamine receptors Rod p -P D E P N Rr l r \
tubulin D2 (Yorek 1987 (D iP ob  1995) (Kobayashi 1999)
(Vitamen 1988)
Synaptophysin Neuron specific Rod T a Recoverin
(Vitamen 1988) enolase
(Tombran-Tink 1989, 1992, 
Siegel 1993)
(Di Polo 1995) (Weichmann 1996)
Neurofilament protein Choline Rhodopsin Catecholam ine
(Tombran-Tink 1989, 1992, 
Siegel 1993)
acetyltransferase
(Yore/c/985, 1986, 1987)
(Di Polo 1995) (Yorek 1987)
Ciliary bodies Melatonin synthesis Pre-m elanosom e
(Bartova 2003, Green 1979) (cf refs Wiechmann 1999) (Bartova 2003)
Retina S-antigen Glycine, G lycogen and Interphotoreceptor P2  Receptor
(Tombran-Tink 1989, 1992, 
Siegel 1993)
P D E  transporters
(Yorek1985,1986, 1987)
retinal binding protein
(Tombran-tink 1989,1992)
(Bartova 2003
Vimentin Glial fibrial acidic NeuroD Insulin receptor
(Yamashita 2002) protein
(Vitamen 1988)
(Noma et at., 1999) (Yorek1985, 1986, 
1987)
A LP L1 C R X , O TX , P R X
(Akey et al., 2002) (Kobayashi et al., 1999; 
Lem eretal., 2002)
M LG A P C N Cadherin
(Yamashita et al., 2002) (Skubitz 1994)
P h L P S I  & 2
(Craft etal., 1998)
Myelin binding protein P N R P h L O P S  1 & 2
(Vitamen 1988) IGF-1
(Kobayashi et al., 1999)
(Craft etal., 1998)
Table2. Compendium of morphological and physiological features associated with the neural retina which have been found to 
be functionally intact in Y79 retinoblastoma cells.
This concert of expressed genes is indicative of a photoreceptor cell lineage. Indeed 
Kobayashi and other groups have shown these homeobox genes to participate in a 
photoreceptor ceil specific transcription cascade influencing each other gene expression 
profiles.
The Y79 cell line, however, does exhibit features associated with other retinal ceil types. For 
instance, vasointestinal peptide and PGEi have been shown to stimulate the trafficking of 
glycine (Yorek et al., 1983; Yorek and Spector, 1983), accumulation of cAMP and synthesis of 
catecholamine; features normally associated with amacrine cells (Yorek et al., 1986). 
Substance-P, NSG and (3~adrenergic receptors are markers of cells belonging to the ganglion 
cell layer of the retina. They also express, under serum free conditions, myelin binding protein 
and switch tight junction type to macular adherens normally occurring between the 
photoreceptor cell and the Muller cell.
1.6.4 What are the limitations o f using this cell line?
The phenotypic plasticity of Y79 cells in monolayer culture permits analysis of interaction 
between molecular-physiological systems that span the entire retina. However, conclusions 
drawn from the analysis of this cell line can only be indicative of actual events in vivo since the 
natural history of any cultured system presents anomalies. These anomalies manifest as 
residual cell cycling processes, progressive undefined genetic mutations, inter-batch 
composition of serum factors and lack of neuroendocrine restraint on the elaboration of 'retinal- 
like’ mechanisms. However, cell technologists are able to limit the dominance of these by 
careful management of the experimental culture system paying attention to complement the 
research question with an appropriate experimental design.
A number of studies investigating various modalities of melatonin synthesis have used sodium 
butyrate and various antibiotics as differentiating agents to force Y79 cells to a more committed 
photoreceptor phenotype. Sodium butyrate is well known to induce apoptosis in Y79 and other 
cell lines (Conway et al., 1998; Deng et al., 1991; Giuliano et al., 1999; Lauricella et al., 2000; 
Lauricella et al., 1998a; Lauricella et al., 1998b; Madigan et al., 1999; Seigel et al., 1994; 
Virtanen et al., 1988). For example in Y79 cells this agent is known to:
> Dramatically upregulates genes associated with induction of apoptosis: BAX, Caspase- 
3, Caspase-6 and extralysomal degraditive machinery (e.g. short lived protein such as 
143-3 & 26S proteosomes)
> Stimulate release of cytochrome c in respiratory chain in mitochondria
> Down regulate cell cycle suppression factors such as P53, n—myc, E2F1 and BCL1.
> Accumulate cells in G2-M phase
> Induce appearance of oligonucleosomal fragments
> Down regulate ribosome biosynthesis
The rate of melatonin synthesis is dependent on the activity of AANAT protein (Janavs et al., 
1995; Janavs et al., 1991; Janavs et al., 1994). Many authors have been concerned by the low 
yield of melatonin from these cells using this agent. In essence NABUT effect on Y79 cells are:
a. Compromised cell viability
b. Reduced stability of short-lived proteins such as AANAT protein
c. differentiation to more mature photoreceptor.
It would appear that the aim of synchronising cells to a more committed photoreceptor 
phenotype is achieved against the ceil entering an apoptotic state.
Some investigators have preferred to grow and differentiate Y79 cells in human (and rodent) 
retina extract conditioned media systems. The tumorigenicity of this cell line has been shown 
to be suppressed when grafted into rodent retinas (del Cerro et al., 1992; del Cerro et al., 1993; 
Seigel et al., 1994). Del Cerro in 1992 demonstrated that Y79 cells integrate and differentiate 
into host retina forming synaptic connection with no signs of renewed cel! division. For 
instance Tombran-Tink et al (1989, 1990 & 1992) noted that Y79 cells grown in media 
conditioned by retinal pigmented epithelia cells differentiated towards a photoreceptor 
phenotype. As with the developing retina where RPCs require extrinsic factors to influence is 
differentiated state, Y79 cells can only behave in culture when given a growth environment that 
mimics that of the retina.
1.6.5 Melatonin synthesis in Y79 cells
Melatonin is not accumulated in microvesicies, but directly released into the growth medium. 
The content of melatonin (when normalised to pg/mg protein/24 h) detected in medium varies 
between each published study and would appear to reflect alternative experimental growth 
systems used in each study (table 3). Each medium system has a specific profile of nutrients 
and growth factors. A review of the supporting literature accompanying each study did not 
reveal a specific reason for the selection of a particular growth medium recipe.
The melatonin synthesis pathway in these cells is functionally intact is cAMP dependent 
(Bernard et al., 1995; Coon et al., 1996; Deng et al., 1991; Janavs et al., 1995; Janavs et al., 
1991; Janavs et al., 1994; Pierce et al., 1989; Wiechmann and Burden, 1999; Wiechmann et 
al., 1990). It responds to inducers of adenylate cyclase (i.e. AANAT) such as forskolin and 
cAMP analogues in a dose dependent manner comparable to that observed in the pineal and 
retina. The biochemical kinetics (and stability) of HIOMT and AANAT are similar to in vivo and 
in vitro data from bovine, ovine and human retinae (Bernard et al., 1995; Coon et al., 1996; 
Deng et al., 1991; Janavs et al., 1995; Janavs et al., 1991; Janavs et al., 1994; Pierce et al., 
1989; Wiechmann and Burden, 1999; Wiechmann etal., 1990).
1.6.6 How has the Y79 cell line contributed to the melatonin field?
Melatonin synthesis in the human retina has been the subject of much debate for the past 2
decades. Melatonin derived from retinal tissue does not contribute to or be dependent the 
melatonin in the general circulation. Many investigators have suggested that retinal melatonin 
in human, unlike rodent, eyes is limited from the general circulation. Naturally, analysis of the 
in vivo situation in human eyes is limited to inherent problems associated with post mortem 
tissue. Comparative analysis between rodent and Y79 cells has led the way to isolating 
various components of the melatonin synthesis pathway from human retina; most notably 
HIOMT (Bernard et al., 1995; Bernard and Klein, 1996; Bernard et al., 1996; Coon et al., 1996; 
Deng et al., 1991; Janavs et al., 1995; Janavs et al., 1991; Janavs et al., 1994; Pierce et al., 
1989; Wiechmann and Burden, 1999; Wiechmann etal., 1990).
HIOMT catalyses (Figure 4) the conversion of N-acetylserotonin to melatonin, in the pineal the 
levels of this enzyme are very high compared to Y79 cells (Wiechmann and Burden 1999,
Bernard, Donohue et al. 1995). Comparative immunoprecipitation and RT-PCR screening 
revealed the existence of 4 isoforms of HIOMT (Bernard and Klein, 1996; Bernard et al., 1996; 
Nowak et al., 1993; Wiechmann and Hollyfield, 1989). The abundance of each HIOMT isoform 
in the pineal gland compared to Y79 cell extracts was markedly different (Wiechmann and 
Burden 1999, Bernard, Donohue et al. 1995). Kinetic analysis of Y79 and pineal derived 
HIOMT showed that no significant difference in Km or Vmax existed (Bernard and Klein, 1996; 
Bernard et al., 1996) (Wiechmann and Burden 1999, Bernard, Donohue et al. 1995). This 
suggested the various isoforms only differed in their regulatory or structural framework 
(Bernard and Klein, 1996; Bernard et al., 1996) (Wiechmann and Burden 1999, Bernard, 
Donohue et al. 1995). Identification isolation of the predominant HIOMT isoform in Y79 cells 
lead to development of RT-PCR parameters and antisera that enabled the observation of 
HIOMT in the human retina (Bernard and Klein, 1996; Bernard et al., 1996) (Wiechmann and 
Burden 1999, Bernard, Donohue et al. 1995).
Retinoic acid is a potent regulator of gene expression. In Y79 cell retinoic acid was shown to 
elevate the expression of HIOMT mRNA and activity at doses which do not affect IRBP activity, 
opsin or phosducin (Deng 1991, Wiechmann and Burden 1999, Bernard, Donohue et al. 1995). 
It is though to stabilise HIOMT protein and indirectly upregulate expression through HIOMT 
gene RARE containing transcription factor. A dose-response effect was evident between 
various stereoisomers (i.e 9-c/s > all-trans > 13 -c/s).
Author Year Medium Cell
Density
Substrata Treatment Melatonin 
As cited
Melatonin
Normalised to 
p g /m g  protein /24  hrs
Deng 1991
DMEM
10% HS 
2.5% 
FCS 
+AB
7-9
x10e
PDL
7d ± NaBut 
*24hrs
±Nabutwith 10 
nMFsk
Baseline
10 pg/mg protein/24
hours
Nabut
200 pg/mg protein/24 
hours
Baseline
10
Nabut
200
Pierce 1989
DMEM
10%
FCS
+AB
0.5
x106
PDL *24 hrs 
10 ^M Fsk 
±100nM HTP 
1mM 8BcAMP
No Baseline quoted 
Fsk
1000 pg/well/24 hours 
FSK/HTP
1250 pg/well/24 hours 
FSK/8BcAMP
350 pg/well/24 hrs
No Baseline quoted
Fsk
43
FSK/HTP
54
FSK/8BcAM P
15
Janavs 1991
DMEM
10%
FCS
+AB
1 x108 PDL
24 hr 
*24hr
100)iM HTP 
± 10 taM Fsk
Baseline
3.34
pmol/mgprotein/24hrs
FSK
100 pmol/mg protein/24 
hrs
Baseline
FSK
Wiechmann 1990
Eagles
basal
medium
with
earls
salts
10%
FCS
AB
1 x106 PDL
5-1 Od 
*6d
± 1mM NaBut 
±1mM8BcAMP
Baseline
1350 pg/sample 
8BcAMP 
7000 pg/sample 
NaBut
150 pg/samples
B aseline
29
8BcAM P
15
N aBut
3
Deng 1991
DMEM
10% HS 
2.5% 
FCS 
AB
7-9
x106
PDL
7d
± 3 mM NaBut 
*24 hrs 
SF
± 10 pM FSK
Baseline
10 pg/mg protein/24 hrs 
FSK
25 pg/mg protein/24 hrs 
NaBut/FSK
220 pg/mg protein/24 hrs
Baseline
10
FSK
25
NaBut/FSK
220
Tab le  3. Com pendium  of studies detailing the modality of melatonin synthesis in Y7 9  
ce lls under various growth conditions.
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Human pineal derived melatonin has repeatedly been shown to be subject to an inter-individual 
variation. The source of this variation is unclear. Studies on the effects of serum on 
components of melatonin synthesis pathway in Y79 cells gave rise to a mechanism that might 
explain this phenomenon (Bernard and Klein, 1996; Bernard et al., 1996) (Wiechmann and 
Burden 1999, Bernard, Donohue et al. 1995). Melatonin synthesis in the pineal gland is under 
the control of (3-adrenergic signaling pathway. Y79 cells maintained on a medium containing 
10% FCS exhibit a stable HIOMT activity and expression profile (Wiechmann and Burden 
1999, Bernard, Donohue et al. 1995) (Bernard and Klein, 1996; Bernard et al., 1996). When 
serum is replaced with BSA both activity and mRNA levels of this enzyme decrease which was 
not associated with other enzymes in the synthesis of melatonin or decreased cell survival rate 
or down regulation of specialised photoreceptor markers such as IRBP ((Wiechmann and 
Burden 1999, Bernard, Donohue et al. 1995, Deng 1991). Replenishment of the medium with 
FCS and BSA restored HIOMT activity and expression to levels prior to serum deprivation 
(Bernard and Klein, 1996; Bernard et al., 1996) (Wiechmann and Burden 1999, Bernard, 
Donohue et al. 1995). Effects of various dialysed fractions of serum indicated that the inhibitory 
serum factor did not belong to agents involved in ceil differentiation (db-cAMP, noradrenaline, 
bFgF, dexamethasone, T3, Somatotrophin, steroid, thryoid hormones or growth factors) but a 
small inhibitory protein that binds to HIOMT or a protein involved transcription of HIOMT 
((Bernard and Klein, 1996; Bernard et al., 1996) Wiechmann and Burden 1999, Bernard, 
Donohue et al. 1995). Out of this research HIOMT was found to be most variable component 
of melatonin synthesis pathway and probable factor that contributes to the inter-individual 
variation in melatonin production in humans via some serum factor (Bernard and Klein, 1996; 
Bernard et al., 1996) (Wiechmann and Burden 1999, Bernard, Donohue et al. 1995).
Y79 cells have also proved to be useful experimental model to dissect expression patterns of 
pineal/retina specific genes (Piece 1989, Janavs 1991), photoreceptor development and 
differentiation (Weichmann 1996) for over 2 decades. Gene expression studies by Di polo 
(1995) showed that Y79 cells express both rod and cone specific photoreceptor genes at 
equivalent levels to the intact mammalian retina (Di Polo and Farber, 1995; Farber, 1995).
2 Aims
The aims of this thesis were to investigate:
1. The temporal profile of melatonin synthesis and clock gene expression
2. The effect[s] of alternating nutrient composition (e.g. serum factors on melatonin 
synthesis
3. The glutamatergic control of melatonin production in this cell line
3.1 Cell culture
3.1.1 Introduction:
All studies discussed in this thesis used the Y79 cell line as the experimental model system. 
Propagation of this cell line was accomplished from four original vials purchased from the 
American Tissue Culture Collection (Rockville, USA), from which daughter cultures were 
dedicated either for experimental purposes or to build up frozen bank of cells for future studies. 
Cells derived from the same passage were used throughout repeat experiments to ensure 
continuity and limit the effects of phenotypic drift resulting from the sub-cuituring process.
3 General m ethodology .
3.1.2 Materials
Heat-inactivated fetal bovine serum, horse serum, RPMI 1640 supplemented with 2 mM L- 
glutamine or Dulbeccos Modified Eagle Medium (DMEM), L-glutamine, fibronectin, poly-D- 
lysine (120-150 kDa) and trypsin were purchased from Sigma, St Louis, USA. Plastic-ware 
such as sterile serological pipettes, growth flasks and multi-well plates were purchased from 
STET (UK). All other consumables were of cell culture grade and purchased either from Life 
Technologies (Rockville, USA) or Sigma; unless otherwise stated.
3.1.3 Maintenance culture system
Y79 cell stock cultures were maintained as a suspension culture in either RPM11640 or DMEM 
medium supplemented with 2 mM L-glutamine and 15% or 10% (v/v) fetai bovine serum 
respectively, without the use of antibiotics, at 37 °C in a humidified atmosphere (>90%) 
containing 95 % air and 5 % CO2. Medium was replenished every 2 days. Cell cultures were 
sub-cultured or preserved in 95% (v/v) FCS and 5 % dimethyl sulphoxide, frozen under graded 
temperatures and ultimately stored in liquid nitrogen until required; when cell density of culture 
exceeded 1x106 / 80 cm2 After five passages or 5 weeks in continuous culture, cells were 
replaced with frozen stocks.
Total, live and dead cell counts were individually determined using trypan blue dye exclusion 
assay from an aliquot of suspended cells. Cells were mechanically recovered from 
maintenance or experimental systems washed twice in temperature equilibrated phosphate 
buffered saline (PBS) to remove medium proteins and 1 volume of 0.4 % (w/v) trypan blue dye­
cell suspension was examined under light microscope at 100 x magnification using a bright-line 
hemacytometer. Cell density was corrected for dilution of original culture and incubation mix.
3.1.4 Experimental Culture system
Y79 cells were grown, in experimental medium, as a monolayer during experimental protocols. 
Cell attachment was induced by coating experimental vessels (growth flasks or multi-well 
plates) with minimal volumes of 0.2 mg/ml poly-D-lysine in PBS for 30 minutes, residue coating 
factors were removed. Experimental vessels were then coated with minimal volumes of 5^g/ml 
human plasma fibronectin in PBS for 1 hour at room temperature; residue coating factors were 
removed by rinsing flasks with 2 washes of serum free RPMI 1640 medium. Experimental 
flasks were seeded at a specific cell density determined under the experimental requirements 
of each study. Cells were acclimatised to experimental environmental and medium systems for
4-7 days prior to commencement of treatment and sample collection (See specific experiment 
protocols). Medium was replenished during the acclimatisation stage of experiment once every 
2 days. The medium composition and frequency of changes varied according to experimental 
protocol used.
3.1.5 Sample harvesting and processing
3.1.5.1 Introduction.
Molecular physiological effects of the experimental design were assessed primarily from three 
response measures; i.e. melatonin content of experimental medium, mRNA and protein profile 
of cells.
All experimental protocols incorporated baseline samples and appropriate controls to assess 
effect of experimental treatments. Baseline and treated samples were harvested and
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processed under the same conditions. Isolation and assessment of these response measures 
was processed from each sample point. The specific details of frequency of sample harvest 
are discussed under separate experimental chapters.
3.1.5.2 Melatonin
Experimental medium was collected and stored immediately at -20 °C. Samples were 
defrosted, aliquot as either 5 ml or 1 ml of medium into glass freeze drying vials refrozen at -20 
°C overnight (O/N), freeze dried for 2 days and stored under nitrogen gas at -20 °C until 
analysis.
3.1.5.3 Protein.
Cells, as soon as the medium was removed from the experimental vessels, were immediately 
washed twice with appropriate volumes of temperature equilibrated PBS to remove residue 
medium. Cells were then physically removed from experimental vessel into 300 \x\J 1e5 cells 
MPER Mammalian Protein Extraction Reagent (Pierce, IL, USA) and stored at -20 °C until the 
extraction process could be completed.
3.1.5.4 RNA
Ceils were immediately washed twice with appropriate volumes of temperature equilibriated 
PBS to remove residue medium, physically harvested into PBS and cell mass pelleted at 400 
RPM for 3 minutes. Cell pellet was either preserved in 100 jul 1 1e6 cells Trizol R LS Reagent 
(Life Technologies (USA) or 5 volumes of RNAIatertm RNA stabilisation reagent at —80 °C until 
analysis.
3.2 Melatonin analysis
3.2.1 Introduction
Melatonin synthesised by Y79 cells was detected using radioimmunoassay technology. The 
specific assay was developed from that described for measurement of melatonin in saliva by 
(English et a!., 1993).
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Modification to the assay protocol were made (and are discussed in Chapter 3) to permit 
detection of melatonin in each samples’ native matrix. The general format of assay was 
standard curve, quality control (QCs) samples that ranged the lower, mid-portion and higher 
ranges of the standard curve, sample blanks, samples, QCs and sample blanks. All samples 
were assayed in duplicate. Samples were, in most cases, freeze-dried and reconstituted in 
0.15 volumes of double glass-distilled water (DGDW).
3.2.2 Materials
Rabbit anti-melatonin antibody (AB-R-03) (prepared by Dr J.P. Ravauit INRA, Tours, France) 
and solid phase secondary cellulose linked donkey anti-rabbit IgG (SAC-Cel, AASacI) 
(obtained from IDS, Boldon, UK) were gifts from Stockgrand Ltd, University of Surrey. 2 -[I125] 
iodomelatonin was obtained from Amersham International, Little Chalton, UK. Melatonin was 
obtained in its powdered form from Sigma, Poole, UK. Melatonin standards were prepared 
from a 1 mg/ml stock in 100 % ethanol, diluted to 10 ng/ml in DGDW and 0.2 ng/ml solution in 
the appropriate assay matrix. The standard curve (0,1, 2, 5,10, 25, 50 and 100 pg/tube) was 
subsequently prepared from the 0.2 ng/ml stock in the appropriate medium matrix. Quality 
control samples (QCs) were, likewise, prepared from a 1 mg/ml stock of melatonin in ethanol 
and diluted down to 5, 25 and 35 pg/tube concentration in RPMI 1640 or DMEM medium, 
aliquoted and frozen at -20°C until use. All other reagents were of analytical grade and 
purchased from either Sigma or Merck unless otherwise stated.
3.2.3 Method
A melatonin standard curve that ranged from 1 to 100 pg/tube was set up to interpolate 
concentrations of melatonin in the samples. Proportionate amounts of sample (as described in 
subsequent chapters), standards (in duplicate) and quality controls were incubated with 100 juJ 
rabbit anti-melatonin antibody at a dilution of 1:32,000 (AB-R-03) for 30 minutes at room 
temperature. 100 jliI 2 -[I125] iodomelatonin (approximately 10,000 counts per minute (cpm)) 
were added to all tubes and incubated at 4 °C for 18 h. A second antibody matrix (SAC-CEL 
AASacI) raised against anti-IgG antibody (donkey anti-rabbit) separated bound and free ligand.
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100 jliI SAC CEL was added to each tube and incubated at room temperature for 1 hour with 
intermittent mixing. Non-specifically bound ligand was removed by washing the solid phase 
antibody complexes in BriJ containing saline wash solution (0.2% (v/v) Brij 35, 0.9% (w/v) NaCI 
in DGDW) and the solid phase was pelleted by centrifugation at 4000rpm for 10 minutes at 20 
°C. The supernatant was immediately decanted. Radioactivity of the pellet was measured 
using a 1260 multigamma gamma counter (LKB Beomma Wallac Sweden) that uses RIAcalc 
software to extrapolate the concentration of melatonin in samples from the standard curve data.
Assays were run against the experimental medium matrix:
> RPM11640 medium 15 % (v/v) FCS,
> RPM11640 medium plus 50 % (v/v) horse serum
>  RPM11640 medium alone
> DMEM medium plus 10 % (v/v) FCS
> DMEM medium plus 10 % (v/v) dialysed FCS.
Assessment
Values were recorded as pg/tube. The data was corrected for dilution effect of reconstituting 
sample and expressed either as pg/mg protein/ 24 hrs or pg 11 x 105 total cells. Sample 
duplicates were carried through some experiment and the mean of these duplicates carried 
through the analysis stages. The precision and reliability of the assay was assessed by 
calculating the inter- and intra-coefficient of variation from the QC samples.
Total p ro tein  A n a lysis
Introduction
Inter-sample analysis of experimental design on cellular protein pool was done using western 
blot technology. Essentially western blot analysis involves production of a semi-permeable 
record of size fractionated proteins enabling immunodetection for proteins of interest.
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3.3.2 Extraction (Dubbels 1988)
Harvested cells were homogenised in MPERtm reagent through a 21-gauge needle. 
Homogenate was added to 4 volumes of methanol, 3 volumes of water, and 1 volume of 
chloroform, mixed by inversion, aqueous phases separated at 8000g for 1 minute to which 3 
volumes of methanol was added to the aqueous phase from which protein mass was pelleted 
at 8000g for 3 minutes. Protein pellet was air dried and re-suspended in an appropriate volume 
of cells MPERtm reagent and stored at -20 °C until analysis.
3.3.3 Protein quantification
Total protein mass of samples was determined using a propriety kit, developed by Pierce ltd 
(USA), based on the Lowry Biruet method of protein detection. The assay took place in a 96- 
well plate in which a standard curve was construct ranging from 1 to 1000 jag/mL BSA standard
in triplicate, blanks and samples. Equivalent volumes of samples and standard were incubated 
with 10 volumes of BSA reagent and measured in a Muliskan BICHROMATIC plate-reader 
under the control of Flexicalc software @  550nm.
3.3.4 Size fractionation of protein
Typically, 10 qg of total protein extracts were resolved through a 5.5% acrylamide Tris based 
stacking gel and size fractionated through a 11.3 % acrylamide tris based separation gel. Gels 
were run in Tris-base buffer in a Mini-PROTEAN electrophoresis cell (BIO-RAD Laboratories 
Ltd, USA). Samples, were initially denatured at 100 °C for 10 minutes in equivalent volumes of 
sample buffer (60 mM Tris base, 70 mM SDS, 25 % (w/v) glycerol containing 0.05 % (v/v) - 
mercaptoethanol and 0.006% (w/v) Pyronin Y tracking dye, pH6.8) and sample were returned 
to room temperature before application to the pre-run gel. Electrophoresis was carried out at 
1.4mA/cm2 for 3 hours until the tracking dye was at the bottom of the separation gel.
The sample loading format:
>  Kaleidoscope Pre-stained Standards (BIO-RAD Laboratories, USA)
> Sample No1, No2, No 3 No4,
>  Biotinylated SDS-PAGE Standards Broad range (BIO-RAD Laboratories, USA).
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Standards were prepared as described in the manufactures instructions and treated as 
samples. Protein quality was assessed by immersing gel in a Coomassie based buffer 
GelCODE Blue stain (Pierce, USA) for 1 hour followed by a wash in water.
3.3.4.1 Preparation of Western blots;
Two gels were prepared for each sample run (Gel No 1 and No 2); from same gel mix. Gel 
No1 was used to assess the performance of fractionation of the protein pool. Gel No 2 was 
used to make the biot that could be used to screen for the presence (or absence) of specific 
protein markers. The fractionated protein profile from the gel dedicated for screening was 
transferred to a polyvinylidene fluoride microporous membrane (PVDF). Immobilon-P Transfer 
Membrane (MILLIPORE, USA) using semi-dry blotting technique. PVDF membrane was 
hydrated in methanol and then equilibriated in transfer buffer (25 mM Tris, 10% (v/v) methanol 
pH 10.4), assembling the transfer stack in the semi-dry blotter (Kem-En-Tec, Coopengaeb, 
Denmark) in the following ascending order from the anode:
> 2x pre-wet (300 mM Tris, 10 % methanol, pH 10.4) Whatman paper,
> 1 x pre-wet (25 mM Tris, 10 %methanol, pH 10.4) Whatman paper,
> Treated PVDF membrane,
>  Gel
> 3x Pre-wet (25 mM Tris base, 40 mM glycine pH 9.4) Whatman paper
>  to cathode.
A current was applied through the transfer stack for 2.5 hrs. After transfer was complete 
screening blot was immersed in blocking solution (1% (w/v) blocking reagent (Roche, USA) 
containing 0.25 %(w/v) Triton-100 in PBS) for at least 1 hr to block non-specific immunogenic 
sites on the membrane.
3.3.4.2 Immunodetection
The immunodetection system; used throughout this thesis was the Vectastain ABC kit (Vector 
laboratories), USA. This is an indirect detection method in that visualisation of primary 
antibody-epitope complex using a biotinylated secondary antibody that targets the Fc portion of 
the primary antibody. Subsequently, biotin binds irreversibly to avidin complex that is
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conjugated to horseradish perxoidase. The horseradish peroxidase complex catalyses a 
reaction between cyclic diacylhydrazide (Luminol) and hydrogen peroxide that emits lights. The 
specific pattern of primary antibody binding is visualised on autoradiographic film.
Non-specific binding sites on membrane were blocked using 1% BSA tris based buffer 
containing 0.1% Triton-100 for 1 hour at room temperature. Excess blocking reagent was 
removed 4 x 5  minute washes in TTBS. Membrane was transferred to primary antibody 
solution as per manufacturer’s instructions. Non-specifically bound primary antibody was 
removed by 4 x 5 minute TTBS washes. Avidin peroxidase complex was made as per 
instruction and incubated with membrane for 30 minutes. Non-specifically bound reagent was 
removed by washing membrane in TTBS as before. Excess moisture was removed by blotting 
membrane on filter paper. Visualisation of detected protein was accomplished using enhance 
chemoluminescence (ECL) technology.
3.4  Total RNA A n a lysis
3.4.1 Extraction of total RNA
3.4.1.1 Materials
Human brain total RNA was obtained from Clontech, La Jolta, USA. Primers were designed in- 
house and synthesised by Genosys (Sigma), UK. ‘Free’ dNTPs were purchased from Promega, 
USA and prepared in autoclaved DGDW to give a final concentration of 10 f±M mixture of each 
base type.
3.4.1.2 Chomczynski and Sacchi organic extraction
Trizol (Life Technologies, UK) preserved cells were homogenised through 21-gauge needle at 
room temperature for 5 minutes. 0.5 volumes of chloroform was added to homogenate, mixed 
by inverting afterwhich it was added (and mixed) to 2-3 volumes of lysis buffer consisting of 7M 
urea and 2% (w/v) sodium dodecyl sulphate equilibrated to 37°C. RNA was extracted using 
three rounds of 1 volume phenol/chloroform, three rounds of 1 volume chloroform extraction 
and 1 volume ethanol precipitation. Genomic DNA was removed by treatment with 2.5 U 
DNase (Promega) 1x DNase buffer at room temperature for 1 hour. A further 
phenol/chloroform and chloroform extraction removed DNases and DNA fragments from the
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RNA pool. RNA pellet was isolated, air-dried and re-suspended in suitable volume of 
nuclease-free water.
3.4.1.3 RNA Quantitation
Total RNA was quantified from 10 \x\ of pooled sample using the RNA-QF by Sigma. The kit is
based on RNA’s ability to fluoresce under particular chemical environments when excited at 
425 nm. The assay was conducted in a 96-well format using 10 jul of RNA sample in 200 p\
1:20,000 dilution of SYBR green assay buffer. The concentration of RNA samples were 
interpolated against standard curve constructed from known amounts of tRNA.
The quality of the RNA was checked by running 1jJ of the sample on a standard 1.2% RNA 
formaldehyde denaturing gel at 1.4 mA/cm2 for 45 minutes. Integrity of RNA was assumed to 
be good and of sufficient quality to warrant further analysis if the resolution of:
»  18S and 28S rRNA bands were discrete,
> smear occurred between the rRNA bands representing mRNA component
> band appeared three-quarters the way down the gel corresponding to tRNA species.
3.4.2 Analysis
ReverseTranscription polymerase chain reaction (RT-PCR)
100 ng of Total RNA was reverse transcribed into cDNA using Ready to Go You-Prime First 
Strand beads, (Amersham-Pharmacia, USA). First strand synthesis was primed using 0.2 jag 
of p (dN) 6 (MWG) in a  final volume of 31 ^l; made with DEPC water. RNA was denatured at 
65 °C for 10 minutes to dissociate secondary structures and cooled rapidly on ice for two 
minutes.
PCR was performed in a final volume of 50 i^l containing 2.6 units of Expand™ High Fidelity 
PCR system enzyme mix (Roche) or Taq polymerase (Sigma or Promega), 300 nM upstream 
and downstream primers (Table3), 200 n M of each dNTPs (Promega) and 1.5 mM MgCI2. 
PCR reactions were performed for 25-35 cycles and products size fractionated on 1.2 %
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agarose TAE gel containing 0.625 jug/ml ethidium bromide. PCR products were compared 
against molecular weight markers.
Primers were designed using P r im e rse lec t software (DNAstar. USA). Essentially the software 
selects regions of the template cDNA sequence that exhibit thermo-physical properties specific 
to that region of DNA. Primer pairs were selected and compared against various worldwide 
gene sequence databanks using the BLASTn search engine (Appendix 2). Primers were 
prepared from a powdered form and re-hydrated in nuclease-free water at concentration of 10 
jliM and frozen at -20 °C until use
PCR conditions were optimised using an annealing temperature step gradient PCR protocol 
calibrated to the theoretical annealing temperature specific to the properties of each primer 
pair; commercial total brain cDNA was used as the positive control (See Appendix 2). 
Resulting amplicons were sequenced and compared to known gene sequences using remote 
bionformatic search engines to confirm the identity of amplicon.
The RT PCR products were sequenced using automated Open Gene Long-Read Tower1111 
System (version 3.0.1) software developed by Visible Genetics Incorporated or Perkin-Elmer 
ABI PRISM1"1 Dye terminator cyclic sequencer (in-house sequencing facility). Both systems 
exploited the dideoxy chain termination protocol originally developed by Sanger (1977). Bio- 
informatic analysing of sequence data was done using Lasergene software developed by DNA 
Star, USA and Human genome mapping project, Hinxton, UK web tools.
3.4.2.2 Northern blot
3.4.2.2.1 Preparation of Northern Blot
5-25|j,g of the sample RNA, positive control RNA (e.g. Human Brain RNA (Clontech, USA)) and 
3jag 0.24-9.5 Kb RNA ladder are heat denatured at 65 °C for 10 minutes in 1 volume of sample 
buffer (containing 5:2:1:0.4 % (v/v) de-ionised formamide, 40 % (w/v) formaldehyde, 50 mM 
MOPS (pH 7.0) and 1 mg/ml ethidium bromide) and rapidily cooled on ice. Denatured RNA 
samples were size fractionated on a pre-electrophoresed 1.2% agarose 2.2M formaldehyde gel 
containing50 mM MOPS (pH 7.0) 1mM EDTA and electrophoresed at 3 V/cm until the 18 S and 
28 S rRNA bands had migrated to the mid-portion of the gel. Gel profile was documented.
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Size fractionated RNA was transferred (“b lo tte d ”)  from the RNA gel onto a Hybond N+ 
membrane, (Amersham) through an ascending transfer stack using 20x Standard Saline Citrate 
(3M NaCI, 0.3M Sodium citrate at pH 7.0); as the transfer vehicle. RNA was cross-linked to the 
membrane with an Uvi tec Cross-linker CL-508 set at 0.120J/cm2 for 30 seconds. Non-specific 
binding sites on the blots were blocked by incubating the blots in prehybridisation solution (0.2 
M Na2HP04, 0.25 M NaH2P 04> 0.001 M EDTA at pH8.0, 0.25 M SDS and 1% Bovine Serum 
albumin) at 65°C for 1 hour.
3.4.2.2.2 Detection of mRNA under investigation
The membranes were then probed with full length cDNA labeled with 3000 Ci/mmol [ a - 32P] 
dCTP (NENTM Life Science Products, Inc) using Ready-to-Go DNA labeling Beads 
(Pharmacia) overnight in prehybridisation solution at 65°C. Non-specifically bound probe was 
removed from the blots by washing the blots twice in high salt solution (0.2 xSSC, 0.1% SDS) 
for 15minutes and twice in low salt solution (2x SSC, 0.1% SDS) for 15 minutes at 55°C. 
Specifically bound probe was visualised by exposing the Kodak X-OMAT film to the blots. 
Blots were re-used after being stripped of any bound probe by immersing the blots in a boiling 
solution of 0.2 % (v/v) SDS and removed when the temperature of the probe stripping solution 
reach room temperature.
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4.2 The effects of various growth media based matrix on saliva melatonin 
RIA.
Four criteria have to be met before this RIA could be relied upon to detect melatonin in Y79 cell 
media preserved under various conditions:
> Assessment of non-specific and specific binding in meiatonin free media.
> Proportional recovery ot cold melatonin added to media under conditions analogous to 
those that the samples were exposed to.
> Parallelism between standard curve and serial dilutions of endogenous melatonin.
> Assessment of intra- and inter-assay covariance.
4.2.1 Materials
As described in Section 3.2
4.2.2 Method.
RIA was setup as described in section 3.2. The matrix for each assay was either made up in 
RPM11640, RPM11640 +15 % FCS or RPM11640 + 50 % FIS, reflecting the media conditions 
planned for future experiments. Standard curves were run in the various media either neat or 
diluted 1 in2 and 1 in 4 and compared with standard curves made up in tricine buffer pH8.0.
4.2.3 Results
The binding characteristics of the RIA in the various media were found to be similar to those 
detected in tricine buffer pH8.0 (Figure 5). The percentage total binding (Bo ) of radiolabeled
ligand in the absence of unlabeled melatonin ranged are shown in Figure 5. Non-specific 
binding of the anti-melatonin antibody in the various matrices was routinely within acceptable 
limits (Table 4). The sensitivity or limit of detection of this assay was taken as 2 S.D from mean 
zero standard. Initially this was around 5-10pg/tube, however, with practice this improved with 
use of fresh radioactive ligand and antisera to 1-2pg/tube.
Table 4 Interassay variance assessment of RIA standard curves made up in various RPM11640 based media.(md missing 
data). Figure5 Compares the construction of RIA standard curve made up in RPM11640 m edia+15% F C S  (Yellow), RPMI 
1640 media +50%  horse serum (dark blue), RPM11640 media alone (pink) and Tricine buffer pH 8.0 (pale blue) on the 
performance of a RIA designed to detect melatonin in saliva.
R IA
Matrix
B o N S B Lo
w Q C
Medium
Q C
H igh
Q C
/ %  T o ta l C P M
(±SEM)
%  T o ta lC P M
(± S E M )
% C V % C V % C V
R15 57+3 8+ 2 13 5 10
R - 52+7 6+1 17 4 12
Tricine 60.9+1 6.9+0.34 8 5 10
R50 49+5 10±m d md md Md
Melatonin concentration (pg/tube)
10
4.2.4 Conclusions
The data collected here suggests that varying the concentration of the serum component of 
growth media does not absorb melatonin at levels sufficient to compromise the performance of 
the RIA standard curve. Similarly, the NSB data indicates that the secondary antibody is not 
significantly absorbed by the proteins in the various KPMI based medium.
A preliminary assessment of Y79 cell melatonin output in basic growth conditions was taken 
from a suspension and monolayer culture after 4 days in culture. The melatonin content of 
suspension culture samples was found to be below the sensitivity of this assay, however, 
monolayer culture samples were above the RIA anaiystical limit of detection (LOD); i.e LOD of 
assay 1pg/ml, sample: 10pg/105 cells). However, measures to maximise the recovery of 
melatonin from the samples will have to be considered to ensure the melatonin content is within 
mid-range of the standard curve.
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4.3 E ffe c ts  o f  fr e e z e  d ryin g  c e ll  cu ltu re m ed ia  on  co n s tru c tio n  o f  sa liva  
m ela ton in  RIA.
4.3.1 Introduction
A crude assessment of Y79 cell melatonin output in the basic growth system used throughout 
this project was taken from suspension and monolayer cultures after 4 days in culture. The 
melatonin content of suspension culture samples was found to be below the sensitivity of this 
assay however monolayer samples were above the RIA analytical limit of detection (LOD) 
(10pg/105 ceils). Considering the possible effects of the planned experimental protocols on 
Y79 cell melatonin synthesis detection could drop below the RIA LOD. It was therefore 
essential to develop and optimise the preparation of the media samples in order to 
appropriately use melatonin as the response measure for future experiments.
Essentially the main adaptation was to concentrate the melatonin content of a sample to a level 
that fell within the mid-range of the RIA standard curve. Various methods were considered 
however freeze-drying was shown to be the most cost/time effective and safest method.
Freeze-drying is a one step process that reduces the aqueous content of a sample, in a frozen 
state under a vacuum. The effect of freeze-drying on melatonin and its’ ability to be detected in 
concentrated samples by RiA was evaluated.
4.3.2 Materails
As described in 3.2
4.3.3 Method
RIA was set-up and processed as described in 3.2 with the exception that the standard curves 
were composed of sample-base matrix instead of tricine buffer. Several RiA standard curves 
were run comparing different sample-based matrices, these were either freeze-dried or freshly 
frozen, on the ligand displacement profile and analytical limit of detection of the assay.
4.3.4 P r e p a r a tio n  o f  s a m p l e  m a tr ix
Freshly frozen sample based matrices were prepared by freezing 50 ml aliquots of media 
(RPM11640 or RPM11640 + 15 % (v/v) FCS). Freeze-dried sample matrix was prepared by 
freezing 50 ml aliquots of media at -20 °C over night and freeze dried to its1 desiccated form 
(approximately 96 hours). Standard curve format was as described in section 2.3 in defrosted 
freshly frozen matrix or freeze-dried matrix re-hydrated, with 0.1 volume original aliquot DGDW.
4.3.5 P r e p a r a tio n  o f  m e la to n in  s ta n d a r d s  a n d  q u a lity  c o n tr o ls
10 ng/ml melatonin standard was derived as described in section 3.2. RIA standard curves
were constructed from 0.2 ng/ml stock using either defrosted aliquot of freshly frozen matrix or 
appropriately reconstituted freeze-dried matrix and compared to standard curves made up in 
tricine buffer. Volume of each standard was made equivalent with appropriate matrix.
Quality control samples, unfortunately due to the low melatonin output of these cells, were not 
derived from an endogenous source. Instead aliquots of media were spiked with cold 
melatonin 10 ng/ml (as used to construct the standard curves) standard and processed as per 
sample matrix to yield an expected assayed concentration: 10, 50 and 70 pg/ml (designated 
QC low, QC Med and QC High respectively). Batches of quality control samples were made 
sufficient to complete quality control al! assays carried out during an experiment. QCs were 
only defrosted once and thoroughly mixed before construction of RIA. Each batch of QCs was 
assessed (n=5 duplicates of each QC range) before use in quantification of samples against 
tricine- and sample-matrix RIA to check for accuracy of preparation and uniformity in detection
4.3.6 R e s u l t s
The binding profiles of the saliva melatonin RIA standard curve constructed in the various 
sample matrices (Figure 6) were similar to those originally described for tricine based RIA 
matrix (Figure 5). The relative displacement of standard curves detected as radiolabeled ligand 
was also comparable to the tricine based RIA. The RIA kinetics between the respective ‘freshly 
frozen' and ‘freeze-dried1 matrix were within the acceptable range of variance for this RIA 
method (Table 5). Alternative matrix preparation methods showed minimal effects on ability of
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this RfA to detect melatonin in the various sample composites. Analysis of the standard curves 
run in re-constituted freeze-dried matrix serial diluted with tricine buffer did not effect the 
detection of melatonin; actually improving replication between RIA runs (Figure 6 & 7). Non­
specific binding of melatonin in ail RIAs was below the acceptable level of the assay and 
comparable to tricine based RIA standard curves. The maximum binding expressed as Bo and 
NSB between the various matrices did vary to some degree (Table 5 -7 ). For instance freeze- 
dried and freshly frozen matrix that contained FCS exhibited a much greater binding capacity 
when compared to sample matrix without FCS.
The melatonin mass in each of the QC samples shown in figure 8 was comparable to expected 
concentration and within the acceptable limits of this assay. The coefficient of variation 
measured against ali QC samples, in all the assays used to derive figure 5,6 & 7 was routinely 
below 20% (n=15). Ideally, the % CV should be below 15% to reliably monitor intra- and inter­
assay shifts. In subsequent experiments the level of precision improved; intra-assay and inter­
assay CV routinely fell below 10% 20% respectively.
R IA
Matrix
B o N S B L o w
Q C
M edium
Q C
H igh
Q C
/ %  T o ta l C P M
(±SEM)
%  T o ta lC P M
(:± S E M )
% C V % C V % C V
R15 50±2 3±2 5 5 5
R - 47+2 6±1 10 6 5
Tricine 56±2 6.9+0.34 8 5 7
R50 40±9 10+4 20 15 15
Table 5. Interassay variance assessment of RIA standard curves made up in various freeze-dried RPM11640 based media 
concentrated (N=3).
100
Melatonin concentration (pg/tube)
Figure 6. Compares the effects of freeze-drying (FD) RPMI 1640 media +15% F C S  (yellow), FD-RPMI 1640 media + 50% 
horse serum (dark blue) and FD-RPM 11640 media (pink) matrix against tricine buffer pH 8.0 (pale blue) on the construction of 
RIA standard curves on the performance of a RIA designed to detect melatonin in saliva.
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R IA
Matrix
B o N S B Lo
w Q C
M edium
Q C
H igh
Q C
/ %  T o ta l C P M
(±SEM)
%  T o ta lC P M
(:± S E M )
% C V % C V % C V
R15 CO-i-'J K-U) K\J-L-\J.\J 7 5 10
R - 50±2 5+1 17 4 12
Tricine 62±1 5+1 8 5 10
R50 34+10 11+4 nd 16 11
Table 6 Interassay variance assessment of RIA standard curves made up in various freeze-dried RPM11640 based media.
Melatonin concentration (pg/tube)
Figure 7 Compares the effects of diluting freeze-dried (FD) RPMI 1640 media +15% F C S  (yellow), FD-RPMI 1640 media + 
50% horse serum (dark blue) and FD-RPMI 1640 media (pink) matrix 1 in 10 wit h tricine buffer pH 8.0 on the construction of 
RIA standard curves.
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Figure 8. C om pares assessm ent of Q C  sam ples made up in (Top Graph) RM P1 1640 medium and (Bottom 
G raph) R P M 1 1640 +  15%  medium. N = 3, error bars represent ± S E M .
4.3.7 C o n c l u s i o n s
Detection of melatonin in the saliva melatonin RIA is a function of proportionate displacement 
of radiolabeled cold melatonin by the relative melatonin content in the sample. ‘Melatonin-like’ 
(e.g. serotonin) compounds are prevented from binding to this antibody by the buffering 
dynamics developed tor this assay. I he reliability of this RIA to detect melatonin is therefore 
dependent upon maintaining the tight buffering constraints of this RIA.
Growth media consists of essential mineral salts and growth promoting agents (Appendix 1). 
Detection of melatonin using saliva melatonin RIA format is based on the specificity of antibody 
raised against melatonin. The interaction between an antibody and its’ antigen is electrostatic 
and therefore is sensitive to subtle changes in the physico-thermal properties (e.g. 
temperature, pH) of the assay. Consideration was therefore given to the constituents of the 
media and the relative difference in protein content of desired matrix to tricine buffer. 
Increased protein content of the desired matrix could offer a higher absorption capacity so 
reducing the assayed melatonin content of samples compared to the actual content. However, 
the data set above shows that melatonin standards can proportionately displace radiolabeled 
melatonin using the saliva melatonin RIA format in diluted, neat and freeze-dried growth media 
matrix in a comparable kinetic manner to the tricine matrix based RIA. These data suggest that 
melatonin produced by Y79 cells in their growth media can reliably be detected using this 
assay system.
4.4 Absolute recovery of melatonin from Y79 growth media
Melatonin is a lipophiiic and labile compound that preferential occupies the lipid compartment of 
a system. Experimental protocols used during this thesis require detection of melatonin from a 
sample, in various growth media systems, incubated with a variety of experimental chemically 
reactive substances over different times at 37 °C. Continuous growth of cells in media over 
time exhausts growth-promoting factors depriving the cells of essential nutrients to sustain cell 
growth and maturation. The isoelectric potential of the media might also be affected during cell 
culture such that the buffering capacity of the media could become suboptimai for growth of the 
cells and the buffering requirements of RIA. The effect of such conditions on the antibody 
binding properties of the RIA for melatonin is unknown. To assess the experimental growth 
parameters on melatonin a series of studies were set-up to determine whether the modified 
saliva melatonin RIA could detect absolute melatonin content of media from samples that had 
been grown under analogous experimental conditions.
4.4.1 Materails
As described in section 3.2
4.4.2 Method.
Freshly prepared RPMI and RPM11690 +15 % (v/v) media was spiked either with 1 or 7 pg/mi 
cold melatonin standard. 30 mi aliquots of each spiked media was incubated in growth vessels 
at 37 °C in a humidified atmosphere containing 5 % C 02 and 95 % air for 5 days. Samples 
were harvested every 24 hours (including stock samples), prepared as discussed above and 
stored under nitrogen gas at -  20 °C until analysis. Detection of melatonin was assessed, 
using modified saliva melatonin RIA, from freshly frozen samples and freeze-dried samples; 
prepared as previously described.
4.4.3 Results
Quantitative recovery of melatonin, as shown in Figure 9, from ‘freeze-dried’ and ‘freshly- 
frozen’ stock samples prepared in both media systems was achieved. Figure 9 also shows that 
detectable mass of melatonin of a sample over time and with repeated exposure to 37 °C 
compared to the stock samples in both matrix ( i able 7.).
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Figure 9. Proportional recovery of cold-melatonin from freeze dried growth media containing RPM11640 + 1 5 %  F C S  (Blue) or 
RPM 11640 media (orange) spiked at 1 pg/ml (Graph A) and 7 pg/ml (Graph B). Data expressed as SEM n = 3.
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Melatonin
content
Pg/tube
R15 (n=3)
%
recovered 
on Day 5
R15
% variance 
Day 1-5
R- (n=3)
%
recovered 
on Day 5
R-
% variance 
Day 1-5
5 90 5 91 3.7
25 95 2.9 94 2.6
35 98 2.5 89 2.3
Table 7 Compares the recovery of cold melatonin spiked from RPMI (R-) and RPMI +15% F C S  (R15) growth media incubated 
in experimental growth flask, for upto 5 days, at 37 °C. %  variance indicates the relative collective difference in recovered 
melatonin over 5 days.
Inter-assay analysis of covariance of the standard curve and QC samples data indicates that 
the diagnostic reliability and precision of this assay system used to evaluate this growth 
parameter was within conventional limits (i.e NSB <7%, analytical LOD 1-2pg/tube, QC <15%).
A couple of diluted preparations of a sample (SSDD2-6 zt2) that was derived from an actual 
culture serial diluted, prior to sample preparation, exhibited proportionate recovery of melatonin 
from the various samples types (Figure 10). The ‘baseline’ melatonin output of monolayer cells 
taken from this samples is 34.8 pg/1e7 cells. Melatonin content of sample matrix blanks when 
run through tricine based RIA was consistently below the LOD of the assay indicating that fresh 
RPMI (±Serum) media does not contain melatonin like moeties and is a suitable matrix for use 
in RIA.
RS
Figure 10. Recovery of endogenous melatonin from a serial diluted freeze-dried Y79 monolayer media sample (designated 
SSDD2-6 ZT 2). Data points represent a sample dilution run through 3 separate RIAs and expressed as mean ±SEM.
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The melatonin content in Y79 cell growth media can be- reliably detected as an absolute 
amount. These data indicate that the processing of freeze-dried samples or the constituents of 
growth media (e.g. proteins, mineral salts) have minimal effects on the saliva melatonin RIA.
I hat is to say the interaction between melatonin and the KlA's antibody is unaffected by the 
higher absorption capacity of serum supplemented media or the physiochemical parameters of 
predicted experimental conditions of Y79 cells. A question remains regarding the absolute 
detection of melatonin produced by these cells versus the metabolic activity or extracellular 
processes (e.g. enzymes liberated by dead cells or attachment factors) on melatonin secreted 
into the growth media.
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5 Temporal profile of melatonin synthesis in Y79 cells.
5.1 Introduction
Melatonin synthesis in the mammalian retina, as discussed in sections 1.5 1 has been shown 
to be restricted to the scrotophase. Y79 cells have contributed to our understanding of the 
mechanism(s) that regulate temporal melatonin production in the retina. However, no formal 
study has been published describing the temporal melatonin profile of Y79 cells; in continuous 
culture. Unfortunately, the conditions (i.e. growth substrata, differentiating agents, media 
composition, time bins) under which these cells have been used to examine melatonin 
synthesis, over the past 2 decades, vary significantly (Table 3.).
Y79 cells under various experimental protocols have been shown to morphologically and 
physiologically differentiate towards photoreceptor, glial and second order retina neuronal cell 
types (Table 2). In vivo the cells from the neural crest commit to retinal cell type through 
combination of neurotrophic stimuli and extracellular matrix-basement membrane patterning. 
Historically, differentiation of Y79 ceils toward a photoreceptor phenotype has been induced 
through agents that primarily modulate the cAMP status of these ceils in suspension culture or 
poly-d lysine induced monolayer culture (see refs in Table 3). No study specifically 
investigating the modalities ot melatonin synthesis pathway has considered mimicing the 
substrata that supports the photoreceptor layer in the retina (Table 3).
Extracellular matrix is composed of proteoglycans such as lamanins and/or fibronectin and 
intercellular adhesion molecules (iCAMs) such as the ephrin and intergrin receptors, 
interaction between iCAM/ICAM and/or ICAM/extracellular-binding molecules (EXBM) is a 
fundamental process in the differentiation and maturation of cells during retinogenesis (see 
Section 1.3). These interactions change with ontogeny until the cell commits to a defined cell 
type. Cell lines such as Y79 cells display antecedent behaviour (e.g. lack of specialised 
structures, sustained cell cycle activity) reminiscent of non-committed cell. These behaviours 
can however be attenuated and manipulated to derive a more robust phenotype (i.e. 
suppressing influence of the cell cycle and up-reguiating vestigial tissue-specific physiological 
processes).
XX
The cell cycle is restrained to its’ quiescent (or Go) state through the appropriate interaction 
between ICAM and extracellular basement membrane receptors. Alteration to the integrin or 
ephrin receptor matrix is known to activate the ceil cycle to move to the Gi/s state.
A number ot studies have shown that alteration to these factors protoundiy affect the 
phenotype of the cell. The differentiating agents used in previous studies (Table 3) are known 
to directly inhibit the cell cycle by increasing the expression of cyclin D and p21 while 
decreasing the phosphorylation of RB. Interestingly, combination of Lamanin and fibronectin 
substrata is known to enhance such phenomena.
In recent years a subset of nr-ICAMs, namely the integrin and ephrins have been shown to 
modulate the basal level and response ot signalling pathways that regulate adenylate cyclase 
and protein kinase A activity. Aii levels of melatonin synthesis pathway, as alluded to in section
1.5.1 are known to be acutely sensitive to changes in cAMP. Therefore, it is plausible to 
suggest that the endogenous oscillation of melatonin synthesis in Y79 cells requires a specific 
basai cAMP level; established through appropriate and precise interaction(s) of nr~ 
ICAM/adenylate cyclase complex and the surrounding supporting extracellular matrix. This 
study set out to establish the basal melatonin output of Y79 cells attached to growth flask using 
fibronectin and poly d-lysine as the substrata matrix. I he experimental protocol spanned 5 
days and incorporated a serum pulse that has been shown to rescue dormant oscillator rat-1 
fibroblast. It also gave an opportunity to reveal if Y79 cells, when acclimatised to a specific ceil 
culture format, could synthesis melatonin in a rhythmic manner.
5.2 Materials
As described in section 3.2
5.3 Method
Y79 cells used in this study were derived from a 4th passage suspension culture maintained, in 
RPM11640 medium containng 15 % FCS (designated R15), on a 12 hr light-dark cycle 4 days 
betore experimental vessels were seeded to entrain any residue endogenous period in these 
ceil. Consequently, the sample harvesting protocol was referenced to this light cycle and 4 
hourly sample bin collected according to this protocol. Experimental growth flasks were coated 
coated with poly d-lysine and fibronectin (as described in 3.1) and were seeded with 1 x 10 6 
single cell suspension (in R15), during the light/dark transition point. These cultures were 
transferred into constant darkness that de-marked the start of the experimental period.
Experimental protocol took place over five days (Experimental Protocol No1) incorporating 
baseline controls that anchored the effects of time and treatment (Figure 11). The first set of 
baseline; maintained on RPM11640 medium, samples [designated ES-R15] was harvested 12 
hours into protocol until (and including) 48th hour. Treatment samples defined as a 2 hour 
exposure (48 to 50th hour) to RPMI 1640 media supplemented with 50 % (v/v) horse serum 
(designated ES-R50) and were collected every 30 minutes. The treatment baseline control 
samples [designated TC-R15] only received a change of media and were harvested as per ES- 
R50 samples. Following the treatment period remaining cultures were maintained on RPMI 
1640 medium (designated ES-R-). ES-R- samples were harvested from 50th hour every 4 
hours until the conclusion of the experimental protocol. The study control samples [SC-R15] 
had not received any treatment or replenishment of media and were harvest from (and 
including) the 96th to the 120th hour of the experimental protocol.
Two response measures were analysed from each sample (in triplicate unless otherwise 
stated). I hese were melatonin from media component and clock gene expression trom cellular 
fraction of each sample. Sample components were immediately separated at the time of 
harvesting and processed as described in section 3.2 and 3.5 respectively
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5.4.1 Melatonin synthesis
Samples were assayed in 3 separate RIA runs for each of the respective media (Figure 12b). 
The precision of each assay was determined from QC samples made up in the respective test
 n  o n \ t l ,  — ------ *— i  n o  n<t r  a  „ i  j . .11leania ( i du ie  o cx z ) .  m e  mtJicuuimi o u m e iii ut qo-pv ra u a y - i oam pico  lecauiieu a  o iecnjy-aiciie
output of 77+1- 28 pg/1e6 total cells SEM following an initial ramping period (ES-R15 12-24 
hrs). Melatonin synthesis in the TC-R15 samples following the change of media became 
dampened when compared to ES-R15 Day -1 samples and did not recover to pre-shock levels. 
Successive replenishemnt of cells with high serum volume then serum free media (ES-R(-)) 
had a sustained suppressive effect on media melatonin content. However, a steady-state was 
observed in ES-R(-) samples +62 hr (12+/-7 pg/1e6 total cells). The SC -R15 samples
l. —  1 — I —  ii—  pm. J    . i  ii . i .  . j . . . . . i . :  i  :i  u i      _ i__j.: ___ _____ n o  n M r
naivesieu uii int! uiM uay ui mt; biuuy uuiuaiiitju siiimai mtJiaiuinii uuiiutJimauuiib as c o -r \ ra
day-1 samples.
The detection of melatonin from samples harvested under experimental protocol No1 was 
monitored using QC samples (Table 8 & 9). The interassay variance data does show a slight 
drift in precision of detection of the assay in the different matrix. I.e in the R15 matrix a positive 
weighting is observed between the pre-sample and post sample QCs; the reverse was noted 
for the R- QC mairix samples. However, the % COemcieru of variance for buih malrix systems 
indicates that the detected levels of melatonin in the assay samples are reliably within the 
acceptable limits of this assay.
5.4 R esu lts
QC sample Assay 1 Assay2 Assay3 Mean SD %
Pg/tube Pg/tube Pg/tube Pg/tube Pg/tube CV
5 ns 4 4.5 4.8 4.6 5.2 4.6 0.4 9.5
25 19 22 21 25 27 23 3.2 14
35 33 34 36 40 35 38 36 2.6 7.2
Table 8. Interassay variance assessment of assays run against R15 FD matrix. Split cell represent melatonin detected before and after 
samples in a single RIA respectively (n=2).
QC sample Assay 4 Assay5 Assay6 Mean SD %
Pg/tube Pg/tube Pg/tube Pg/tube Pg/tube CV
5 4 4.5 5 4.6 6 5 4.9 0.7 14
25 23 29.5 20 18.8 25 23 23 3.8 16
35 35 31 32 40 36 34 35 3.2 9.2
Table 9 Interassay variance assessment of assays run against R-FD matrix. Split cell represent melatonin detected before and after samples 
in a single RIA respectively (n=2).
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AExperimental time (hours)
R15 baseline No1 (n=3) R-(n=3)
R15 baseline No2 (n=3)........................ ..R15 baseline No3 (n=1)
Time (hours)
— ■------ES [-] live - -a- - ES[ ] DEAD — * ------ES [+] live
- - - ES [+JDEAD --------------TC  live - - - - TC DEAD
— * — SC Live - * -  - SC DEAD
Figure 12. Melatonin production (Graph A) and Y79 cell viability (Graph B) in response to changes in media matrix and media 
replenishment observed under experimental protocol No 1. Data is expressed as SEM (n = 3) as indicated by in the graph 
other data point refer to n = 1.
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5.4.2 Clock gene activity
E) aected Ar iplicon 
Sib (bp)
410
Clock gene analysis of Experimental Protocol No1 confirmed the expression of these genes in 
Y79 monolayer culture (Figure 13 & 14). No gross differences in the expression level of these 
genes were detected between culture systems or over time. Unfortunately, definitive 
quantative analysis (i.e. northern blot or qRT-PCR) could not be carried out due to loss of RNA 
sample to nuclease activity. RNA degradation during harvesting and storage of sample was 
not expected as all necessary precautions had been taken when extracting total RNA. In light 
of this, a new sample protocol was sought and assessed in order to preserve the integrity of the 
sample.
h t i m
* * *
tifritrg
Figure 13. RT-PCR analysis of dock genes in ES samples derived from Experimental Protocol Not ES dav-1 refers to samples harvested 24 h 
prior to serum pulse, ES day 0 refers to samples harvested during and within 24 hours of the serum pulse, ES day +1 refers to samples harvested 
24 -48 h after serum pulse was administered to cells. Time bins are identified within bottom monogram. 10fj.l of sample was run on a 2 % E-geltm 
(invitrogen, USA) against 250ng Phi-X/Haelll. DNA size markers (Promega, USA) and 5|+g of Commercial Total Brain RNA (positive clock gene 
control). Expected amplicon size refers to size of cDNA sequence amplified, from sample mRNA/cDNA pool, expected from the distance between 
primer pair.
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Figure 14. RT-PCR analysis of clock genes in ES samples derived from Experimental Protocol Not ES day-1 refers to samples 
harvested 24 h prior to serum pulse, ES dayO refers to samples harvested during and within 24 hours of the serum pulse, ES day +1 
refers to samples harvested 24 -48 h after serum pulse was administered to cells. Time bins are identified within bottom monogram. 
10pl of sample was run on a 2 % E-geltm (Invitrogen, USA) against 250ng Phi-X/Haelll. DNA size markers (Promega, USA) and 5pg of 
Commercial Total Brain RNA (positive dock gene control). Expected amplicon size refers to size of cDNA sequence amplified, from 
sample mRNA/cDNA pool, expected from the distance between primer pair.
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S iS  Discussion
Basal levels of melatonin remained within a constant range irrespective of incubation time 
suggesting the presence of active endogenous metabolic pathway. Alternatively, the melatonin 
synthesis pathway in Y79 cells could contain feedback mechanisms limiting melatonin output 
by thresholds gating mechanism possibly involving MT1. However, no rhythmic pattern of 
melatonin production was observed in any of the media systems, augmented by the serum 
pulse or following sustained culture (Figure 12). Interestingly, a ten-foid sustained difference in 
melatonin synthesis between those cells maintained on serum free and R15 media (Figure 12 
cf. Table 3) was observed. A number of explanations could account for this such as the 
induction of a quiescent state following withdraw of a source of growth factors. The serum 
pulse could have created a hypoxpic state (i.e. gross adjustment of oxygen potential of the 
media) sufficient to trigger cells to undergo apoptosis (Chow 1998). Under such conditions 
cells are known to downregulate specialised cellular activitie (these could include melatonin 
synthesis) thereafter entering a quiescent phase. However, if the hypoxpic conditions a 
reversed the cells may be rescued to a specialised state.
Apoptosis is a cellular process that limits; by means of a controlled programme of cell- 
destruction and disposal, proliferation of cell death to a foci of cells directly affected by the 
cytopathic event, it can be reversed if the cytopathic factors are removed at an early stage in 
the development of the apoptosis. The apoptotic prgramme, and destruction of the cell, is 
completed if hypoxyic conditions are sustained. The serum pulse given to Y79 cell under 
experimental protocol No1 did not appear, after comparing the cell counts for each treatment 
group, to increase the cell death rate (Figure 12). However, further analysis using 
immunocytochemistry (e.g. TUNNEL) would indicate whether; during, the serum pulse caused 
the cells to enter an apoptotic state or not.
A direct effect ot serum deprivation on melatonin synthesis has been previously reported to 
disrupt HIOMT transcription. Bernard et al in 1996 showed in differentiated and nativeY79 cells 
that serum free conditions but not selective dialysis of the serum component of media gave rise 
to a 50% drop in HIOMT transcription. The serum free or dialysed serum condition did not 
have any significant effect on AA-NAT transcription or enzymic activity and neuronai 
biochemical marker were found to be unaffected (cf. Table 3). However, the culture system 
was based on a suspension culture. They also failed to correlate the effects on serum on
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melatonin synthesis. I he data presented here would appear to complement and extend 
Bernard et a! (1996) work.
The data derived from experimental protocol No 1 documents the first attempt and assessment 
of clock gene activity in Y79 cells. The fact that these cells have all known constituents of the 
‘oscillator complex’ indicates that it has the potential to organise neuro-physiological process in 
a circadian manner. Unfortunately, without qRT-PCR or northern blot data a functioning 
oscillator could not be described. Combining this data with that outlined in Table 3 and section
1.6 provides more evidence that these cell in monolayer culture are of a photoreceptor 
phenotype. However, histological analysis of the samples under this experimental protocol was 
not carried out. A direct association between clock gene activity and melatonin synthesis could 
not be assessed.
6 The affects of the experimental media composition on Y79 
Retinoblastoma cells’ capacity to produce detectable levels of 
melatonin.
6,1 Introduction
Melatonin synthesis as assessed under experimental protocol No 1 demonstrated that 
monolayer Y79 ceiis are sensitive to a growth maintenance schedule. For instance, the media 
melatonin content in serum free (R-) medium was significantly lower than cells maintained on 
serum rich media. Experiment 1 protocol included 3 successive changes of media system over 
a 4 hour period. However, analysis of data failed to associate the suppression for melatonin to 
co-ordinate or compositional effects of any media change. To determine if these effects were a 
result of a media change or media composition Experimental Protocol No2 was designed.
This study attempted to differentiate the effects of serum supplemented media and 
consequences of media change on melatonin synthesis and clock gene expression in cells 
maintained as a monolayer culture entrained to a 12 hour light-dark cycle.
6.2 Materails
As described in section 3.1,3.2 and 3.5.
6.3 Method
Y79 cells used in this study were derived from a 5th passage suspension culture maintained, on 
RPMI 1640 medium supplemented with 15 % (v/v) (R15) or RPMI 1640 (R-). Cell cultures 
were placed on a 12 hr light-dark cycle 4 days before study to entrain any residue endogenous 
oscillator in these cell. Consequently, the sample harvesting protocol was referenced to this 
light cycle and the 4 hourly sample bin collected according to this protocol. Experimental 
growth flasks were coated with poly d-lysine and fibronectin (as described in 3.1) and were
4X
seeded with 1 x 1 0 6 single cell suspension (in R15 or R-), immediately before the light to dark 
transition point. These cultures were transferred into constant darkness that de-marked the 
start of the experimental period.
Experimental Protocol No2 essentially describes parallel cultures that differed in the serum 
content of the media system the cells were exposed to (R15 or R-). Baseline samples (R- and 
R15) were collected every 4 hours until the 24th hour of the experimental protocol.
Treatment was defined as replenishment of media on the 48th hour of the experimental 
protocol. Treatment samples were collected from the 48th to the 96th hour of the experimental 
protocol.
Two response measures were analysed from each sample (in duplicate); these being 
melatonin from media and clock gene expression from cellular sample. Sample components 
were immediately separated at the time of harvesting and processed as described in section
3.2 and 3.5.
CTO CTO
ScS -R 15
Cells were maintained on R15 media (blue Boxes) 
for 48 h. Samples (cell & media) taken from Ct 0 
on Day 2 and then harvested at 4 hourly intervals 
untill the 481*1 h. At CT 0 on day 3 media was 
replenished as illustrated by the blue arrow; 
samples were harvested at 49 h, 50 h and 52 h. 
Media was replenished, again, (blue arrow) and 
samples were, thereafter, taken at 4 hourly untill 
then end of the protocol.
Day1 Day 2 Day 3 Day 4
S cS -R H _______________________
Cells were maintained on R[-] media (green boxes) 
for 48 h. Samples (cells & media) taken from Ct 0 
on Day 2 and then harvested at 4 hourly intervals 
untill the 48th h. At CT 0 on day 3 media was 
replenished as illustrated by the green arrow; 
samples were harvested at 49 h, 50 h and 52 h. 
Media was replenished, again, (green arrow) and 
samples were, thereafter, taken at 4 hourly untill 
then end of the protocol.
Figure 15. Illustrates Experimental Protocol No 2 blue boxes represent a flask (and data point) in which cells were maintained on RPMI 1640 + 15% v/v FCS 
(R15), green boxes represent a flask (and data point) in which cells were maintained on RPM11640 media (R-). Arrows represent time points at which growth 
media was changed for fresh media. The experimental protocol and sample harvesting was conducted in constant darkness. References to circadian time 
(CT) were synchronised to Oh day 1 of the protocol. Samples were processed and response measures analysed once the final sample had been processed 
and stored for 24 h in the respective storage condtions.
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Melatonin content of samples harvested between 28th to 48th hour of the protocol maintained on 
R15 media was 158.5 pg/105 total cells/4 hrs with minimal difference between the parallel 
cultures (Figure 16 a). Samples derived from cells in serum free media produced a mean 13.9 
pg/105 total cells/4 hrs again with no apparent difference between parallel cultures (Figure 
16b). The observed 12-foiu difference in meiaionin uulpui between the different cuiiuie 
systems was consistent and in agreement with that observed under Experimental protocol No1. 
Immediately following medium change melatonin production in both media systems exhibited a 
30-60% drop in melatonin production. However, 4 hours following the replenishment of media 
melatonin synthesis in both culture systems restored melatonin output in both systems to 
previous level (cf Figure16 (a &b) & 12b). As observed in Experimental Protocol No1 melatonin 
content of the media did not resemble an accumulative profile. Interassay variance, 
determined by covariant analysis, of the RiAs used to aeiect meiaionin in the above sampies 
for both sample matrices was within the acceptable limits of this analytical method (Table 10 
&11).
Results
Q C sample Assay 7 Assay8 Assay9 Mean SD %
Pg/tube Pg/tube Pg/tube Pg/tube Pg/tube CV
5 8.4 7 9 8 5 4 6.9 1.99 28
25 25 39 29 30 23 29 29.2 5.5 19
35 69 39 36 37 40 41 44 12.5 28.7
Table 10. Interassay variance assessment of assays run against R15 FD matrix. Split cell represent melatonin detected before and after 
samples in a single RIA respectively (n=2). RIA standard curve R15-FD: Bo= 31%±1.3% (SEM), NSB 7.8±1% (SEM), LOD 1-2pg/ml.
QC sample Assay 10 Assayl 1 A ssa y l2 Mean SD %
Pg/tube Pg/tube Pg/tube Pg/tube Pg/tube CV
5 4 13 3 2 4 6.5 5.4 4 73.9
25 22 17 25 21 23 24 22 2.82 12.8
35 39 27 31 27 39 32 32.5 5.4 16.7
Table 11. Interassay variance assessment of assays run against R-FD matrix. Split cell represent melatonin detected before and after samples 
in a single RIA respectively (n=2). RIA standard curve R15-FD: Bo= 45%±4.3% (SEM), NSB 7±1% (SEM), LOD 1-2pg/ml.
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Figure 16. Effects of R[-] media replenishment on melatonin production (Graph B) and Y79 cell viability (Graph B) in a 
discontinuous culture system (n = 1).
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Figure 17 Effects of R15 media replenishment on melatonin production (Graph A) and Y79 cell viability (Graph B) in a 
discontinuous culture system (n = 1).
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Clock gene analysis confirmed the observations made during Experimental Protocol No 1 
(Figure 13 & 14) supporting the existence of a potential ‘oscillator complex’ in Y79 cells (Data 
not provided). Again progressive RNA degradation prevented quantative assessment of clock 
activity. A number of RNA extraction and quantitation protocols were evaluated first using rat 
liver then Y79 monolayer cells. During this trial a method was adopted for this Experimental 
Protocol No2 that yielded sufficient RNA and quality as assessed by RNA gel fractionation to 
be able to perform proposed mRNA profiling using northern blot and qRT-PCR techniques.
6.4 Conclusions
Experimental protocol No2 indicated that the suppression of melatonin observed in protocol 1 
was due to the change in relative media constituents of the media and not an artefact of media 
replenishment. The time interval between replenishment of media and recovery of baseiine 
melatonin levels was relatively short. Although direct analysis of the differential effects of the 
experimental design on melatonin synthesis pathway was not evaluated it appeared to support 
Bernard et al (1996) analysis.
Unfortunately, Experimental Protocol Nos 1 and 2 failed to reveal an active oscillator or rhythm 
in melatonin synthesis in this cell line.
im
7 Evaluation ©f 12 well plate format for future characterisation of Y79 
ceils
7.1 Background
Experimental protocols No 1 & 2 attempted to define the temporal characteristics of melatonin 
production and clock gene expression in Y79 cell (Figure 12-17). In those experiments cells 
were grown in 75 cm2 flask format. However, the isolation and analysis of RNA from those 
samples were inconclusive as nuclease activity was apparent (section 5.4 and 6.4.). Various 
anti-nuclease reagents and collection methods were found to mitigate to prevent degradation of 
RNA when piloted;but ali proved unsuccessful when used on an experimental scale.
1) Melatonin output is above the LOD of the modified saliva melatonin RIA.
2) Cell viability could be sustained in culture over a number of days.
3) Quality of RNA permits northern blot analysis and RT-PCR
7.2 Methods
Cell culture-scaled down cell culture system from 75 cm2 flasks to a multi-well format. Initially, 
a 6 well plate was trialed, however, the data from this study suggested that the growth format 
could be further reduced without compromising the above criteria. Cell density (0.5 x 105 
cells/well) and DMEM +10% dialysed-FCSmedia volume (1 ml) was proportionally adjusted to 
that used to culture cells in 75 cm2 flask growth area. The wells were seeded as described in 
section, from same passage of cells at a density to attain 50% confluence. Experimentation on 
the cells took place when the cells were 80% confluent. Basic microscopic examination of the 
cells under low powered inverted microscope was carrired out to determine the effect of this 
culture system on the general well-being of the cells. Sampling protocol consisted of entraining 
cells to alternating 12 h light 12 h schedule, cells were then maintained under constant 
darkness and media replenished when wells became sufficiently confluent (80%) with cells 
marking the commencement of the Experiment and demarked Time 0 h. Analysis of protein 
content, RNA, melatonin was carried out as described in section 4.3-5
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7.2.1 Melatonin analysis
Media was aspirated from celts using 2 ml syringe and hypodermic needle (gauge 21), to 
minimise disturbance to cells, and immediately frozen at -20°C until they were analysed. 
Samples were freeze-dried as described in section 4.2 and reconstituted in 110 jll! of DGDW. 
Melatonin analysis was carried out using 100 jal of reconstituted sample diluted in 400 jql of 
tricine buffer pH8 .0 using the modified saliva melatonin RIA as described in section 4.2 except 
that the sample buffer was reconstituted in DMEM-tricine buffer pH 8.0 (0.25:0.75).
7.2.2 Protein analysis of clock genes
Extraction of total protein from Y79 cells was done as described before except that the lysis 
buffer and homogenisation steps were carried out in situ. Cells were washed in 2 x 500 jul PBS 
and lysed/homogenised in M-PERlm extraction reagent. Protein from the homogenate was 
extracted using chloroform/methanol protocol as described before and resuspended in 0.1% 
SDS. Proteins were size fractionated using 11.3 % formaidehyde-SDS 5.5 x 8 x 0.75 cm 
protein gels as described in section 5. Protein samples from 2 wells were serially diluted, to 
check for accuracy of loading, in buffer such that a 15, 5,1 ug protein loading of each sample 
was run on a gel. Samples were heat-treated and denatured in equivalent volumes of loading 
mix containing mercaptoethanol and SDS. Gels were run in Tris base buffer until the coloured 
high molecular weight size marker bands were visibly separated. The resulting gel was 
immersed in Pierce GelCODE blue stain for 1 hour and bands were visibly separated. 
Separated proteins were transferred, by semi-dry blotter method, onto PDVF membrane using 
the Tris-methanol buffer system. Membranes were exposed to a buffer containing affinity- 
purified antibodies raised against hCLOCK, hPER1 and hPER2 in accordance with 
manufacturers instructions. Immunodetection of clock proteins was done using the Vectastain 
ABC kit immunoperoxidase method and enhance chemoluminesance technology as described 
in section 4.
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7.2.3 RNA analysis.
Cells were washed 2x in cold PBS, scrapped and homogenised in 100 ft TriZOL,m reagent in 
situ. The homogenate was transferred into 150ft chloroform and incubated for 5 minutes at 
room temperature. Aqueous layer was separated at 13,000 RPM for 10 minutes and RNA 
pelleted from the aqueous phase using isopropanol. RNA pellet was harvested at 13,000 RPM 
for a furhter 10 minutes and washed in 500 ft 75% ethanol, air dired and resuspended in a 
suitable volume of autoclaved miliQ water.
RNA samples were fractionated on a RNA formaldehyde denaturing mini-gel. Ihese 
concentrations of RNA from each sample were derived by serially diluting the sample in 
storage buffer (i.e. 10,5,1 jug). This was done to check for accuracy of loading and handling.
7.3 Results
7.3.1 M e la to n in  a n a ly s i s
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hours following replenishment of media (Figure 18b). The construction of the standard curve in 
reconstituted DMEM medium was as expected and compares to those described in section 5.4 
& 6.4. The entire contents of one well was only sufficient for single analytical point. Each time 
bin (4 h) was represented in triplicate (Figure 18-20) and expressed pg/mg protein; protein 
mass being determined from a well. The concentration of melatonin was comparable across 
the entire time sequence 160±0.14 pg/mg protein/24 hours.
7.3.2 Protein analysis
Total protein recovered from Y79 cells grown in a 12 well format after 24, 48, 72 and 96 h 
(Figure 19a). Protein mass did not shown a significant variance in mass of protein harvested 
across the time sequence; i.e 29.6±0.6 jug/well which was equivalent to 2.8+0.1 jixg/105 cells 
(n=12) (Figure 19a). Size fractionation of serially diluted protein samples (Figure 20a) was 
representative of expected amounts. Immunodection of hPER1 and hPER2 was achieved but
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required further optimisation ot detection method and comparison with expressed protein 
control (data not shown). However, detection of hCLOCK was unsuccessful.
7.3.3 R N A  a n a ly s is
Figure 21b shows good separation of all RNA species from each of the 12 wells. I.e. 18S, and 
28S rRNA band clearly separated around the middle half of the gel with mRNA smear between 
these 2 bands and faint tRNA band towards the bottom of the gel. This is indicative of good 
quality RNA with minimal nuclease activity. I he RNA bands in serially diluted sample wells, as 
expected, are relative in ethidium bromide staining to the dilution sequence
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Figure 18 Y79 cell viablity during the evaluation of 12 well plate format [Graph A], Cells were counted using a haemocytometer and dead five 
cells were distinguished using the trypan blue dye exclusion test. Assessment of protein content of cell harvested from 12 well format [Graph 
B] Data expressed as SEM n = 3.
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Figure 19. Melatonin production of Y79 monolayer cells grown in a 12 well format cutlure system over a 72 h period. Data 
expressed as SEM (n = 3).
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Figure 21 Panel (a) show the size fractionation of 5 pig total Y79 cell protein from well number 6 and 12. Panel (b) show size fractionation of total Y79 cell RNA 
Lane A RNA derived from 1 in 4 dilution of well 2, and Lane B 1 in 4 dilution of total RNA derived from well 4, Lane C1 is 10p.g Total Y79 cell RNA derived from 
lane 2, Lane C2 is 10pig Total Y79 cell RNA derived from well 4, Lane D1 is 1 in 2 dilution of 10pig Total Y79 cell RNA derived from Well 2, Lane D2 is 1 in 2 
dilution of 10pig Total Y79 cell RNA derived from well 4.
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Conclusions
The data set above indicates that the 12-well cell culture format would be a good experimental 
system to assess various treatment protocols on Y79 cells capacity to produce melatonin and 
RNA/protein clock gene profiles.
Detection of hPER1 and hPER2 proteins n the Y79 cell protein samples was achieved but does 
require further optimisation. The background noise in Figure was high indicating that the 
concentration of primary antibody should be lowered.
I he quality of KNA isolated in this study indicates that this culture format minimises the activity 
endogenous/exogenous nuclease in the extraction of RNA from Y79 cells. Furthermore, the 
study was run at a scale comparable to that planned in future experiments.
Little inter-well variance in the recovery ot RNA, protein or melatonin from this system was 
evident. In summary, this system will provide a convenient format to improve reproducibility, 
quality and throughput of analysis of Y79 cells.
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8 Melatonin synthesis in Y79 cells is sensitive to the composition of 
growth media.
8.1 Introduction
Reviewing the literature that has used this cell line as a toot to delineate the modality of 
melatonin synthesis it became apparent that baseline melatonin output between theses studies 
significantly varied (Table 3). A source of this variation in melatonin synthesis, upon reflection 
ot the maintainance schedules used in those studies was:
a) differing composition of the respective growth media (Appendix 1),
b) time in culture and the growth substrata matrix profile.
Data collected (Experimental protocol Nos 1 and 2) so far in this project has shown that:
a) altering one component of the growth media (namely serum) has a potent effect on 
melatonin output and
b) basal activity of Y79 cells, as measure by melatonin output, is rapidly restored (4-8hrs) 
following a treatment.
Ihese data, when combined, suggest that the growth parameters under which these cells are 
grown are critical to establish a baseline profile of the examined response measure prior to 
examination of any response of these ceils to a experimentai protocol.
In the following study composition ot the growth media was assessed. A growth media is 
choosen with respect to the cell type under study. Most commercially available growth media 
used for routine cell culture, such as RPMI 1640 or DMEM, contain the same mineral and 
growth promoting constituents profile. If the mass of any these constituents significantly varies 
or is at a supraphysioiogical concentration profound effects on the neuro-physiological plasticity 
of the cell line understudy can arise and give rise to anomolies in the pursuant data set.
I he glutamate content of the media used in the cited studies either was present in its p e r  s e  or 
derived d e  n o v o  form L-glutamine. The glutamate content of RPMI 1640 medium used in ail 
the studies discussed thus far was 136 jiM (Appendix 1 cf Table 13a & b). At this 
concentration both iGluR and mGluR receptor would elicit a response thus Y79 cells bathed in 
RPM11640 medium would receive sustained [suppressive or stimulatory] glutaminergic activity. 
The effect of glutamate in the Y79 cell, at these concentrations, could possibly moderate the 
regulation of endogenous neurotransmitter recycling processes potentially preventing the 
stabilisation ot a robust cell phenotype and/or induce the cell to enter apoptosis.
Glutamate as alluded to in section 1.8.4 is an important neurotransmitter throughout the retina. 
Glutamate has been shown in the rat pinealocyte cultures to be a negative modulator of 
melatonin synthesis (Schomerus et ai., 2002; Yamada et al., 1998; Yatsushiro et al., 2000a; 
Yatsushiro et al., 1999; Yatsushiro et al., 2000b). However, coordinated regulation of the 
pinealocyte and photoreceptor neuro-physiological tone is maintained by the contra-regulatory 
effects of two structurally distinct melatonin subtypes, namely the G-protein coupled 
metabotrophic glutamate (mGluR) and the ligand gated cation channel glutamate receptor 
(iGluR) (Table 13a & b) (Ishio et al., 1999; Takeda et a!., 2000; Yamada et al., 2002; Yamada 
et al., 1996; Yamada et al., 1998; Yatsushiro et ai., 2000a; Yatsushiro et al., 1999; Yatsushiro 
et al., 2000b).
Little is known about the role of glutamate in the regulation of melatonin synthesis in the retina; 
providing a further urgency to discover a competent retinal cell line; such as the Y79 cell. 
However, the story is more complete in the pineal gland a [cautious] model of retinal melatonin 
system. Rat pinealocytes are stimulated to produce melatonin via noradrenergic stimulation 
from the SCN. Pinealocyte sequesters extracellular L-glutamate via GLT-1 Na+ -dependent 
glutamate transporter and accumulates it in iGluRI sensitive microvesicles (Yamada et al., 
1997). Glutamate is secreted through an exocytic mechanism triggered by activation of iGiuRI 
(Ishio et al., 1999; Takeda et al., 2000; Yamada et al., 1998). Melatonin synthesis and AANAT 
activity is inhibited by tonic application ot glutamate to pinealocyte culture and can be mimicked 
by pharmacological stimulation of mGiuR3 (Ishio et al., 1999; Yamada et al., 1998; Yamada et 
al., 1997). Activation of mGluR3 has been shown to mobilise intracellular and extracellular 
Ca2+ stores resulting in the depression of cAMP production, consequently affecting the activity 
of PKA kinase on AANAT and CREM limiting the pool of AANAT to convert serotonin to N-
acetyl serotonin; i.e. resulting in suppression of melatonin output (Yamada et al., 1998; 
Yamada etal., 1997).
The pineal and retina in a number of species have been shown to [functional] express iGluR 
and mGluRs (see Table 13a & b). The actions of glutamate on those tissue and involvement of 
glutamate receptors on melatonin synthesis is not yet fully understood.
I he neuro-physioiogical role ot glutamate in the retina has only been documented tor image 
forming processes (Brandstatter, 2002). No study to date has investigated the glutaminergic 
control of melatonin synthesis in the retina. Takeda et al (2000) described the functional 
expression of iGluR on the Y79 cell melatonin synthesis and calcium homeostasis (Table 13a). 
The data from this study suggested that glutaminergic control of photoreceptor melatonin 
synthesis might be similar to that described for the rat pineal. However, this paper failed to 
describe the effect of iGluR agonists and its response to mGluR pharmacology on melatonin 
synthesis.
Topical administration of glutamate has been shown to phase shift electrophysiological rhythms 
in SCN slice culture that mimic the effects of light (Hannibal et al., 1998; Mintz et al., 1999). 
Recently, a number of studies have attempted to simulate these effects in the SCN to identify 
the photoentrainment target within the molecular oscillator (Akiyama et al., 1999a; Akiyama et 
al., 1999b; Tamaru et al., 2000). Glutamate was found to potential the negative limb of the 
oscillator through induction of mperlexpression and proteolytic reduction of BMAL1 (Akiyama 
et al., 1999a; Akiyama et al., 1999b; Tamaru et al., 2000). The exact biochemical mechanism 
remains unknown. Although, the cited studies used NMDA as the glutamate analog suggesting 
that the photoentrainment signal is transduced via an intracellular signalling pathway 
downstream of the NMDA receptor (Tamaru et al., 2000) (Akiyama et al., 1999a; Akiyama et 
al., 1999b). However, SCN like the pineal and the retina functionally expresses both mGluR 
and igluR that are known to co-ordinately regulate the autocrine activities of glutamate (Chen 
and van den Pol, 1998; Haak, 1999; Liu et al., 2001; Park et al., 2003). It therefore remains to 
be determined whether mgluR participate in modulating specific components of the oscillator to 
augment glutamate (or light) dependent entrainment of the clock (Tamaru et al., 2000) 
(Akiyama et al., 1999a; Akiyama et al., 1999b).
I I A
Photoreceptor cells actively sequester glutamate from the extracellular space through 
specialise GLUT Na- exchange transporters and are capable of endogenously synthesising 
glutamate from L-glutamine (Redburn et al., 1992; Voaden and Morjaria, 1980).
A study was set-up to determine (a), glutamate content ot the growth media used in 
experimental protocols No 1 & 2 suppressed Y79 ceil melatonin synthesis (b).Continuous 
exposure to glutamate affected clock gene expression (c) the contribution of mGluR 3 to 
melatonin synthesis.
The rationale for experimental protocol No3 was based on the known suppressive effect of 
glutamate, via mGluR 3, on adenylate cyclase and cAMP; an important component of the 
melatonin synthesis pathway, as reported in rat pinealocyte studies. (25, 2’R, 3’R)-2-(2’,3’- 
dicarboxy-cyclopropyl) glycine (DCG-iV) was selected as the most appropriate agonist (Brabet 
et al., 1998). DCG-IV is a specific agonist of mGluR 2 & 3 and antagonist of all other known 
mGluRs and iGluRs (except NMDA receptors) (Table 13). Its activity at these receptors is such 
that low doses can be used to elicit an effect avoiding the cytopathic effects of glutamate (and 
analogues) on Y79 cells (Takeda et al., 2000). The neurotoxic effects of glutamate have been 
attributed to stimulation of iGluR, either: triggering apoptosis or if the dose is sufficiently high 
necrosis (lentile et al., 2001; Kwong and Lam, 2000; Linden, 2000; Linden et ai., 1996; Naskar 
and Dreyer, 2001; Rocha et al., 1999; Villani et al., 1997). Interestingly, stimulation of various 
mGluRs, particularly mGluR 3, rescues cells from the glutamate-induced apoptosis (lentile et 
al., 2001; Kwong and Lam, 2000; Linden, 2000; Linden et al., 1996; Naskar and Dreyer, 2001; 
Rocha et al., 1999; Villani et al., 1997). Takeda e t  al (1999) data could therefore be explained 
by neurotoxic mediated mechanism rather than direct effect on melatonin pathway. DCG-IV 
should therefore provide data reflecting specific activation of group II mGluRs with little 
biochemical noise associated with other GluRs.
Experimental Protocol No3 essentially took the form of a classical dose response curve that 
should reveai whether or not Y79 cells functionally express and chronically respond to DCG-IV. 
This protocol differed to Experimental Protocols No 1 & 2 in that the media system was 
composed of DMEM and diaiysed FCS (Appendix 1) requiring L-glutamine as a source of 
glutamate. Melatonin synthesis was enhanced by stimulating the cells with the adenylate 
cyclase activator forskolin permitting analysis of a full drug dose range on Y79 cell. The
n«i
rationale tor using torskolin to amplify melatonin production was (a) reveal subtle effects ot 
DCG-IV on Y79 cell melatonin synthesis and (b) determine whether the DCG-IV and therefore 
mgluR3 modulation of Y79 cell melatonin synthesis was cAMP dependent.
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Table 12a & b Compares the iQuR (Table A) and mGluR (Table B) receptors identified in tissues known to possess chronotrophic properties 
and indicating the level of DCG-IV bioactivity. (mGluR data adapted from (Godwin et al., 1996; Mis try et al., 1996), Godwin 1996 and * from 
Experimental protocol 3 study ). Data adapted from Takeda 2000 and www.Tocrisco.uk. [+] positive immunoreactivity and detection of mRNA 
transcript of various subtypes in respective tissues. ? refers to unkown expression of receptor subtype at protein or gene level.
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8.2 Material.
Cell culture and response measure analysis as described in section 4.1 to 4.5 respectively. 
DCG-IV was obtained in its’ desiccated form from Tocris Chemicals, UK. Forskolin also 
purchased in its’ desiccated from Sigma Chemicals.
8.3 Method.
Y79 cells were maintained as a suspension culture on DMEM +10% dialysed FCS 
supplemented with 2mM L-glutamine (D10d) 7 days prior to experimental protocol. 
Experimental protocol No.3 was carried out as a monolayer culture seeded on to poly d-lysine- 
fibronectin coated (as described in section 3.1) 12 well plates at a density of 500,000 single 
cells per well and maintained on 1 mL D10d. Cells were allowed to acclimatise to the 
experimental vessels for 4 day. Drug treatment was prepared from stock solutions as batches 
in D10d to ensure homogeneity of drug delivery. Administration of drug was carried at the 
same time (17:00hrs GMT) for each replicate experiment 5 minutes before addition of 10 mM 
forskolin in sequence to drug administration. The format of the response curve was identical in 
each replicate experiment and included a 2 x baseline samples, forskolin control (+ vehicle) 
and a series of wells devoted to determining the total protein content of cells. Each dose point 
was carried out in triplicate. Treatment period was terminated 24 hrs after administration of 
drug; samples were harvested and processed as described in section 3.2 and 3.3 to 3.5 
respectively. Each dose response curve was replicated 6 times.
8.4 Results
A significant pharmacological response to a bolus dose (10 mM) of DCG-IV on forskolin 
stimulated Y79 monolayer cultures was observed (t-test p=0.053) to have a suppressive effect 
on melatonin synthesis. RT-PCR analysis of mGluR in untreated Y79 cells maintained on 
D10d repeated revealed the expression of mGluR 3 and 7 (cf Figure 24 & 25 to Table 12).
Total protein mass between each experiment did not vary significantly (33±4 |qg protein SEM 
n=6) (Figure 22b) and is supported by cell harvesting efficiency data (Figure 22a).
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Interestingly, Figure 22a either shows that the viability of cells across a dose range was similar 
to the negative control group and unaffected by any cytopathic effects of DCG-IV treatment.
Six dose response curves were then set-up to derive figure 24 data set. Each sample set was 
assayed with same batch of QC samples to determine the reliability of the assay (Table 13). 
Basal levels of melatonin (n=6) were 116±26 pg melatonin /mg protein/24 hrs (Figure 23a). 
Forskolin stimulated cells produced melatonin that ranged over 978 ±113pg melatonin/mg 
protein/24 hrs (Figure 23a). Of the 6 dose-response curves 4 experiments recorded almost 
identical melatonin output profiles (cf 23b & 24). Magnitude change in melatonin production 
compared between negative and positive control groups is in aggreement with previous studies 
(cf Figure 23a & Table 3). There was no significant difference (t-test, p=0.05, n=6) between the 
basal and 1e-5 M DCG-IV data sets. However, a significant difference (t-test, p=0.05, n=6) 
was observed between forskolin and the 1e-9 M data sets.
Each dose response curve graphically appeared to show that DCG-IV had a pharmacological 
effect on Y79 cell monolayer melatonin synthesis (Figure 24). However, the form of the 
steepness of the response appeared to differ. Calculated EC[5oj dose ranges between the 
different curves were similar with mean calculated pEQso] 7.04 (ECpoi = 9.1 x 108M). DCG-IV 
drug activity did appear to be apparent at the lower concentration (nM) range of DCG-IV 
(Figure 23 & 24).
Table 13 Interassay variance assessment < 
in a single RIA respectively (n=2).
! run against D10d matrix. Split cell represent melatonin detected before and after samples
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Figure 22 Graph A: Viability of Y79 cells during the DCG-IV dose response experiments. Each data point represents trypan 
blue exclusion assay data on cells taken from each treatment group (n =3). Graph B : Total mass of protein harvested from 
DCG-IV experiment. Data expressed as SEM n = 3.
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Figure23. Graph A: Compares basal (Purple) and Forskolin stimulated (Blue) Y79 monolayer cells in DCG-IV experiments. 
Graph B: Mean of 6 individual DCG-IV-Y79 monolatyer cell dose response curves. Response measure is melatonin production 
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8.5 Conclusion
Basal melatonin output of these cells using glutamate free media was much higher 
(retrospective theoretical analysis) than measured in previous studies. However, a direct 
comparison between cells grown in R-, R15 and D10d would have to be done to confirm this 
analysis. The RT-PCR profile of the mGluR receptor family has a similarity to that exhibited by 
the rat retina (cf Figure 25-26 & Table 13). Glutamate is a key neurotransmitter in the retina. 
The function and response of glutamate between the various specialised retinal neuronal 
subtypes, in the retina, is unique to that subtype and reflected in their glutamate receptor 
profile. It would appear that the basal mGluR profile of Y79 monolayer cells shown in Figure 23 
represents a particular cell phenotype; but again without a comprehensive histological survey 
of these cells this can not be confirmed. The dramatic effect of the bolus dose on forskolin 
melatonin synthesis suggests that DCG-IV (and therefore glutamate) is a result of a receptor- 
specific process and not a synergist or passive event. Tying the pilot melatonin data to the 
genetic analysis of mGluR it would appear that the candidate receptor is mGluR3.
DCG-IV is a potent and highly selective mGluR agonist; and antagonist. The dose response 
data appears to show DCG-IV-induced suppression Y79 cell melatonin synthesis that 
corresponds classical dose response model which is not associated with an increase in cell 
death. A direct association between DCG-IV; therefore mGluR3, and melatonin synthesis in 
these cells can be not be reported untill the response of Y79 melatonin synthesis to DCG-IV 
can be shown to be:
a. reversed with mGluR 3 antagonist,
b. correlative analysis of DCG-IV ±antagonist (±pertusis toxin) on AANAT (& HIOMT) 
transcription and gene product expression and cAMP/Ca2+has been conducted;
v  * 7 c. negative for mafl&rs of cell death (e.g. cysteine protease p32) or using such assays as 
TUNNEL to assess the intergrity of the genome.
However, the specific and robust expression mGluR 3 and not mGluR2 strongly suggest that 
the suppressive effects of DCG-IV (and maybe media supplemented glutamate) targets 
mGluR3 mediated pathway. Comparing the basal and forskolin ±DCG-IV data from both the 
pilot and experimental data suggests that the [possible] interact between DCG-IV:mGluR3 in
12S
Y79 cell melatonin synthesis pathway affects adenylate cyclase activity (evident even at the 
lowest dose). However, this would have to be confirmed by cAMP analysis.
The data from this study has shown Y79 melatonin production to be acutely sensitive to a 
glutamate agonists. In addressing the aims (and concerns) of this project it would appear that 
the glutamate content of the media in previous study could have dampened melatonin 
synthesis. The concentration in the RPM11640 media if depleted by 10 fold still would fall into 
a pharmacoactive dose to activate mGluR 3. Only the effects of a glutamate agonist on 
melatonin synthesis has been assessed here. However, exposure of other cell processes 
regulated by the glutamate receptors characterised in this project and in table 9 could be 
similarly affected. It is therefore plausible to conceive; when reflecting on published cytological, 
biochemical data, that these cells under the recommended ATTC maintenance guidelines are 
burdened by glutamate stimulus. It would be interesting to determine if these cells could 
produce melatonin in a rhythmic manner after being acclimatised to a glutamate free media. 
Sustain own neurotransmitter signalling and recycling.
The aims in set out in section 8.1 were not completed. To confirm mGluR 3 actively regulates 
melatonin synthesis in Y79 cell culture a reversal study using an appropriate mGluR3 
anatagonist using the calculated ECpo] DCG-IV dose assessing the camp status of the cells. 
Furthermore, clock gene expression in monolayer cells acclimatised and maintained on D10d 
media, ± serum pulse and compared to the other media systems has to be assessed to full fill 
the aims of this study and project.
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